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Abstract
Whole body modelling of glucose metabolism in malaria
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K. A. Green
Department of Mathematical Sciences
University of Stellenbosch,
Private Bag X1, Matieland 7602, South Africa.
Thesis: MSc BSc (Math Sc)(Bio-math)
March 2017
Diagnosing a patient with a disease is typically done by considering a list of clini-
cal symptoms. For severe malaria two of the key pathophysiological indicators for
poor chances of survival are hypoglycemia (blood glucose < 2.2 mmol/L) and lactic
acidosis (blood lactate > 5 mmol/L). These could be due to accelerated glycolytic
flux (conversion of glucose to lactate) in parasite infected red blood cells, anaemia
brought about by the parasites destroying the red blood cells, or reduced perfu-
sion resulting from coagulation of red blood cells (parasites change the red blood
cell shape) in the bloodstream. To date, no mathematical models exist that can
quantify the relative contribution of increased glycolytic flux to hypoglycemia and
lactic acidosis. In this study we constructed a physiologically relevant model of
human glucose metabolism that contains the molecular mechanisms of erythrocyte
and Plasmodium glycolysis. This allows for the investigation of the extent to which
hypoglycaemia and lactic acidosis can be explained by the increased metabolic bur-
den of the parasite. This was accomplished by combining three independent models
of glucose metabolism in the parasite, red blood cell and the whole body to form
a model of glucose metabolism at the level of the whole body that now contained
mechanistic detail of reactions at the level of the red blood cell and malaria parasite
(the green1 model). Predictions from the green1 model were compared to clinical
data which showed that the increased glycolytic flux caused by the presence of the
parasites could be sufficient to explain clinical symptoms of hypoglycemia and lactic
acidosis seen in malaria patients. It was seen that for the strength of this mod-
elling technique to be tested, better quality data are needed to validate the model
ii
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predictions. Furthermore with local and global sensitivity analysis it was observed
that there are reactions and parameters in the Plasmodium glycolysis pathway that
could guide the development of possible drug targets that could lead to a reversal
of hypoglycemia and lactic acidosis.
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Uittreksel
Whole body modelling of glucose metabolism in malaria
patients
K. A. Green
Department of Mathematical Sciences
University of Stellenbosch,
Private Bag X1, Matieland 7602, South Africa.
Tesis: MSc BSc (Math Sc)(Bio-math)
Maart 2017
Diagnose van ’n pasiënt met ’n siekte word tipies gedoen deur die oorweging van
’n lys kliniese simptome. Vir ernstige malaria is twee van die belangrikste patofi-
siologiese aanwysers vir swak kanse op oorlewing hipoglukemie (bloedglukose <2.2
mmol/L) en laktaatversuring (bloed laktaat> 5 mmol/L). Dit kan wees as gevolg
van versnelde glikolitiese fluksie (omskakeling van glukose na laktaat) in parasiet-
geinfekteerde rooibloedselle, bloedarmoede teweeg gebring word deur die verniete-
ging van rooibloedselle deur parasiete, verminderde perfusie as gevolg van koagulasie
van rooibloedselle (parasiete verander die rooibloedselle se vorm) in die bloedstroom.
Tot op datum, bestaan geen wiskundige modelle wat die relatiewe bydrae van ver-
hoogde glikolitiese vloed te hipoglukemie en laktaatversuring kan kwantifiseer. In
hierdie studie het ons ’n fisiologies relevante model van menslike glukose metabo-
lisme gebou wat die molekulêre meganismes van direritrosiet en Plasmodium glikolise
bevat. Dit maak voorsiening vir die ondersoek na die mate waarin hipoglukemie en
laktaatversuring verduidelik kan word deur die verhoogde glikolitiese las van die
parasiet. Dit is bewerkstellig deur die kombinering van drie onafhanklike modelle
van glukose metabolisme in die parasiet, rooibloedselle en die hele liggaam om ’n
model van glukose metabolisme te vorm op die vlak van die hele liggaam wat nou
meganistiese besonderhede van reaksies vervat op die vlak van die rooibloedsel en
malariaparasiet (die green1 model). Voorspellings van die green1 model is verge-
lyk met kliniese data wat toon dat die verhoogde glikolitiese fluksie wat veroorsaak
word deur die teenwoordigheid van die parasiete voldoende is om kliniese simptome
van hipoglukemie en laktaatversuring gesien in malaria pasiënte te verduidelik. Dit
iv
Stellenbosch University  https://scholar.sun.ac.za
UITTREKSEL
is gesien dat vir die krag van hierdie modelle tegniek om getoets te word, ’n be-
ter gehalte data benodig word om die model voorspellings te versterk. Verder met
plaaslike en globale sensitiwiteitsanalise is dit opgemerk dat daar reaksies en para-
meters in die Plasmodium glikolitiese pad is wat lig kan werp op die ontwikkeling
van moontlike dwelm-teikens en sodoende kan lei tot ’n ommekeer van hipoglukemie
en laktaatversuring.
v
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Chapter 1
General Introduction
Malaria is a mosquito-borne infectious disease that has created major public health
concerns particularly in the developing world. While accurate estimates on the pre-
cise number of deaths caused by this disease are unreliable [4], we do know it affects
many children in sub-Saharan Africa with at least 236 000 deaths in 2015 [5]. In
May 2015 the World Health Assembly accepted the Global Technical Strategy for
Malaria 2016-2030 which shares goals with the Roll Back Malaria Partnership. This
strategy outlines goals and targets for the next few years that are required for re-
ducing and ultimately eliminating malaria incidence. It is outlined that a challenge
would be the use of effective antimalarials and innovation to develop vaccines. Cur-
rently artemisinin is the most commonly recommended prophylaxis but it is only
administered in combinations with other compounds due to the fear of parasite re-
sistance (as was seen with a previously frequently used anti-malarial chloroquine)
[6]. Adverse effects of artemisinin include nausea, vomiting, anorexia, and dizziness
[7]. Parasite resistance to antimalarials has created a demand for a continued effort
to identify new possible drug targets that could lead to more effective treatment
(with fewer side-effects).
The malaria parasite has a multi-stage life cycle using both human and mosquito
hosts. During the bite from an infected female Anopheles mosquito the parasite
(in sporozoite form) is transmitted into the bloodstream of the human host. These
sporozoites then move to the liver where they infect hepatocytes and begin to divide
asexually into merozoites. These merozoites can invade more hepatocytes or can
move into the bloodstream where they invade red blood cells, causing the clinical
symptoms observed in malaria patients. Merozoites that invade red blood cells
then grow into immature trophozoites (ring phase) that can either develop into
mature trophozoites or gametocytes. Mature trophozoites divide asexually to form
a schizont (multinucleated) which divides further into mononucleated merozoites.
This results in the rupturing of the red blood cell and release of merozoites that are
free to invade other red blood cells. This releasing of merozoites is the cause for the
fevers associated with malaria. If the immature trophozoites form gametocytes, they
are be taken up from in the blood stream through a blood meal by the Anopheles
mosquito and move to its gut. Next, the gametocytes fuse and after a number of
intermittent phases form sporozoites. These sporozoites move to the salivary glands
1
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of the mosquito and are injected into the human bloodstream during a bite. The
life cycle then repeats.
There are five Plasmodium spp. that cause malaria in humans but for this work only
Plasmodium falciparum, the most lethal (responsible for most malaria deaths [8])
of the Plasmodium species, is considered (in the trophozoite phase). Plasmodium
falciparum does not have carbohydrate reserves and relies solely on the human host
for glucose. Once it has invaded the erythrocyte it transports glucose across its
membrane which undergoes a multiple-step catabolism in a glycolytic pathway that
closely resembles that of the human erythrocyte. A by-product of this metabolic
pathway is lactate which is transported out of the parasite cell into the red blood
cell (RBC). Thereafter the lactate is transported from the red blood cell into the
blood stream.
Severe malaria is often accompanied by hypoglycemia (low blood glucose concentra-
tions) and lactic acidosis (high blood lactate concentrations). A number of different
factors can contribute to these clinical symptoms: accelerated glycolytic flux (con-
version of glucose to lactate) in parasite infected red blood cells, anaemia, or reduced
perfusion (blood flow). The anaemia could be caused by the parasites destroying the
red blood cells. Infection by Plasmodium falciparum causes a change in red blood
cell shape that results in the coagulation of RBCs from the bloodstream which re-
duces perfusion. This leads to less oxygen being transported in the bloodstream
to tissues. This creates an anaerobic environment which results in an increase in
the production of lactate (rather than oxidative metabolism) by the body itself,
amplifying the problem of high blood lactate. Although hypoglycemia and lactic
acidosis are clinically diagnosed at the whole body level, they occur due to molecular
mechanistic effects of the malaria parasite’s interaction with the host.
So too will any effect that a drug has on the disease, clinically manifest at the level
of the whole body, but be a result of a molecular effect of the drug. A quantitative
understanding of malaria symptoms as they emerge from the complex network of
enzyme catalyzed reactions of the parasite and human host could therefore not only
facilitate a deeper understanding of the pathophysiology of the malaria disease state
but also assist in the identification of possible drug targets. Such a quantitative
understanding could be obtained by linking a model that describes the relevant
features at the whole body level, to a model that contains the molecular mechanisms
of the relevant cells and parasites in the body.
One of the objectives of this project is to link an existing model that describes whole
body glucose metabolism in humans with a detailed kinetic model for Plasmodium
glycolysis and human erythrocyte glycolysis into a multi-level hierarchical frame-
work. This will allow us to test to what extent accelerated glycolytic flux in red
blood cells contributes to hypoglycemia and lactic acidosis by considering different
levels of parasitemia. Model analyses can further lead to the identification of drug
targets and the mechanistic explanation of the effects of pharmaceutical intervention
at the whole body level.
2
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The research question is:
Can we merge three existing kinetic models for glucose metabolism in Plasmodium
falciparum, red blood cell, and whole body Homo sapiens and use the resulting
model to estimate the contribution of Plasmodium falciparum to hypoglycemia and
lactic acidosis in malaria patients?
Aims:
1. Construct a multi-level model of human glucose metabolism that contains the
molecular mechanisms of erythrocyte and Plasmodium glycolysis.
2. Simulate to what extent an increased parasitemia leads to an increased utilisa-
tion of glucose and production of lactate, taking into account the homeostatic
mechanisms for glucose and lactate at the whole body level.
Objectives:
• Identify existing mathematical models that sufficiently describe the compart-
ments that will be needed
• Combine and make necessary adjustments to existing mathematical models
to create a framework that describes whole body glucose metabolism in a
hierarchical manner
• Compare predictions from the newly constructed mutli-level model with ex-
perimentally measured blood glucose and lactate in the disease state
• Identify the reactions that are most crucial in generating the predicted outcome
or point at important steps in the model using e.g. Metabolic Control Analysis
(MCA)
This thesis is structured in the following way:
A literature review is presented in Chapter 2. Chapter 3 consists of three sections.
In the first section, we present the original models for the i) parasite model [1],
ii) the red blood cell model [9–11] and iii) the whole body model [3] with initial
validations (steady state analysis, plots, etc.). In the second section the linking of
the parasite with the red blood cell model (done by Du Toit [2]) to create a model
of parasitized red blood cell is presented and extended to describe a parasitized red
blood cell culture with varying degrees of parasitemia. The third section of Chapter
3 explains the linking of the extended parasitized red blood cell culture model with
the whole body model including a description of changes that were made to combine
the two models (called the green1 model). Chapter 4 consists of two sections: In the
first section we present the validation of the combined green1 model with available
data from the scientific literature; the second section shows the results of sensitivity,
robustness and control analysis applied to the green1 model. Lastly, Chapter 5
3
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consists of a discussion of the results and outlines the limitations of the model,
concluding remarks and suggestions for future work.
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Chapter 2
Literature Review
In this thesis we intend to construct a physiologically relevant model for human
glucose metabolism that can describe certain features of the disease state of malaria
patients in terms of molecular mechanisms at work in the malaria parasite and its
interaction with the human erythrocyte. Diagnosing a patient with a disease is typ-
ically done by considering a list of clinical symptoms. For severe malaria two of
the key pathophysiological indicators for poor chances of survival are hypoglycemia
(blood glucose < 2.2 mmol/L) and lactic acidosis (blood lactate > 5 mmol/L) [12].
Accelerated glycolytic flux in infected red blood cells [2], anaemia [13] and reduced
perfusion [14] have been observed experimentally, but to date there are no mathe-
matical models that are able to quantify their relative contributions to hypoglycemia
and lactic acidosis. While these metabolic complications are likely to be caused by
a combination of factors we intend to investigate the extent to which accelerated
glycolytic flux leads to hypoglycemia and lactic acidosis.
In this chapter we give a brief description of the biological processes, including the
functions of major organs, that play a crucial role in whole body glucose metabolism.
Thereafter different modelling approaches used to study metabolism and disease
states are described. These include mechanistic, phenomenological, pharmacoki-
netic, pharmacodynamic, multi-scale and multi-level modelling techniques. We then
present a literature review on the different models available for each of the studied
levels, in the construction of the hierarchical framework. Lastly a description of
sensitivity analysis that is used to analyse and verify accuracy of model predictions
is given.
2.1 The biology of whole body glucose metabolism
in humans
Whole body glucose metabolism consists of multiple metabolic pathways interacting
with each other in different parts of the body. It is a comprehensive network and can
be complex when considering all the biological detail associated with it. Therefore
we will provide a brief discussion (that follows from D. Voet & J. Voet [15]) on
some of the key tissues and organs, including the metabolic pathways associated
5
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2.1. The biology of whole body glucose metabolism in humans
with each in an attempt to explain human glucose metabolism. A realistic model
of whole body glucose metabolism should contain descriptions of as many of these
components as possible.
The main source of energy in the brain is glucose. Since it is unable to store
glucose it depends on a continuous supply to sustain brain functioning [16]. During
periods of starvation the brain switches to using ketone bodies. Most of this energy
is required for the brain to maintain the sodium potassium membrane potential
allowing for nerve pulses to be transmitted [16]. The glucose transporter (GLUT-3)
transports glucose into the brain cells where it is metabolised via glycolysis. The
brain can not utilise fatty acids as an energy source because they are unable to
cross the blood-brain barrier [16]. This results in the brain consuming about 20%
of the whole body glucose [16]. In cases of hypoglycaemia, which can be caused
by an insulin overdose or, in the context of this study, the increased demand on
blood glucose by the malaria parasite, the individual could become comatose, suffer
irreversible organ damage or die.
Muscle tissue also relies on glucose and ketone bodies as a fuel source but unlike
the brain it can metabolise fatty acids and store excess glucose as glycogen. Glucose
is broken down by glycolysis resulting in the formation of pyruvate which can lead to
the production of lactate under anaerobic conditions. Muscle tissue can not export
glucose; however during the energy deprived states muscle glucose can be converted
to alanine which is then transported to the liver. Once at the liver, the alanine
is converted back to glucose that is released into the bloodstream. This process is
known as the glucose alanine cycle. However, in resting muscle tissue fatty acids
are the main source of energy [16]. In particular, the heart muscle (when "resting"),
relies mostly on fatty acids for energy but can also metabolise ketone bodies and
lactate if needed.
The liver, which is about 2-4 % of a persons body weight [16], is responsible for
regulating many metabolic activities. After a carbohydrate containing meal, the glu-
cose levels in the blood rise. This glucose is transported into the hepatocytes where
it is converted to glucose-6-phosphate after which it stored in the form of glyco-
gen. Importantly, insulin is not required for the uptake of glucose in hepatocytes
unlike the insulin dependent muscle cells and adipose tissues. During starvation the
glycogen stores in the liver are utilised (via gluconeogensis) to replenish the glucose
concentrations in the blood thereby maintaining homoeostasis.
Another function of the liver, when the energy supply is abundant, is to synthesize
fatty acids and export them into the blood stream. These fatty acids, in the form
of lipoproteins, then move towards the adipose tissue where they are stored. In
contrast, during periods of fasting the fatty acids are converted into ketone bodies
and exported into the circulatory system.
Muscle tissue and the liver work together to maintain glucose homeostasis in the
body. To elaborate on the role of the liver let us consider anaerobic metabolism for
muscle cells. The product of glucose metabolism in the absence of oxygen is lactate.
6
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2.1. The biology of whole body glucose metabolism in humans
This metabolite is exported from the muscle tissue into the blood and moves to the
liver where it is imported and undergoes gluconeogensis (to produce glucose) and
lipogensis (formation of fatty acids) as well as oxidative phosphorylation (producing
ATP).
In addition to these specialised functions the liver also plays a crucial role in amino
acid metabolism however this will not be discussed in the current work.
Even though the liver is the major tissue responsible for fatty acid synthesis, fatty
acids are stored in the form of triacylglycerols in adipose tissue. Adipose tissue
can not take up triacylglycerols and therefore relies on the lipoproteins exported by
the liver [16]. The low density lipoproteins are hydrolyzed through stimulation from
the hormone insulin releasing free fatty acids. In the adipose cells they reassemble to
form triacylglycerols. When energy is in demand triacylglycerols are hydrolyzed to
fatty acids and glycerol through regulation by the hormones glucagon, epinephrine
and insulin [16]. Glycerol is released and exported to the liver while the product
glycerol 3-phosphate, derived from the esterification of a fatty acid, is released into
the blood stream [16].
The last organ that will be briefly discussed is the kidney. The main function of
this organ is to filter out waste products from the blood [16]. Metabolites such as
glucose are filtered out of the blood and reabsorbed by the kidney. The kidney
excretes excess H+ ions (in the form of urea) allowing for the pH balance in blood
to be maintained. During starvation gluconeogenesis occurs in this organ leading to
almost half of the glucose supply in the bloodstream [16].
The balance between different fuel sources, their formation and their excretion by
different tissue types, is regulated by a number of metabolites and hormones. For
the present study we will briefly describe how the hormones insulin, epinephrine and
glucagon regulate glucose levels in the body.
When blood glucose levels are high, beta cells in the pancreas secrete insulin into the
blood stream. This hormone causes the uptake of glucose from the blood into the
liver, muscle and adipose cells. These tissues are known as insulin dependent tissues
while the brain, kidney and red blood cells do not require insulin for glucose uptake
and are therefore insulin independent. In constant, when blood glucose levels are low
the alpha cells in the pancreas secrete the hormone glucagon. Glucagon stimulates
the release of glucose from the liver through the regulation of gluconeogenesis and
glycogen degradation. Epinephrine, also known as adrenalin, has a similar role to
that of glycagon. It regulates the release of glucose to restore blood glucose levels
and it usually activated in "fight or flight" responses which require a sudden burst
of energy. These hormones work together to carefully maintain glucose homeostasis
in the body.
In the next section we will introduce systems biology models as a tool to integrate
multiple components, such as body organs, to analyse overall systems behaviour,
such as whole body physiology.
7
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2.2. A mechanism based whole body model
2.2 A mechanism based whole body model
Models of whole body physiological processes are typically not formulated in terms
of intra-cellular molecular mechanisms but with phenomenological descriptions of
whole-organ or whole-cell level processes. This is usually sufficient to describe clin-
ical features at the whole body or organ levels. Models that use phenomenological
functions to describe observables are usually only valid under the conditions for
which the model was constructed since model parameters contain no information
on how they are dependent on surrounding conditions. Such models are therefore
limited in terms of predictive power. Phenomenological models do not contain infor-
mation at the enzyme level therefore they cannot be used to accurately predict drug
effects. In addition, when trying to understand the clinical features of a disease state
as an emergent property of complex molecular networks on the sub-cellular level,
these models need to be extended to contain the molecular mechanistic detail of the
metabolic networks in the organs or compartments of interest. In the context of
the current discussion, hypoglycemia and lactic acidosis associated with the malaria
disease state are clinically described at the level of the whole body. These conditions
are brought about by changes at the level of the enzyme catalyzed reactions in cells
related to glycolysis and lactate production. A hierarchical model that links the
features of the whole body to these detailed molecular mechanisms would therefore
greatly assist in understanding disease causing mechanisms in the malaria parasite
and point to possible drug targets.
Our construction of a whole body model that describes glucose metabolism in
malaria patients and contains the detailed molecular mechanisms of the most im-
mediately relevant cellular components, will employ three existing models: a Plas-
modium falciparum parasite glycolytic model, a red blood cell glycolytic model and
a model of whole body glucose metabolism. Knowing how much detail each model
should have can be challenging: since we are ultimately interested in understanding
the molecular reasons for the appearance of the disease state and identifying molec-
ular drug targets, the lower levels that are directly related to the metabolism of the
malaria parasite need to be more detailed. Linking models of differing complexity
across hierarchical levels requires intensive planning as models are not always cre-
ated in the same mathematical formalism, computational framework or have the
same units. Furthermore detailed kinetic models provide considerable amounts of
information and can become complex once the multiple models are linked. Lastly,
even if these models can be linked successfully, the computational power required
to conduct analyses on these models may be prohibitively high.
An illustration of how this hierarchical concept is going to be utilised to better
understand disease states of malaria patients can be seen in Figure 2.1.
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Figure 2.1: Scheme showing the hierarchical multi-level model for malaria
patients. The whole body model consists of different tissues and organs while the
red blood cell and parasite model compartment are modelled at a cellular level. This
figure was originally published in [http://www.biochemsoctrans.org/content/
43/6/1157, Jacky L. Snoep, Kathleen Green, Johann Eicher, Daniel C. Palm, Gerald
Penkler, Francois du Toit, Nicolas Walters, Robert Burger, Hans V. Westerhoff,
David D. van Niekerk, Biochemical Society Transactions, 2015].
2.3 Mechanism based models for pharmacology
Typical SB models are able to analyze the effects of drugs at the level of molecular
mechanisms but usually do not take into account the way a drug is affected by the
body (pharmacokinetics). In pharmacology, this process of drug ADME (absorp-
tion, distribution, metabolism and excretion) is usually treated in a phenomenolog-
ical model that describes the change in a drug’s concentration over time at different
sites in the body. The effect of the drug concentration at the site or organ of interest
is also typically described in a phenomenological way using pharmacodynamic mod-
els, which gives little to no insight into the drug’s molecular mechanism of action
or mechanistic reasons for side effects. Inclusion of molecular mechanistic detail
of the target of interest and other compartments (cell types) responsible for drug
metabolism could, in the end, then also assist in not only understanding a drug’s
pharmacological properties but also aid in drug design. The concept of integrating
SB and PK/PD models (sometimes referred to as Systems Pharmacology) to allow
for more accurate pharmacological analyses has been suggested by Swat et al. [17].
9
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2.4 Multi-scale and multi-level approaches to
modelling
The recent progress in the fields of genomics, proteomics and metabolomics has
resulted in large amounts of data and scientific knowledge on biological phenom-
ena. These are on different levels of biological organisation, such as cell, tissue or
organ level. This has required development in computational modelling to include
models that are in different forms or structures to describe the respective levels of
organisation. As a result multi-level and multi-scale modelling approaches have been
developed to combine models in hierarchical manners. Multi-level models have dif-
ferent parts of the model described in different levels of detail, but the whole model
uses a single modelling framework (e.g. ODEs). Multi-scale models use different
frameworks to deal with the different spatial and temporal scales [18]. Multi-level
and multi-scale modelling has allowed for the linking of subcellular processes to
physiological processes of the whole system rather than studying sub-systems in
isolation [18, 19].
The development of a platform that allows for the study of combined metabolic func-
tions is beneficial as the understanding of complex diseases often requires knowledge
of the molecular, cell/tissue and organ level (as well as the interaction between these
levels) [20, 21]. The combined description of the whole body level will not only give
mechanistic insights into diagnostics but help with drug development [22]. Such a
model would aid in identifying adverse side effects that a drug might possibly have
on a patient.
An alternative method used to reduce drug side effects include the administration
of medication or drugs in combination [21]. Hwang et al. [21] mention that this ap-
proach becomes experimentally challenging as determining the effects attributable
to individual drugs and their combinations requires expensive and labour intensive
medical trials. For this reason multi-scale and multi-level modelling become desir-
able as it can determining possible predicted outcomes at a very low cost [21].
There are some software packages, specification standards and tools that have been
developed which allow for the reuse or automated merging of mathematical mod-
els. SemGen [23] is a semantics based model composition software that allows for
composite annotations through existing ontologies. This software is an example of
support that can be added to Systems Biology Markup Language (SBML) files, one
of the most commonly used standards for format exchange [24], to allow for better
annotation required when merging sub-models. Models can be merged in SemGen;
however currently it does not support initial assignment rules which were essential
in our approach, due to moiety cycles that were present (see Section 3.2.4). Pro-
cess Modeling Tool (ProMoT) [25] is another example of a software tool that has
been developed to support the linking of mathematical models. ProMoT provides a
framework that allows for the construction, manipulation and visualisation of math-
ematical models in a modular structured way. Potential Coupling Interface (PCI),
developed by Bulatewicz et al. [26], is example of an interface that allows for the
10
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coupling of models. This tool aims to display models in a visual way that allows
for the merging of models to be done without prior knowledge of the of the source
code [26]. The CellML language (based on the XML markup language) has been
developed to simplify components of different formats allowing for easier multi-scale
integration of models [18] (for more detail refer to the Physiome Project [27]).
2.5 Bottom-up approaches using mechanistic
models
The Systems Biology (SB) field allows for the understanding of detailed metabolic
networks through mathematical models that describe system behaviour in terms
of defined molecular mechanisms such as enzyme-catalysed reactions and transport
steps. The advantage of using these types of models is that they are often mecha-
nistic and contain many experimentally determined parameters opposed to models
in which parameter identifiability is not always possible or accurate. These features
make for more realistic interpretation and explanation of causative factors of emer-
gent system behaviour. In SB models, the time-evolution of system state (in terms
of, for example, metabolite quantities or concentrations) are often modelled using
ordinary differential equations (ODEs) formulated in terms of mechanistic rate equa-
tions associated with the different reactions in the system. Living systems are open
systems, meaning that there is an import and export of substances. Metabolic path-
ways of interest are therefore typically modelled as open systems where there is a
constant source of substrates and removal of products. These systems tend towards
steady state in which the rate of formation and consumption of metabolites are equal
therefore keeping their concentrations constant in time. This rate is referred to as
the steady state flux. The steady state flux and metabolite concentrations can be
computed by finding the roots of the ODEs (i.e. values of the metabolites for which
the ODEs are zero). Using software such as Wolfram Mathematica, the ODEs can
also be numerically integrated to determine how the metabolites change over time
from some initial state or in response to a change in the system. Such models give
insights into the appearance of phenomena at the level of the network as a result of
(a combination of) individual steps or reactions. The effect that an external modifier
such as a drug can have on the network can therefore also be understood in terms
of mechanistic effects within the network.
2.6 Existing mathematical models
The construction of a hierarchical model to explain hypoglycemia and lactic acidosis
in malaria patients requires the use of models that describe Plasmodium falciparum
glycolysis, erythrocyte glycolysis and whole body glucose metabolism. Therefore this
multi-level model will consist of three different levels. Next, we present a literature
review on the available models for each of the levels of organisation that will be
required to form the hierarchical model.
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2.6.1 Existing Plasmodium falciparum models
Penkler et al. [1] described the metabolic pathways for Plasmodium falciparum gly-
colysis using a mechanistic mathematical model. It uses a bottom-up approach with
rate equations to describe individual enzyme catalysed reactions in the glycolytic
pathway and a glycerol producing branch. Each glycolytic enzyme was characterised
by fitting an enzyme mechanistic rate equation to a complete experimental data set.
This resulted in a mechanistic kinetic equation for each reaction. Eighteen reaction
steps were needed to explain the conversion of glucose into lactate, pyruvate and
glycerol and the production of ATP. It is the first of its kind for Plasmodium falci-
parum in the sense that all of the enzymes have been experimentally characterised
under the same physiologically relevant conditions. The model has been validated
and shows good predictive abilities [1].
2.6.2 Existing erythrocyte models
Moving up one level, an erythrocyte model is required but in contrast to the parasite
there are multiple options to choose from. One of the first models that was used
to describe glycolysis in red blood cells is that of Rapoport et al. [28]. They
describe glycolysis (including ATP synthesis and consumption) using four differential
equations and used Michaelis Menten kinetic equations to model the enzyme reaction
rates. Another example of a detailed erythrocyte model is that of Schuster et al.
[29]. They developed a mathematical model which included reactions for glycolysis,
the hexose monophosphate shunt (HMS) and the glutathione system. Schuster et
al. [29] included experimental information on kinetic properties of enzymes that
are responsible for regulating glycolysis, the oxidative pentose phosphate and the
glutathione systems.
Simulation platforms such as the E-Cell System, which allows for the prediction of
metabolism under different physiological and pathological conditions, have also been
used to model and analyse mathematical models of human erythrocyte metabolism.
Kinoshita [30] describes a simulation of human erythrocyte metabolism in this way
by focusing on glucose-6-phosphate dehydrogenase (G6PDH) deficiency. Nakayama
et al. [31] is another example of an in silico red blood cell model. It is able to describe
the glycolytic pathway, the pentose phosphate pathway and the nucleotide metabolic
pathway. This type of modelling uses rate equations with a flux-based approach to
reduce the number of equations and parameters. In cases where complete sets of
data are not always available for parametrization, flux-based approaches can be
beneficial. According to Nakayama et al. [31] these E-Cell simulation systems are
not always good at predicting what happens during abnormal conditions such as
deficiencies because sometimes alternative metabolic pathways are used. This could
create problems when studying hypoglycemia and lactic acidosis as these effects are
not normally present in a healthy individual.
Friedman & Lungu [32] constructed a model that includes the dynamics of the red
blood cells and malaria parasites. They modelled the dynamics using the density
of the normal and infected red blood cells as well as the intracellular and extracel-
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lular parasites. The model incorporates the effect of adaptive and innate immunity
of malaria infected individuals. In contrast, Chiyaka et al. [33] did not include
immunity in their model; however they did focus on using mathematical analysis
which includes the evaluation of the reproductive number R0 using three differential
equations with compartments for the normal red blood cells, infected red blood cells
and merozoites. Both of these studies used mathematics to understand the malaria
infection during the erythrocytic stages but neither are detailed enough in terms
of erythrocyte or parasite metabolism (i.e. containing individual enzyme catalysed
reactions) that would be needed to identify drug targets.
The required level of mechanistic detail is an important consideration when choosing
a suitable red blood cell model. Not only does the parasite glycolytic pathway share
many features with the red blood cell glycolytic pathway, but in an experimental
study by Mehta et al. [34, 35] it was found that only a small percentage of the red
blood cells need to be infected to cause the down regulation in the glucose utilisation
rate in the uninfected erythrocytes. The glucose flux was considerably higher in the
infected red blood cells and showed almost a 100-fold increase in glucose utilization
compared to the uninfected red blood cells [1, 34]. The glucose flux was maximal
at the trophozoite stage. Mehta et al. [35] suggested that the decrease in the
glycolytic flux of the uninfected RBCs is due to the regulation of glycolytic enzymes
by some unknown compound related to parasite metabolism. This motivates the
investigation of mechanisms of the glycolytic enzymes in order to understand what
happens during malaria infection in the erythrocytic stage and should be considered
when choosing a model with sufficient detail for the red blood cell.
One such model with a high level of experimentally characterized and validated en-
zyme kinetic detail, is that of Mulquiney & Kuchel [9–11]. This model contains a
high level of metabolic detail and is able to explain erythrocyte metabolism under
different physiological and experimental conditions. It includes the glycolytic path-
way, the pentose phosphate pathway (PPP), the 2,3-bisphosphoglycerate shunt, the
transportation of metabolites, the binding of metabolites to haemoglobin and Mg2+
as well as the effect of pH on certain reactions.
2.6.3 Existing whole body models
Lastly the features related to the appearance of the disease state (i.e. blood glucose
and lactate) need to be modelled at the level of the whole body. Several math-
ematical models have been developed to describe glucose metabolism on a whole
body level [36, 37]. While some focus on including different organs as compartments
[3, 38, 39], others address hormonal regulation and signalling [37, 40, 41]. Model
predictions have mainly been studied to be able to understand how glucose home-
ostasis is maintained when perturbations are made in the glucose-insulin system,
such as the effects of diseases like diabetes.
According to Kang et al. [42] one of the first simple whole-body glucose regulation
models was that of Bolie [43]; however it has been described as being too simplis-
tic for understanding the complex glucose-insulin system [37, 42]. Another simple
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model known as the "minimal model" was developed by Bergman & Cobelli [44].
It explains glucose kinetics with compartments for peripheral tissues and liver that
take up glucose in response to secretion of insulin from the remote insulin compart-
ment. Two drawbacks of the minimal model are firstly the assumption that glucose
and insulin effects on organs are linear, and secondly the fact that the effects of
glucagon on the liver glucose production are ignored. Cobelli et al. [45] addresses
these drawbacks with a comprehensive model to include glucagon and non-linear
dynamics. It is argued [45] that simple models can not necessarily give the correct
description for understanding the behaviour of parameters but poor validation and
excessive detail should also be avoided when developing comprehensive models. This
more comprehensive model has been validated [45] and many other extensions that
follow from the basic minimal model can be found in the literature [46–48].
A disadvantage of using the models described above is that most of them have been
developed to better understand how glucose levels return to normal physiological
conditions after a perturbation leading to an increase in blood glucose, for example
in intravenous glucose tolerance tests. Using an existing model that has only been
tested for hyperglycaemic states would be a concern as these models consist of
lumped reactions (lacking the mechanistic detail) and might not be representative
of a hypoglycaemic individual. These models consider disease states of Type 1 and
Type 2 diabetes (specifically models by Wang et al. [49] and Dalla Man et al. [39])
which could be used as proof of concept to show metabolism of different diseases on
a whole body level. However they are either not able to describe the hypoglycemic
and lactic acidosis state of a malaria-infected individual or lack the necessary details
of processes crucial for the understanding of the dynamics under this condition.
An example of a model that includes the Cori-cycle (blood lactate being converted
back to glucose by the liver, possibly a very important feature for glucose and lactate
homeostasis) is that of Konig et al. [41]. This model provided insights into using a
detailed kinetic model for hepatic glucose metabolism using tools such as metabolic
control analysis (MCA). The effects of hormonal regulation by insulin, glucagon
and epinephrine were also studied. While this model is much more detailed it was
not developed to describe different organs in the whole body (e.g. adipose tissue,
muscle, etc.) and obtaining a working model description has been difficult.
Kim et al. [38] claim to have developed the first mechanistic model of glucose
homeostasis that links cellular metabolism to whole-body responses and includes
hormonal control after exercise. This model is a constraint based model and is
therefore limited in kinetic description of the enzymes (each rate equation was de-
scribed by a general irreversible bi-bi substrate to product reaction).
The glycogen regulation model of Xu et al. [3] was constructed to address the role
of substrate cycling in maintaining glucose homoeostasis (regulated by the liver for
feeding and fasting reference states). The model includes blood glucose and blood
lactate which are the linking metabolites that are needed between the RBC and
whole body levels. Xu et al. [3] suggest compartments for the brain, kidneys and
red blood cells could be added to give a more accurate description of the whole body.
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The provision for incorporating a red blood cell compartment in the framework is
hugely beneficial.
2.7 Sensitivity analysis
One technique that is used to better understand and interpret mathematical models
is known as sensitivity analysis. Sensitivity analysis is performed on the results of
mathematical models for two main reasons. Firstly it can be used to determine
which process e.g. parameter, reaction, etc. are most important in generating a
desired outcome. Hill et. al. [50] discuss how this approach of sensitivity analysis
can be used to identify important model parameters, parameter interactions and
correlations, observation dominance in complex models, and the effect of uncertainty
of estimated parameters. The study of uncertainty in model predictions or outputs
is the second motivation to perform sensitivity analysis on a model [51]. Essentially
it tests how much the model output would differ if the model inputs were slightly
different. Therefore sensitivity analysis provides confidence in the accuracy of model
predictions.
Sensitivity analysis can be described as local or global. For the purpose of this
work we define local sensitivity analysis to be the analysis of the sensitivity of
system behaviour to small changes in single inputs (as is done in Metabolic Control
Analysis) and global sensitivity analysis to be the analysis of changes in system
behaviour due to larger changes in combinations of model inputs [52].
Metabolic Control Analysis, developed by Heinrich & Rapoport [53] and Kacser &
Burns [54], quantifies the effect that small perturbations in the biological system
would have on steady state behaviour. In system biology, sensitivity analysis tools
such as MCA can provide insights into the impact of uncertainty of parameter values
and indications of control of processes on system behaviour or responses of system
behaviour to changes in a metabolic pathway.
Metabolic Control Analysis defines three coefficients that can be used to describe
how a change in local property effects the systemic property[55]. Consider the
elasticity coefficient that is given by
vp =
∂ ln v
∂ ln p
where v and p represent an enzyme rate and parameter respectively. This coefficient
describes how the activity of an enzyme is altered by making a 1 % perturbation in a
parameter. Control coefficients explain how much control a rate has over a systemic
property such as the steady state of a metabolite (CXv ) or flux (CJv ) therefore we
have
CXv =
∂ lnX
∂ ln v
and CJv =
∂ ln J
∂ ln v
.
with X representing a metabolite steady state and J representing a reaction flux.
An enzyme will have a high control coefficient, if a 1% perturbation has a large
effect on the flux or steady state concentration.
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The third coefficient, namely the response coefficient, can be defined in terms of the
elasticity and control coefficients. Response coefficients describe the effect that a
local property like a parameter has on the steady states in a system. Hence,
RXp =
∂ lnX
∂ ln p
and RJp =
∂ ln J
∂ ln p
. (2.7.1)
or
RXp = C
X
v · vp and RJp = CJv · vp. (2.7.2)
If the parameter is a multiplier of the rate that is being studied the elasticity coef-
ficient is 1 and as a result the response coefficient will be the same as the control
coefficient for the systemic property. Metabolic Control Analysis can be computa-
tionally and experimentally evaluated. For example, the effect of an inhibitor could
be studied using these response coefficients.
These coefficients are an example of how sensitivity analysis allows for the inves-
tigation of the effect of variations in model inputs. An application of control and
response coefficients could be drug target identification. A way in which drug tar-
gets can be identified is through the analysis of systemic effects after the addition
of a reaction effector. Furthermore, Cascante et. al. [56] suggest that Metabolic
Control Analysis can be used to understand genotype-phenotype correlations as it
provides a mechanism in which to link gene expression with gene products.
In global sensitivity analysis, the combinations of model inputs are changed to give
insights into model predictions. This allows for the investigation of predictions based
on the uncertainty of parameter spaces.
In the following chapter we elaborate on the existing models that were chosen to
represent each level for the construction of a model for human glucose metabolism
that can explain the disease state of malaria patients.
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Model construction and initial
validation
The construction of a hierarchical model to explain abnormalities in glucose home-
ostasis in malaria patients requires the use of models that describe Plasmodium
falciparum glycolysis, erythrocyte glycolysis and whole body glucose metabolism.
The modelling approach used in this study consists of detailed bottom-up mod-
els for the lower levels (Plasmodium falciparum and erythrocyte glycolysis), and a
phenomenological model for whole body glucose metabolism.
Penkler et al. [1] described the metabolic pathways for Plasmodium falciparum gly-
colysis using an enzyme mechanistic mathematical model. This model was chosen to
represent the parasite compartment, since all of the enzymes have been experimen-
tally characterised and the validation of the model showed good predictive abilities
[1]. Similarly, the Mulquiney & Kuchel model [9–11] was chosen for the red blood
cell compartment as it contains all the essential details of erythrocyte glycolysis and
provides a good structure that can be modified to link to whole body and parasite
models.
There is no clear best option for a whole body model of glucose metabolism that
can explain disease states in terms of physiological or molecular mechanisms but
multiple phenomenological models were investigated (see Chapter 2). It was de-
cided that the Xu et al. [3] model would be the best choice for the linking to the
combined RBC and parasite model for several reasons: 1) the inclusion of multiple
compartments for various organs involved in glucose metabolism 2) the provision
made for incorporating a red blood cell compartment 3) unit compatibility and 4)
the ability to obtain a curated and working model description. Most importantly
this whole body model was developed to study how glycogen regulates blood glucose
levels which is beneficial when studying hypoglycemia as the body tries to maintain
glucose homeostasis through the action of glycogen.
This chapter is divided into three main sections. The first section describes the
original models for Plasmodium falciparum glycolysis (Penkler et al. model [1]),
erythrocyte glycolysis (Mulquiney & Kuchel model [9–11]) and the whole body glu-
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cose metabolism (Xu model [3]). The parasite and original red blood cell models
were obtained from JWS Online [57]. The whole body model was coded and curated
by comparing the model simulations with the published paper results.
The second section in this chapter describes how the changes were made to the
units of the red blood cell model for further compatibility with the parasite model.
Furthermore, this section includes the description of linking the red blood cell model
to the parasite model. While the concept of linking the red blood cell model with
the parasite model has been studied by Du Toit et al. [2], in this thesis we include a
different equation for the glucose transporter. Note that the original Mulquiney &
Kuchel model [9–11] does not have a glucose transporter reaction and we needed to
include this reaction step in the red blood cell model. We also extend the red blood
cell compartment to include an uninfected red blood cell compartment.
In the third section of this chapter the scaling up of volumes to represent a whole
body level and linking of the Xu et al. [3] model to the parasitized RBC culture
model is described. Model adaptations that were necessary to be made after or
during the linking of the models are also discussed.
Figure 3.1 shows a flow digram of the process followed in combining the different
models (including the model units, their description source and in what sections
they can be found in this chapter).
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Whole body 
model (Xu et al.)
*Coded and 
curated (on JWS 
online xu)
Units: mM/min
Section 3.1.3
RBC model 
(Mulquiney & 
Kuchel)
*JWS Online 
(mulquiney)
Units: M/s
Section 3.1.2
Parasitized red 
blood cell model
(dutoit1 & 
dutoit2)
Units: fmol/min
Section 3.2.3
New unit red 
blood cell model
Units: fmol/min
Section 3.2.1
Parasitized red 
blood cell culture 
model
(dutoit3)
Units: fmol/min
Section 3.2.4
Parasite model 
(Penkler et al.)
*JWS Online 
(penkler1)
Units: fmol/min
Section 3.1.1
Green model
(green1)
Units of dutoit3: 
mmol/min
Units of Xu: 
mM/min
Section 3.3
Addition of glucose 
transporter 
(Sec. 3.2.2)
Unit conversion
Volume scaling 
(Sec. 3.3.1)
and linking
(Sec. 3.3.2)
Figure 3.1: Flow diagram of Chapter 3. Models in blue circles are discussed
in Section 1, models in green circles are discussed in Section 2 and the final green1
model (yellow circle) is described in Section 3. The * indicates where the model was
obtained from or can be found. In the case of the whole body model it was coded
and curated as "xu" on JWS Online. Text on the arrows indicate changes that were
made in the linking process.
3.1 Original models and validation of model
description
This section consists of the original models for Plasmodium falciparum glycolysis
(Penkler et al. model [1]), red blood cell model (Mulquiney & Kuchel model [9–11])
and the whole body model (Xu model [3]). Both the parasite model and red blood
cell model were obtained (and are available) on JWS Online. For the whole body
model the Matlab files (obtained from the supplementary information of the original
manuscript) were used to build the Xu et al. [3] model on JWS Online. Figures
in the published paper Xu et al. [3] were compared to confirm that the model is
correctly coded.
3.1.1 Parasite model
The detailed kinetic model of Plasmodium falciparum describes the glycolytic path-
way of the parasite (Embden-Meyerhof-Parnas pathway). A schema of this pathway
can be seen in Figure 3.2. Each enzyme in this metabolic pathway was experimen-
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tally characterised to obtain a parameterized kinetic rate equation [1]. These rate
equations were used to generate a system of eighteen ODEs. Independent data sets
were used to validate the model which confirmed the accuracy of the model predic-
tions [1]. JWS Online (http://jjj.bio.vu.nl/database/penkler) has the two
different penkler models (penkler1 represents an open system and penkler2 a closed
system).
Plasmodium falciparum
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ATP
ADP
ATP
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Figure 3.2: Overview of the Plasmodium falciparum glycolysis model [1].
Orange blocks show enzymatic reactions, blue circles are the metabolites (each have
an ODE) and green circles represent the fixed metabolites in the steady state model.
In the blood form, trophozoite stage, Plasmodium falciparum parasites reside inside
red blood cells. In a mechanistic model, the transfer of metabolites between these
two organisms is typically modelled in terms of concentration dependent reactions
(diffusion or concentration dependent transport). Penkler et al. [1] constructed a
model in terms of metabolite amounts (fmol) and reaction rates in terms of amount
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per time (fmol/min) (rather than molar concentrations) to allow for the possibility to
model a growing parasite i.e. with variable compartment volumes. Since enzymes
and transporters are sensitive to concentrations, this necessitates the inclusion of
additional volume factors in an enzyme’s rate equation to convert the metabolite
quantity to concentration i.e. a metabolite amount will be divided by the volume
of the compartment in which it occurs. In addition, if a rate constant is in units of
concentration per time it has to be multiplied by the volume of the compartment
to generate a differential equation that describes an amount per time change in a
metabolite. An example of how this was done in Penkler et al. [1] is shown for a
Michealis-Menten equation.
The textbook equation is:
v =
Vmax · s
Km + s
v =
Vmax · sKm
1 + s
Km
(3.1.1)
where Km is the substrate concentration at half the maximal velocity (in units of
M) and s the substrate concentration (in units of M). The overall unit of v is the
same as Vmax which for the sake of argument, we assume to be concentration per
time (M/min). If we would like to work with S in terms of fmol rather than molar,
the equation becomes
v =
V · Vmax · SV Km
1 + S
V Km
. (3.1.2)
If we assume that a compartment volume V is measured in units of fL, then
v units =
fL Mmin
fmol
fL·M
1 + fmolfL·M
(3.1.3)
v units =
fmol
min
(3.1.4)
The maximal velocity (Vmax) still has units of concentration per time but Equation
(3.1.2) is in amount per time (fmol/minute). This conversion allows the modelling
of ordinary differential equations to be in mole amounts per time which generates
the variables/metabolites in units of amounts. In the Penkler model the internal
metabolites in the Plasmodium falciparum glycolysis model were scaled to fmol
amounts per 28 fL (volume of a trophozoite [1]) while the metabolites external
to the parasite, namely RBC glucose, pyruvate, glycerol and lactate were scaled
according to the volume of one RBC (90 fL) [58].
It was necessary to confirm that the model that would be worked with agreed with
the results of Penkler et al. [1]. This initial validation consisted of comparing the
steady state results (for metabolites and fluxes) with Table 14 in Penkler et al.
[1]. Verification of the model required unit conversions using Vpf = 28 fL, and a
conversion factor 4.67
µL cytosol
mg total protein
). Table 3.1 shows the results.
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Table 3.1: Validation of the Penkler model. Steady state results for metabolites
and some fluxes from our parasite model which is identical to Table 14 in the Penkler
et al.[1].
Metabolite Model (mM)
GLC 0.71
G6P 0.79
F6P 0.24
F16BP 1
DHAP 1.1
G3P 0.53
GAP 0.048
B13PG 0.001
3PG 0.5
2PG 0.049
PEP 0.054
PYR 1.1
LAC 2.9
ATP 2.5
ADP 0.5
NADH 0.058
NAD+ 2.9
Flux Model
(
µmol mg
protein min
)
JGLCTR 0.044
JLACTR 0.081
JGLY TR 0.004
JPY RTR 0.004
Figure 3.3 shows our simulations of the penkler2 model which is identical to the
graphs (Figure 16) from Penkler et al. [1]. External glucose and external lactate are
plotted over 90 minutes. It is assumed that the external metabolites are unclamped
and reach a steady state due to lack of substrate supply (http://jjj.bio.vu.nl/
database/penkler2). Metabolite amounts (fmol) were divided by the volume of
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incubation (taking into account 28 fL and 0.0106 cytosolic volume/total volume)
and then converted to mM.
Figure 3.3: Validation of the Penkler model. External metabolites in the our
parasite model which agrees with the Penkler model (Figure 16 in Penkler et al.
[1]). (Excludes experimental data)
For more detail on this model refer to Penkler et al. [1].
3.1.2 Red blood cell model
The red blood cell (Mulquiney & Kuchel [9–11]) model was obtained from JWS
Online [57] (http://jjj.bio.vu.nl/database/mulquiney). In this model a rate
equation was derived for each enzyme catalysed reaction resulting in a system of
108 differential equations leading to a high level of kinetic detail. To account for
the accuracy of prediction under a wide range of physiological conditions it was
necessary that the parameters had to be identified (through experimentation and
simulation); iteratively changed; and further refined (until model validation was
acceptable). These physiological conditions included validation of the normal in
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vivo steady state, and refinement of model parameters by comparison with experi-
mental data considering the response to external effectors such as pH, glucose-1,6-
bisphosphate, inorganic phosphate and total magnesium concentrations [10].
Mulquiney & Kuchel [9–11] assumed that only glucose, lactate, pyruvate and in-
organic phosphate can cross the cell membrane. External metabolites that were
fixed in the Mulquiney & Kuchel model include lactate, glucose, pyruvate, inorganic
phosphate and carbon dioxide. All other metabolites were time dependent vari-
ables. This model also considers the percentage of volume of blood that consists of
erythrocytes (known as the hematocrit) and the total cell volume accessible to the
intracellular solute (α). Figure 3.4 shows a simplified scheme of the main metabolic
pathways involved in erythrocyte metabolism.
This model was described in units of molar per second. In Section 3.2.1 and Section
3.2.2 a number of changes are introduced to the model to make it compatible with
the parasite model, such that the two models can be linked (Section 3.2.3).
The initial model validation for our red blood model showed that the JWS Online
results are in close agreement with that of the original Mulquiney & Kuchel model
[9–11] (see Table 3.2). Differences can be explained by numerical issues in the model
and model changes that occurred after the initial publication which was confirmed
with the authors.
Table 3.2: Validation of the Mulquiney & Kuchel model. Steady state results
for some glycolytic metabolites from Mulquiney & Kuchel [9–11] compared to our
red blood cell model ("mulquiney") steady state results from JWS Online.
Metabolite Mulquiney & Kuchel [9–11] model JWS Online output
(mM) (mM)
G6P 0.0375 0.0403
F6P 0.0122 0.0131
F(1,6)BP 0.00231 0.00220
GraP 0.00531 0.00508
1,3-BPG 0.000369 0.000207
3-PGA 0.0721 0.0713
2-PGA 0.0120 0.0119
PEP 0.0203 0.0199
PYR 0.0586 0.0588
LAC 1.40 1.40
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Figure 3.4: Schema of the red blood cell model [9–11]. Orange blocks show enzyme catalyzed reactions, blue circles are the
metabolites (each have an ODE), green circles represent the fixed metabolites and orange circles represent the release of inorganic
phosphate [2].
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3.1.3 Whole body model
Xu et al. [3] created a whole body model for glycogen regulation to study the role
of substrate cycling of glycogen in maintaining blood glucose homoeostasis. This
physiological model consists of the following compartments: adipose tissue, skeletal
muscle, liver and blood. The liver compartment is the most detailed due to the key
role that it plays in glycogen regulation. Schema’s for the liver, adipose tissue and
muscle compartment are shown in Figure 3.5, Figure 3.6, and Figure 3.7 respectively.
We coded this model on JWS Online using the original Matlab files that were pub-
lished. It was necessary to confirm that the model description that was coded in this
project was in agreement with the published results of Xu et al. [3]. This was done
by checking that the Figures (for example see Figure 3.9) generated by our model
description were identical to that of Xu et al. [3], after which the model was cu-
rated and made available on JWS Online (http://jjj.bio.vu.nl/database/xu).
The translation of code from the Matlab files to SBML was done manually using
the model builder of JWS Online. The SBML model was obtained using the JWS
Online output facility.
LIVER
B_alan B_lacB_gluc B_ffaB_ket
gluc
g6p
pyr
pep
glycgn
oa_c
alan lac
oa_m
malate
aK glutamate
cit
acet_m ket
palmCoA
palm
malonyl
acet_c
BLOOD
cytosol
mitochondria
࢚࢜ࡸ૟
࢚࢜ࡸ૚ ࢚࢜ࡸ૛ ࢚࢜ࡸ૜
࢜ࡸ૛ ࢜ࡸ_૚ ࢜ࡸ૚
࢜ࡸ_૛
࢚࢜ࡸ૞
࢜ࡸ૜࢜ࡸ_૜
࢜ࡸ૝࢜ࡸ૛૙࢜ࡸ૛૚
࢜ࡸ_૛૚
࢜ࡸ૚૚ ࢜ࡸ_૚૚
࢜ࡸ૚૛
࢜ࡸ૟
࢜ࡸૠ
࢜ࡸ_૞
࢜ࡸ૞
࢜ࡸૡ
࢜ࡸૢ
࢜ࡸ૚૙ ࢜ࡸ૛૚࢜ࡸ_૛૚ ࢜ࡸ૛૛
࢜ࡸ૚૝
࢜ࡸ૚ૡ
࢜ࡸ૚ૢ
࢜ࡸ૚ૠ
࢜ࡸ૚૟
࢜ࡸ૚૞
Figure 3.5: Liver compartment of the Xu model. Schema showing the metabo-
lites and reaction rates for the liver compartment in the Xu model [3].
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BLOOD
FAT TISSUE
B_gluc
F_g6p
F_acyl
F_ffa F_TG
B_ffa
࢚࢜ࡲ૚
࢜ࡲ૚
࢜ࡲ૞ ࢜ࡲ૜
࢜ࡲ૝࢚࢜ࡲ૜
Figure 3.6: Adipose tissue compartment of the Xu model. Schema showing
the metabolites and reaction rates for the adipose tissue compartment in the Xu
model [3]. The blue metabolite for free fatty acids in the adipose tissue (FFFA) is
fixed in the model.
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BLOOD B_gluc
M_g6p
B_lac
MUSCLE
B_ket
M_ketM_glyc
M_pyrM_lac M_alan
B_alan
࢚࢜ࡿ૚ ࢚࢜ࡿ૛
࢜ࡿ૚
࢜ࡿ_૚
࢜ࡿ૛
࢜ࡿ૜
࢜ࡿ_૜
࢚࢜ࡿ૜ ࢚࢜ࡿ૝
࢜ࡿ_૝
࢜ࡿ૝
࢙࢜_ࢊ࢑ࢋ࢚
Figure 3.7: Muscle compartment of the Xu model. Schema showing the
metabolites and reaction rates for the muscle compartment in the Xu model [3].
The blue metabolite for muscle alanine Malan is fixed in the model.
The Xu model incorporates the effects of the two hormones insulin and glucagon
on blood glucose. There are two separate scenarios that can be modelled, namely
fed and fasting, depending on the glycogen stores in the liver. In the model, the
switch between fed and fasting states is controlled by an "injection" of glucose
into the blood. The rate of injection is called vfeed. A constant vfeed leads to a
large glycogen pool whereas vfeed = 0 leads to glycogen depletion. For constant
glucose input vfeed = kf. In Xu et al. [3], a simulation is shown for the scenario
where there is an initial glucose input (kf = 0.5 mM/min), followed by a decay
function for 250 minutes, and a final resumed feeding rate of kf = 1.4 mM/min. We
successfully reproduced this simulation as shown in Figure 3.8 (see Figure S5 in the
supplementary information for Xu et al. [3]).
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Figure 3.8: The glucose influx rate of the Xu model. The three-step glucose
influx rate vfeed in a fed liver from Xu et al. [3] is shown: first there is constant
feeding of 0.5 mM/min for 20000 min, followed by a decay function for 250 min and
a resumed feeding of kf = 1.4 mM/min.
Figure 3.9 shows two reproduced plots from Xu et al.[3] for a fed and fasted liver.
These results can also be seen on JWS Online (http://jjj.bio.vu.nl/database/
xu) by plotting the assignment rules GPaPlot and GSaPlot.
A B
Figure 3.9: Validation of the coded Xu model. Verification of two of the plots
in our coded model description that are identical to those in Figure 9 of Xu et
al.[3]. Glycogen synthase (GSa) activity in blue and glycogen phosphorylase (GPa)
activity in orange in a fed liver (A) and fasted liver (B) for kf = 1.4 mM/min.
In this section we presented the three original models that have been chosen for
the multi-level whole body glucose metabolism model in malaria patients. Initial
validations of our model descriptions for the parasite and red blood cell model are in
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agreement with the published results for each model. Furthermore we have shown
that we were able to successfully code and reproduce figures from the Xu et al. [3]
model.
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3.2 Building the parasitized RBC culture model
During the erythrocytic stage of malaria, the Plasmodium falciparum parasite in-
vades the erythrocyte. In order to model this parasitised red blood cell, the red
blood cell and parasite model must be combined. Linking mathematical models is
not as simple as combining the species, parameters, differential equations, etc. Chal-
lenges occur due to models being in different units, modelling formats and models
having different naming conventions. Furthermore, the level of detail of mechanistic
models can create computational difficulties.
The Mulquiney & Kuchel model was constructed in units of M/s while the Penkler
model is in units of fmol/min. This section describes the changes that had to be
made to the red blood cell model to allow for linking with the parasite model. Du
Toit et. al. [2] described the fundamentals of building the parasitised RBC model.
In this chapter the units of the parasitised RBC model were checked (Section 3.2.1
and Section 3.2.3), a new glucose transporter was added to the red blood cell model
(Section 3.2.2) and lastly the parasitised RBC model was extended (Section 3.2.4)
to allow for a better description of the parasitised red blood cell culture by including
an uninfected red blood cell compartment, which is more representative of blood at
the level of the whole body in a malaria infected individual.
3.2.1 Building the red blood cell model (Mulquiney &
Kuchel model) with new units
Mathematical models are not always formulated in the same units. Unit consistency
is necessary for models to be linked so that the variables in each sub-model are
directly relatable. In addition, quantity or concentration units need to be compatible
with the units of the parameters or constants in the rate equations. Furthermore, due
to the time stepping nature of numerical integration the time scales of the separate
models to be merged need to be the same at least at the level of the differential
equations. Changing the unit descriptions of a model can be challenging, especially
when models are large and contain a great amount of detail.
The rates in the Mulquiney & Kuchel model were modelled in units of concentration
per time (molar per second). Mulquiney & Kuchel introduced a volume ratio in
the stoichiometry of transport reactions (lactate transporter, pyruvate transporter,
phosphate transporter) to account for different volume sizes of intracellular and
extracellular compartments. This creates complications if we want to alter volumes
dynamically, by for example modelling the growing parasite volume over time, as
it changes the stoichiometry. Therefore these volume ratios were removed and all
the rate equations converted to amount per time units (fmol/s) as described in
Equation (3.1.2). In Du Toit [2] the volumes were explicitly modelled in fL using
a volume of 90 fL [58] for a red blood cell, while the externals (pyruvate, lactate
and inorganic phosphate) were scaled according to an incubation volume of 129 fL
(representative of the incubation volumes used in their study [2]). With this rate
unit change, the metabolite unit in the rate equations correspondingly changes to
fmol amounts. In addition all initial values were multiplied by 90 fL to convert from
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a molar concentration to a fmol amount. The parameter Tsrbc was also introduced
into all the rate equations to convert from seconds to minutes by multiplying by 60
so that the final rate unit was fmol/min. Lastly annotation changes were made to
the red blood cell model (names of variables and rate equations) to make different
compartments in the merged model more distinguishable.
3.2.2 Adding a glucose transport to the new unit red blood
cell model
The original Mulquiney & Kuchel model did not include a kinetic rate equation for
the glucose transporter and the reaction was assumed to be in equilibrium. It was
essential to add a mechanistic equation for red blood cell glucose transport as it can
play an important role in the glycolytic flux of the infected red blood cell. In Du
Toit et al. [2] the glucose transport rate equation that was used in the Holzhütter
model [59] was chosen to extend the red blood cell model with a glucose transport
reaction. However, we discovered the RBC glucose transporter by Potts & Kuchel
[60] which we decided to use as it was from the same research group that constructed
the glycolytic model and made use of experimentally determined parameters.
Figure 3.10: Reaction scheme for the Potts & Kuchel [60] glucose trans-
porter. Either α or β glucose is transported across the transport membrane. ES
and EI represent single carrier-substrate complexes while the forms of the carrier,
with binding sites exposed to the extra-cellular and intra-cellular sides of the mem-
brane, are denoted with E and E’ respectively.
The Potts & Kuchel [60] rate equation is based on experimental observations and
considers the binding of the two different anomers (α and β) of glucose to the integral
membrane protein which transports glucose in and out of the red blood cell. Potts
& Kuchel derived this rate equation using the King Altman method [61] (a scheme
can be seen in Figure 3.10). According to Neuman [62] 36 % of the equilibrium
mixture for D-glucose is the α anomer and 64 % consists of the β anomer.
Since most models just include glucose (not the different anomer forms) for this
work it was assumed that 0.36 (glcalpha) of the blood glucose goes via the transport
route for α-glucose while the other 0.64 (1−glcalpha) is transported via the β-glucose
route with a different binding affinity. Additionally it was assumed that these two
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routes are reversible and symmetrical, with the use of Equation 1 and 2 in Potts &
Kuchel [60] the following equations were obtained:
vα =
Vmaxα · αo
Kα +
Kα
Kβ
βo + αo
− Vmaxα · αi
Kα +
Kα
Kβ
βi + αi
(3.2.1)
vβ =
Vmaxβ · βo
Kβ +
Kβ
Kα
αo + βo
− Vmaxβ · βi
Kβ +
Kβ
Kα
αi + βi
(3.2.2)
where β = 1−α and Kβ and Kα were determined assuming equilibrium conditions.
The first term in vα is the rate at which glucose outside of the red blood cell is
transported into the red blood cell. The second negative rate in vα is the rate for
glucose moving from within the red blood cell back into the blood. The two terms
for vβ can be explained in the same way. From Potts & Kuchel [60] Kα and Kβ are
given as 8.3 mM and 7 mM at 37 ◦C. The K values were chosen for 37 ◦C (and not the
alternatives at 34 ◦C) as this temperature is closer to the physiological reference state
for body temperature of a healthy individual (usually between 36.5 ◦C−37.5 ◦C [63]).
These K values were then converted to molar concentrations by dividing by 1000.
Lastly the Vmax was assumed to be the same for both the α and β-glucose anomers
and was determined by Potts & Kuchel [60] to be 33 mmol/s/litre of RBCs. Since
the other Vmax values of the RBC enzymes in the new unit red blood cell model are
in M/s, converting the glucose transporter Vmax would be beneficial. The Mulquiney
& Kuchel model includes a parameter called alpha (called AlphaCellWaterFraction
in the new unit red blood cell model) that describes the fraction of volume of cytosol
(in litres) to the volume of a red blood cell (in litres), namely 0.7. The parameter
Tsrbc is included to convert from seconds to minutes. Therefore multiplying the
time-scaling factor Tsrbc with the Vmax we have
VRBCvGLCTRANSPORT = Tsrbc
33 mmol
s · RBC
resulting in
=
Time scaling factor︷︸︸︷
60 s
min
·
Vmax︷ ︸︸ ︷
33 mmol
s · L of RBCs ·
1/cytosolic ratio of RBCs︷ ︸︸ ︷
1L of RBCs
0.7 L cytosol · 1000
= 2.82
M
min
(3.2.3)
The glucose transporter rate equation was converted from concentration units to
amount per time units in a similar way as mentioned above, to be compatible with
the rate units of the new unit red blood cell model.
3.2.3 Combining the parasite and new unit RBC model
(with glucose transporter)
The parasite (Penkler) and red blood cell (Mulquiney & Kuchel) models were com-
bined in a previous study (Du Toit model [2]) to describe a parasitized RBC. In the
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combining of these two models, Du Toit [2] had to make certain changes in order
to link them. The two metabolites that provide the linking points are red blood
cell glucose and red blood cell lactate. In the Penkler model these two metabolites
were external to the parasite cell and modelled as fixed parameters. Since the new
unit red blood cell model is in the same units as that of the parasite model, the
combining of the models only required a change in the parasite glucose and lactate
transporters. These transporters in the parasite model were changed by removing
the source (external glucose) and replacing it with red blood cell glucose. Similarly,
the external lactate sink in the parasite model was changed to red blood cell lactate
from the new unit red blood cell model. This implementation was reproduced on
JWS Online, as well as the merging of all the reactions, parameters, initial values,
rules, etc. Figure 3.11 shows the combined schema of the parasite and red blood
cell model. For the scope of this work it was necessary to confirm the merging of
the models done by Du Toit [2] (and add a more appropriate glucose transporter as
discussed in Section 3.2.2).
In the combined new unit red blood cell and parasite model glucose, pyruvate, lactate
and phosphate can move across the red blood cell membrane. These metabolites that
are external to the red blood cell are scaled to a fixed external volume (vBld). When
the red blood cell and parasite models were linked, the parasitized red blood cell
lactate flux was too low to explain the experimental data and therefore an additional
multiplier was included in the red blood cell lactate transporter. Physiologically this
can be explained by the parasite creating new permeability pathways (NPPs) in the
red blood cell membrane [2, 64] allowing for lactate to move more freely into the
bloodstream. In the parasitized RBC model the external metabolites can either
be modelled as a constants (model called dutoit1), or they can be unclamped to
simulate a batch incubation experiment in which glucose is completely consumed
(called dutoit2). These models were constructed by Du Toit [2] but in this thesis a
different glucose transporter was adopted. Through inspection of the code for the
transporter steps and analysing the steady states the merging of these models was
checked and found to be correct.
34
Stellenbosch University  https://scholar.sun.ac.za
Plasmodium falciparum
glcRBC
g6pRBC
f6pRBC
b13pgRBC
pepRBC
lacRBC
lacEXT
PGI 2
PGM 8
ENO 9
dhapRBC
TIM
5
hbRBC
b13pgRBC
hbb13pgb13pgRBC
53
mgatpRBC
hbRBC
b23pgRBC
hbbpg b23pgRBC
hbRBC
adpRBC
adpRBC
hbRBC
atpRBC
50
hbRBC
atpRBC
hbatp hbadp
52
hbmgatp
49
mgb13pg
mgRBC
b13pgRBC
b13pgRBC
mgRBC
b23pgRBC
mgb23pg
b23pgRBC
mgRBC
adpRBC
adpRBC
mgRBC
atpRBC
mgRBC
atpRBC
mgatp mgadp
mgglc16p2
mgRBC
glc16p2RBC
glc16p2RBC
mgRBC
fru16p2RBC
mgfru16p2
fru16p2RBC
46
44 45
mgphos
P 48
4342
gssgRBC
gshRBC
25
nadpRBC
nadphRBC
2
gssgr 37ox
p6glRBC 23
g6pdh
p6gRBC
p6gdh
grapRBC
ta tk2
tkxu5pRBC 28
tk1
xu5pRBC
CO2
tkgery4pRBC
rib5pRBCsed7pRBC tkgrib5pRBC
ery4pRBC
tkgRBC
34 29
tk4 tk3
31 30
33
32
pglhydrolysis
tk5
tk6
ALD 4
f16pRBC
nadpRBC nadphRBC nadpRBC nadphRBC
bpgspRBC
bpgsppp2gaRBC bpgspb23pgRBC
bpgsppRBC
bpgspb13pgRBC
bpgsp2
bpgsp4
bpgsppphosRBC
15
bpgsp3
bpgsppp3gaRBC
bpgsp6
18
bpgsp5 17
bpgsp9
PP
21
bpgsp8
P
20
bpgsp7 19
bpgsp1
ak 35
mgadpRBC
mgatpRBCampRBC
adpRBC
mgadpRBC
mgatpRBC
nadRBC
nadhRBC
P
    phosEXT
mgadpRBC
mgatpRBC
36atpase
phostransRBC
41 P
lactransRBC
39
ru5pRBC
r5pi27
26ru5pe
hk 1
6
PGK 7
mgadpRBC
mgatpRBC
PFK 3
p2gRBC
PK 10
p3gRBC
13
14
16
glctransRBC
54
nadhRBC
nadRBC
LDH 11
gapRBC
glcEXT
22 24
hbRBC
mgatpRBC
51
glyEXT
A
B
C
D
E
F
GAPDH
47
mgRBC
P
pyrRBC
tkRBC
tkRBC
pyrEXT
nadphRBC
nadpRBC
LDHP12
pyrtransRBC
40
NADNADH 38
oxnadh
LACtr
PYRtr
g6pPF
f6pPF
gapPF
p3gPF
f16bpPF
b13pgPF
pepPF
lacPF
adpPF
atpPF
PGI57
PGM63
ENO64
atpPF
adpPF
PFK 58
PGK62
adpPF
atpPF
PK 65
p2gPF
glcPF
TPI
60
g3pPF
nadPF
nadhPF
GAPDH61
pyrPF
ALD59
nadhPF
nadPF
LDH66
G
70 atpase
GLCtr
55
69
68
atpPF
adpPF
HK 56
Erythrocyte
nadhPF
nadPF
dhapPF
67G3PDH
Figure 3.11: Schema from Du Toit [2] showing the combined Plasmodium falciparum and red blood cell model.
Orange blocks show enzyme catalyzed reactions, blue circles are the metabolites (each have an ODE), green circles represent the
fixed metabolites and orange circles represent inorganic phosphate for the steady state version of the model.
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3.2.4 Building the parasitized RBC culture model (dutoit3)
Thus far we have confirmed that the merging of the parasite and new unit red
blood cell models was correctly implemented. The parasitized RBC model can
be used to understand what happens to the red blood cell after invasion by the
Plasmodium falciparum parasite, however a malaria culture typically includes a
mixture of infected and uninfected red blood cells. Also, according to Metha [34]
malaria infected red blood cells can down-regulate the glucose flux of uninfected red
blood cells. The importance of including uninfected red blood cells in the model was
two-fold. Firstly, the incorporation of the uninfected red blood cells would allow
for further investigations into understanding the effect that the parasite infected
red blood cells have on the uninfected red blood cells. Secondly, with the aim to
develop a whole body model it would be more realistic to have a total red blood cell
compartment that consists of uninfected and infected red blood cells. Figure 3.12
shows a schema of the two separate red blood cell compartments.
VrbciVrbcu
Vpf
VBld
Figure 3.12: Scheme showing the different volume compartments in the
parasitized red blood cell culture model. The blood volume vBld, the unin-
fected RBC volume Vrbcu, the infected RBC volume Vrbci, and the parasite volume
Vpf. Each volume compartment can consists of multiple cells, but is simulated as a
total volume.
Constructing an infected red blood cell compartment (volume represented by Vrbci)
and uninfected red blood cell compartment (volume represented by Vrbcu) requires
the use of the new unit Mulquiney & Kuchel model for the uninfected part and the
parasitized RBC model (dutoit2) for the infected part. In the current context, the
uninfected and infected red blood cell volumes need to sum up to a total red blood
cell volume as expected in the human body. For simplicity the current discussion
only considers one uninfected red blood cell and one infected red blood cell. When
the red blood cell volume is scaled up to the whole body level (Section 3.3.1) this is
changed to represent multiple red blood cells (infected and uninfected) on the whole
body level.
The volume of the infected RBC compartment is calculated by using the para-
sitaemia to determine the infected fraction of the total RBC volume (see Equations
3.2.4). Modelling the total Vrbc using these two compartments also makes it easy
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to move between the extremes of 0% and 100% parasitaemia (called par) with the
simple implementation of a parameter called parMulti which switches between 0
(healthy individual) or 1 (malaria infected individual). The parasite volume de-
pends on how many red blood cells are infected (Vrbci) and on the ratio of volumes
of one trophozoite parasite (24-40 fL according to Du Toit et al. [2], typically 28
fL) to one red blood cell (90 fL according to McLaren et al. [58]) resulting in the
parameter trophToRBC equalling 28/90.
Vrbc = 90 fL
Vrbcu = Vrbc− parMulti · Vrbci
Vrbci = Vrbc · par
Vpf = trophToRBC · Vrbci

(3.2.4)
The rates and metabolites of the new unit red blood cell model were added to the
parasitized RBC model to describe the uninfected and infected RBC compartments.
The parasitized RBC model includes a number of definitions of parameters in terms
of other parameters and variables. As such, these also needed to be duplicated
and renamed to correspond to Vrbci and/or Vrbcu explicitly. For example, the
model would now consist of a glcRBC (glucose in the uninfected red blood cells)
and glcRBCi (glucose in the infected red blood cells). All infected red blood cell
rates and parasite rates include an additional parameter parMulti resulting in these
reactions becoming zero (as well as Vrbci) when parasitaemia is zero. Similarly a
parameter called unparMulti was added to the uninfected rate equations that can
be set to zero to allow for 100 % parasitaemia to be modelled. The blood glcEXT,
lacEXT, phosEXT, pyrEXT, glyEXT and Co2RBC (and Co2RBCi) still remain
external and shared between both the infected and uninfected red blood cells. The
glucose and lactate transporters for the red blood cell were the linking points of the
two models. For example, glcEXT (which represents the glucose in the blood) can
either move into the uninfected red blood cell compartment or into the infected red
blood cell compartment.
The parasitized RBC culture model (dutoit3) contains a number of moiety con-
served cycles. Mathematically they appear in the linear dependence of metabolite
differential equations on one another. Consider the cycle in Figure 3.13 where A is
converted to B (by v1) and then back to A (by v2), then
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Figure 3.13: Scheme of a moiety cycle. The metabolite A is converted to B by
v1 and then back to A by v2.
dA
dt
= v1− v2 (3.2.5)
dB
dt
= −v1 + v2 (3.2.6)
The initial values for A and B determine A+B for all time in the system. Usually
these conservation relations are modelled in terms of concentrations and there is
not a general solution to modelling these cycles in terms of amounts (as required by
Penkler and Mulquiney & Kuchel models) but here we assume that the amount of a
species that is present in a volume should be adjusted with the increased volume size
- a larger volume would contain a larger amount of metabolite to ensure the same
concentration. We assume that the total moiety concentration is conserved over
growing volumes as we do explicitly include biosynthesis moiety concentrations in
the model. To account for this in the model description there are initial assignments
which scale all the metabolite amounts to their respective compartment volumes.
Adaptations to initial assignments required the uninfected red blood cell metabolites
to be scaled to a volume of Vrbcu and for the infected RBC scaling by the infected
RBC volume Vrbci to obtain initial values in units of fmol. The initial value for
each metabolite consists of a molar concentration which is multiplied by Vrbcu or
Vrbci (in fL) to obtain the metabolite in units of fmol amounts in the relevant
compartment.
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3.3 Model adaptations, scaling up and linking the
models to represent the whole body level
The description of how the Xu et al. model (in units of mM/min) and para-
sitized RBC culture model (in units of fmol/min) were combined to explain glucose
metabolism in malaria infected individuals will be divided into two sections. First,
how the aspects (such as volumes) of the parasitized RBC culture model had to
be modified to be representative of a whole body level and second the adaptations
that had to be made to the transporters to link the models with consistent units.
Figure 3.14 shows a schema of the different compartments of the whole body model
including the red blood cell structure that will be added in this section to allow for
the modelling of disease states in malaria infected individuals.
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Figure 3.14: Scheme of the green1 model which consists of the whole body
model [3] combined with the compartment for the red blood cells (namely
the parasitized RBC culture model). This figure was originally published in
[http://www.biochemsoctrans.org/content/43/6/1157, Jacky L. Snoep, Kath-
leen Green, Johann Eicher, Daniel C. Palm, Gerald Penkler, Francois du Toit, Nico-
las Walters, Robert Burger, Hans V. Westerhoff, David D. van Niekerk, Biochemical
Society Transactions, 2015].
3.3.1 Scaling up the parasitized RBC culture model
volumes to represent the whole body level
In the parasitized RBC model (Section 3.2.3) only one red blood cell and parasite
cell were considered (i.e. one infected red blood cell). An accurate description of
the whole body level would require the scaling up from one pRBC to multiple red
blood cells infected and uninfected (as seen in the body). In the parasitized RBC
culture model (Section 3.2.4) the division of the red blood cell compartment into
an infected and uninfected part was modelled in such a way to make provision for
scaling up to the number or red blood cells on the whole body level.
There are different ways in which the total red blood cell compartment can be
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modelled to represent the red blood cell population in an individual. Ideally an
accurate description of the mechanistic biological phenomenon would model the red
blood cells individually. This would entail having a Mulquiney & Kuchel [10] model
for each red blood cell present in the body. The computational power required
to model/simulate such a large and complex model would be a restriction. As
metabolites inside the red blood cell see the same external environment (the same
concentrations of blood glucose and lactate) an alternative is to lump all of the red
blood cells into one compartment that is able to represent the total volume of RBCs
at the whole body level. One approach to achieve this is to take the average number
of red blood cells that can be expected for a human and multiply it by the volume
that is expected for one red blood cell (90 fL according to McLaren et al. [58]).
Initially this approach was considered but since the average number of RBCs in a
human is between 2− 3 · 1013 [65] it created a 1013 error range for the red blood cell
volume. Another option is to follow the same approach that was used in the building
of the parasitized RBC culture model by allowing for the grouping of all infected
red blood cells to be in the Vrbci compartment and the uninfected red blood cells
to be in the Vrbcu compartment (with the incorporation of the hematocrit).
On average a human has 6.24 L of blood, assuming a volume of distribution of 0.08
L/kg [66] and an average body weight of 78 kg[39]. This 6.24 L consists primarily
of plasma and red blood cells. The fraction of total blood volume occupied by red
blood cells is known as the hematocrit. Mulquiney & Kuchel [10] used a hematocrit
of 0.5, therefore by extension our model assumes the same. The parameters for the
total blood volume and hematocrit are called vtotblood and HCT respectively. The
volume of red blood cells is then determined by vtotblood ·HCT and is then converted
to fL by multiplying by 1015. To accommodate for the volume of cell organelles
a factor called AlphaCellWaterFraction from Mulquiney & Kuchel [10] is included.
The total cytosolic red blood cell compartment volume is therefore given by:
Vrbc = vtotblood · HCT · AlphaCellWaterFraction · 1015 fL (3.3.1)
The volumes for the parasite infected red blood cell compartment (Vrbci) and unin-
fected red blood cell compartment (Vrbcu) sum to total red blood cell volume Vrbc.
The infected red blood cell compartment is determined by the level of parasitemia
while the parasite volume depends on how many red blood cells are infected. These
volume equations can be seen in Equation (3.2.4).
The volume of blood in litres that does not consist of red blood cells (considered to be
all plasma in this study) can be represented by the expression vtotblood · (1.0−HCT).
This is the volume in which the metabolites external to the red blood cells are
dissolved. From this an equation for blood plasma vBld is derived to be
vBld = vtotblood · (1.0− HCT) · 1015 fL (3.3.2)
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3.3.2 Modifications of the glucose and lactate transporters
to link the parasitized RBC culture model with the
whole body model
Using the parasitized red blood cell culture model to represent all red blood cells
in a malaria infected human host not only requires a change in volumes, but also
an adjustment of the transport equations that will link to the whole body model.
Extracellular glucose and lactate were identified as the species that would link to
the whole body model. These two species are equivalent to the blood glucose (Bgluc)
and blood lactate (Blac) in the whole body model. The combining of these models
was done on the JWS Online platform to allow for full SBML (the standard spec-
ification format for Systems Biology models) compliance. Furthermore having the
final combined model on JWS Online allows for other outputs in languages such as
Mathematica and Python. It is advantageous to combine the models in the browser
as it is user-friendly and the Xu et al. [3] model was already added the curated JWS
Online database earlier in the current study.
A derivative of the parasitized RBC culture model was created on JWS Online and
the compartment structures, species, initial assignments, rate equations, parameters,
assignment rules and unit definitions from the whole body model were added. The
event for reducing glycogen accumulation in the liver present in the Xu et al. [3]
model was omitted as the glucose influx was assumed to be a low constant to reduce
model complexity.
Table 3.3: Initial units for components of each model.
Model Rate Metabolites Rate constant Volumes Km Typical rate expression
or Vmax
Xu [3] mMmin mM
1
min - - rate ∝ rate constant · metabolite
dutoit3 fmolmin fmol
M
min fL M rate ∝ Vmax ·Volume ·
metabolite/Volume
Km
(1+ metaboliteVolume·Km )
When modelling combined systems of differential equations it is possible to have
sub-systems in different units provided that the linking species in the rate equations
between systems are seen in the correct units consistent with the respective system
parameters and that the time units are the same (for numerical integration). The
dutoit3 model (parasitized RBC culture model) has rate units of fmol/min but the
whole body is in units of mM/min (see Table 3.3). The models were initially linked
in this way i.e. separate transport equations were used for RBC and whole body
that converted Bgluc and Blac to correct units on the fly. This can best be explained
by showing the differential equations and transporter rates. The blood glucose and
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red blood cell glucose differential equations looked as follows
B′gluc(t) = vfeed − vtF1 − vtL1 − vtS1 − vd_Bgluc − vWBvGLCTRANSPORT
glcRBC′(t) = vRBCvGLCTRANSPORT− vRBCvHK
where vRBCvGLCTRANSPORT is the red blood cell glucose transport in units of
fmol/min while the duplicated red blood cell glucose transport vWBvGLCTRANS-
PORT is in mM/min even though they represent exactly the same transport process.
Each transport is in the same units as the ODE in which it appears. Expanding on
the unit description for the glucose transporters we have
vRBCvGLCTRANSPORT:
= TsRBC ·Vrbcu ·
 glc_alpha ·VRBCvGLCTRANSPORT ·
B_gluc(t)
1000(
(1−glc_alpha)·B_gluc(t)
1000
·k_alpha
k_beta + k_alpha + glc_alpha ·
B_gluc(t)
1000
)
− glc_alpha ·VRBCvGLCTRANSPORT · glcRBC(t)
Vrbcu ·
(
(1−glc_alpha)·glcRBC(t)·k_alpha
k_beta·Vrbcu + k_alpha +
glc_alpha·glcRBC(t)
Vrbcu
) + . . .

Units of vRBCvGLCTRANSPORT:
=
s
min
· fL ·
 1 ·M/s · mM1000( 1· mM
1000
·M
M
+ M + mM
1000
) − 1 ·M/s · fmol
fL ·
(
1·fmol·M
M·fL + M +
1·fmol
fL
) + . . .

=
s
min
· fL ·
(
1 ·M/s ·M
M
− 1 ·M/s · fmol
fL · (M) + . . .
)
=
s
min
· fL ·
(
M
s
)
=
fmol
min
(3.3.3)
and vWBvGLCTRANSPORT:
= TsRBC ·Vrbcu · 1000
vBld
·
 glc_alpha ·VRBCvGLCTRANSPORT ·
B_gluc(t)
1000(
(1−glc_alpha)·B_gluc(t)
1000
·k_alpha
k_beta + k_alpha + glc_alpha ·
B_gluc(t)
1000
)
− glc_alpha ·VRBCvGLCTRANSPORT · glcRBC(t)
Vrbcu ·
(
(1−glc_alpha)·glcRBC(t)·k_alpha
k_beta·Vrbcu + k_alpha +
glc_alpha·glcRBC(t)
Vrbcu
) + . . .

Units of vWBvGLCTRANSPORT:
=
s
min
· fL · 1000
fL
·
 1 ·M/s · mM1000( 1· mM
1000
·M
M
+ M + mM
1000
) − 1 ·M/s · fmol
fL ·
(
1·fmol·M
M·fL + M +
1·fmol
fL
) + . . .

=
s
min
· fL · 1000
fL
·
(
1 ·M/s ·M
M
− 1 ·M/s · fmol
fL · (M) + . . .
)
=
s
min
· fL · 1000
fL
·
(
M
s
)
=
mM
min
(3.3.4)
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The duplication of the RBC glucose transporter (with units consistent with each re-
spective model) was numerically unstable when the model was simulated on Math-
ematica 10.3. A possible solution to such numerical problems (such as machine
precision errors) is to avoid having a combination of very small and large numbers
in expressions that need to be integrated. This led to the conversion of the para-
sitized RBC culture model from fmol/minute to mmol/minute. Ideally, the whole
body model should also be modelled in amounts which led to an unsuccessful initial
attempt to convert the units of the whole body model to amounts. After closer
inspection, it was found that the volumes in the Xu et al. [3] model were not well
described (see Discussion). Since it is beyond the scope of this work to change
the content of the Xu et al. [3] model the whole body rates were kept in units of
mM/min.
Model descriptions for species, volumes and time units for dutoit3 therefore need to
be in mmol, mL and min. Modifying the volumes to be in units of mL rather than fL
is a simple adjustment by a factor of 10−12. The initial assignments for the red blood
cell and parasite metabolites are determined by a concentration (molar) multiplied
by the respective volume compartments now in mL resulting in initial values in units
of mmol. In the rate equations for the dutoit3 the species are explicitly divided by
the volumes which now have units mL. This results in a reappearance of molar
concentration values as required by the model parameters (e.g. Km values are
in molar). The differential equations for these metabolites are in mmol per min
resulting from the multiplication of Vmax values (in M/min) by volumes (in mL).
Table 3.4 shows a summary of the converted units for the respective models.
Table 3.4: Final units for components of each model.
Model Rate Metabolites Rate constant Volumes Km Typical rate expression
or Vmax
Xu [3] mMmin mM
1
min - - rate ∝ rate constant · metabolite
dutoit3 mmolmin mmol
M
min mL M rate ∝ Vmax ·Volume ·
metabolite/Volume
Km
(1+ metaboliteVolume·Km )
To link the Xu and dutoit3 models the transporters (for glucose and lactate) need
to be in the same units. A simple solution to overcome unit differences in rate
equations (as determined by rate constants (in Xu model) and Vmax (in parasitized
RBC culture model)) between models is to incorporate a conversion factor as seen
in Equation (3.3.4). The conversion factor ω was created to change the whole body
model unit descriptions of mM/min to mmol/min and is given by:
ω =
vBld
1000
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where initially vBld was modelled in fL and the division by 1000 was required to con-
vert the rates between fmol and mM per minute. In the context of the changed units
of the parasitized RBC culture model rates from fmol to mmol, vBld is modelled in
mL.
The description of the conversion factor ω allows for the duplicated transport rates
that are in whole body model to be written as
vWBvGLCTRANSPORT =
1
ω
· vRBCvGLCTRANSPORT
=
1000
vBld
· vRBCvGLCTRANSPORT
=
1000
mL
· mmol
min
=
mM
min
Similarly this construction was done for blood lactate and red blood cell lactate in
the infected and uninfected RBC compartment. The modification of this model to
include multiple transport rates required us to confirm that mass balance is still
conserved in the system. This is shown in the next chapter (see Table 4.2).
3.3.3 Model adaptations made during the linking of the
parasitised RBC and whole body model
Understanding disease states in malaria patients by combining existing mathemati-
cal models requires the analysis of model simulations. We are interested in knowing
what happens to the steady state values of model variables such as blood glucose,
blood lactate (indicative of disturbances in the homeostasis of these metabolites)
as well as to the fluxes of transporters (indicative of increased flow of metabolites
to and from compartments possibly linked to an increased metabolic burden on an
organ). After merging the Xu et al. [3] model with the dutoit3 model (Section
3.3.1 and Section 3.3.2) it was discovered that not all metabolites reached a steady
state (even for uninfected individuals). Initially it was thought that a possible rea-
son for this could be that the time required for the combined model to reach a
steady state is much longer due to differences in time scales of the separate models.
However increasing the time of integration did not show different results. An alter-
native explanation for this unrealistic physiological behaviour of ever accumulating
metabolites (i.e. lactate and glycogen levels in the liver) could be that we were us-
ing models, particularly the phenomenological Xu model, to describe physiological
conditions for which it has not originally been constructed and validated. To avoid
the accumulation of ever accumulating lactate concentration and glycogen stores in
the liver two modifications were made.
Blood lactate is transported into the liver, after which it undergoes a multi-step
metabolic process called the Cori-cycle that converts lactate back into glucose. The
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glucose is stored in the liver in the form of glycogen and is transported back into
the blood stream as glucose during low blood sugar levels. Xu et al. [3] modelled
the transport of blood lactate into the liver with a simple mass action rate law.
However, it was noticed that a constant input of vfeed resulted in an accumulation
of glycogen in the liver due to the lack of reversibility and product sensitivity of the
lactate transporter. In an attempt to address the accumulation of both lactate and
glycogen stores in the liver, it was decided that the hepatocyte transporter in the
whole body model would have to be changed. A literature search on human liver
metabolism highlighted a possible solution from the Virtual Liver Project[67].
The lactate hepatocyte transporter was adopted from the Virtual Liver Project,
more specifically, Konig et al. [41]. While little is known about the hepatocyte
lactate transporter in humans, this reversible Michaelis Menten equation is cur-
rently the only available option. In this equation the binding constant KmtL2 was
described in units consistent with the original Xu model, namely 0.8 mM. The max-
imal velocity VmtL2 was modelled in µmol/kg/min and converted to the unit of the
other rate constants in Xu using the average kg weight per L of blood in humans as
before (see Section 3.3.1). Therefore,
VmtL2 =
33 µmol
kg min
· kg
0.08 L
· 103
= 0.4125
mM
min
.
The lactate liver transport is
vtL2 =
VmtL2 · (Blac(t)− lac(t))
KmtL2 ·
(
Blac(t)
KmtL2
+ lac(t)
KmtL2
+ 1
)
Units of vtL2 =
mM
min · (mM−mM)
mM · (mM
mM
+ mM
mM
+ 1
)
=
mM
min
Xu et. al. [3] used a three step function (including a form of a decay function) to
model the feeding rate of an individual. Their study was concerned with under-
standing the differences between fed and fasting states in terms of glycogen stores
in the liver. For simplification purposes we assumed a constant feeding rate of 0.5 in
the green1 model. Plotting the whole body metabolites over time it was seen that
glycogen stores in the liver continued to show a continued accumulation despite the
modifications made to the liver lactate transporter. This led to the investigation
of the steady state value for blood glucose in the original Xu et al. [3] model. It
was discovered that when setting vfeed to zero the steady state value for Bgluc was
around 6.4 mM. The physiological reference state for blood glucose is around 5 mM
[68], suggesting that the original whole body model predicts a higher steady state
for blood glucose than biologically expected.
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A simple calculation was done to determine the average glucose consumption for an
individual per day. The implementation of this calculated constant value, namely
0.68 mM/min and the inclusion of the parasitised RBC model with the whole body
model with this adjusted value for vfeed did not solve the behaviour of glycogen seen
in the liver.
Further investigation showed that two fixed parameters FFFA (free fatty acids in
the fat compartment) and Malan (alanine in the muscle compartment) have a large
effect on the blood glucose steady state which prompted the second modification
that had to be made. This involved the determination of vfeed by manipulating two
fixed species Fffa, Malan so that the original Xu model (with the new liver lactate
transporter) reaches a blood glucose steady state as close to 5 mM as possible.
Despite attempts made to have a more realistic feed rate, through optimisation it was
found that by setting vfeed to 0.2 mM/min, Fffa = 0.029mM, andMalan = 0.0mM the
most physiological relevant blood glucose concentration was obtained. Thereafter,
these fixed values were adopted in the green1 model leading to steady state solutions
for the metabolites allowing for simulation analysis to be done (discussed in the
following chapter). It could be suggested that we could have made vfeed zero and
then adjust Fffa and Malan to obtain a blood glucose steady state of 5 mM; however
physiologically we would except an individual to have a glucose intake therefore we
decided to have a low (constant) glucose feeding rate.
In this chapter we were able to reproduce simulations from the original models for
each level of description in the green1 model, including coding and reproducing plots
from the Xu et al. [3] model. Furthermore these models were modified as required
in order to successfully merge them by making changes to units and adaptations
that allows for a more physiologically realistic description of whole body glucose
metabolism in malaria patients. The full description of the green1 model can been
seen in Appendix A. In the next chapter we present simulations and sensitivity
analysis results for the green1 model.
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Model Simulations and Sensitivity
Analysis
In the previous chapter, a hierarchical model was constructed to describe glucose
metabolism in malaria patients (green1), using three existing mathematical models.
The first Section (4.1) of this chapter shows initial validations and steady state
solutions of blood glucose and blood lactate for the model. The second section
describes both local (Section 4.2.1) and global sensitivity analysis (Section 4.2.2).
4.1 Initial validation and steady state solutions
In any type of modelling it is important to validate the model to verify the accu-
racy of the predictions. Thorough validation of computational simulations requires
complete and accurate sets of data which are almost never available. Recall that
Xu et al. [3] made provision for the inclusion of a red blood cell compartment in
the framework; however they did not explicitly include a red blood cell model. Dur-
ing the construction of the green1 model a red blood cell compartment was added
(Section 3.2.4). Since combining models can lead to unexpected outcomes it is good
practice to have checks during the linking process so that any unexpected behaviour
can be identified. Therefore we needed to confirm that the addition of the red blood
cell compartment did not result in unexpected behaviour of the whole body sys-
tem. Table 4.1 shows the effect of adding the red blood cell compartment to the
original whole body model by analysing some of the whole body fluxes. This initial
validation is achieved by comparing some of the fluxes of the original whole body
model, with the adaptations as described in Section 3.3.3 for Fffa, Malan, vfeed and
the lactate transporter in the liver, and to the green1 model for zero parasitaemia.
Only the rates that influence blood glucose and lactate are shown.
In Table 4.1 it can be seen that with the addition of the red blood cell compart-
ment there was an increase in the fluxes for blood lactate degradation (v_d_Blac)
and liver lactate transport (v_tL2) while the other rates showed a decrease. The
incorporation of a red blood cell compartment to the whole body model results
in lower blood glucose levels (Bgluc) and higher lactate levels (Blac) due to the in-
48
Stellenbosch University  https://scholar.sun.ac.za
4.1. Initial validation and steady state solutions
creased metabolism caused by erythrocyte glycolysis. Since both the degradation
rates (v_d_Bgluc and v_d_Blac), from the RBC absent Xu et al. [3] model, are
of the mass action form, a constant multiplied by a concentration, the decrease in
blood glucose leads to a decrease in the degradation rate for glucose while the inverse
is true for blood lactate. The rate of glucose transport from the blood into the fat
(v_tF1) or muscle compartment (v_tS1) similarly decreases due to the reduced lev-
els of glucose in the blood. The transport of lactate from the muscle tissue into the
blood compartment also decreases (v_tS3). This is mostly likely due to increased
blood lactate levels inhibiting the muscle lactate transporter.
The rate of transport for glucose in the liver (v_tL1) decreases while the liver lactate
transport rate (v_tL2) shows an increase. The increase in blood lactate levels causes
the increase in transport of lactate from blood to the liver. Once in the liver, the
lactate is converted back to glucose through a multi-step process known as the Cori
cycle. The rate of transport for blood glucose into the liver is given by the expression
k(Bgluc − gluc) where k is a rate constant. Therefore a decrease in the rate v_tL1,
as can been seen in Table 4.1, results in less blood glucose being imported into the
liver. This is expected as the addition of the red blood cell compartment leads to
lower glucose levels in the blood which would reduce the amount of glucose that can
be transported from the blood into the liver. While the rate (v_tL1) decreases, the
rate of the liver lactate transport increases in order to accommodate the increased
levels of lactate in the blood.
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Table 4.1: Initial validation of the addition of the red blood cell compart-
ment to the whole body model. Comparison of selected steady state metabolite
concentrations and some relevant fluxes for the Xu et. al [3] with model adaptations
and green1 with zero parasitemia.
Metabolite Description Xu et. al [3] with green1
(mM) model adaptations (with 0 % par)
Bgluc Blood glucose 5.6 5.1
Blac Blood lactate 0.072 0.79
Flux Description of rate
(mM/min)
v_d_Bgluc Blood glucose degradation 8.4 · 10−2 7.7 · 10−2
v_d_Blac Blood lactate degradation 1.1 · 10−3 1.2 · 10−2
v_tL1 Liver glucose transporter −5.9 · 10−4 −5.3 · 10−3
v_tL2 Liver lactate transporter 6.7 · 10−3 4.2 · 10−2
v_tF1 Fat tissue glucose transporter 5.8 · 10−2 5.3 · 10−2
v_tS1 Muscle glucose transporter 5.8 · 10−2 5.3 · 10−2
v_tS3 Muscle lactate transporter 7.8 · 10−3 7.0 · 10−3
During the construction of the green1 model the glucose and lactate transporters
(from the blood to the red blood cell) had to be duplicated due to unit differences
between the dutoit3 and Xu model (see Section 3.3.2). This required the inclusion
of a conversion factor (ω) allowing for the whole body transporters to be in units of
mM/min and the dutoit3 transporters to be in units of mmol/min. To verify that
mass was conserved between the two models during this conversion, the fluxes that
link the different models were calculated in their respective units and compared by
using the unit conversion factor.
Table 4.2 shows the results for the duplicated transporters for each system along
with the dutoit3 transporters to units of mM/min for green1 with 5 % par (using
the conversion factor ω). For example, the first entry in the table describes the
glucose transport rate vRBCvGLCTRANSPORT in the red blood cell part of the
green1 model in units of mmol per min, followed by its value in mM/min through
conversion by division with ω (see Section 3.3.2), and lastly the value for glucose
transport in the whole body part of the model (vWBvGLCTRANSPORT). Since
all of the red blood cell transporters (that have been converted to mM/min in Table
4.2) are identical to the whole body transporter rates mass is conserved within the
green1 model.
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Table 4.2: Verification of conservation of mass during the combining of the
Xu and parasitized red blood cell culture model. Flux results for duplicated
transport rates of parasite infected and uninfected RBC transporters in their differ-
ent units. Conversion between mmol/min and mM/min was done by division with
ω = vBld
1000
(see Section 3.3.2) for 5% parasitemia.
Transport rate RBC transporter RBC transporter Whole body
(mmol/min) (mM/min) RBC transporter
(mM/min)
Uninfected glucose flux 7.0 · 10−2 2.2 · 10−2 2.2 · 10−2
Uninfected lactate flux 1.4 · 10−1 4.3 · 10−1 4.3 · 10−1
Infected glucose flux 3.2 · 10−1 1.0 · 10−1 1.0 · 10−1
Infected lactate flux 5.9 · 10−1 1.9 · 10−1 1.9 · 10−1
Another approach to check that mass is conserved is by considering the glucose influx
and utilisation rates. In the green1 model the only input for glucose is the feeding
rate which was set to 0.2 mM/min. Glucose, in the blood, can be transported
into the adipose tissue (vtF1), liver (vtL1), muscle tissue (vtS1), uninfected RBC
(vWBvGLCTRANSPORT), parasite infected RBC (vWBivGLCTRANSPORT) or
it can degrade at a rate vd_Bgluc. Therefore, using the fluxes from the green1 model
(for 5% parasitemia), we have
Glucose utilisation = vtF1 + vtL1 + vtS1 + vd_Bgluc
+ vWBvGLCTRANSPORT+ vWBivGLCTRANSPORT
= 0.0257− 0.0133 + 0.0257 + 0.0376 + 0.0223 + 0.102
= 0.2
mM
min
(4.1.1)
From equation (4.1.1) it can be seen that the glucose influx is equivalent to the sum
of the utilisation rates and therefore mass is conserved within the merged system.
One of the aims of this thesis is to simulate to what extent an increased parasitaemia
leads to an increased utilisation of glucose and production of lactate at the whole
body level. Table 4.3 shows the important steady states (of metabolites and rates)
in the green1 model in two scenarios. The first is the case where there is 0% para-
sitaemia, namely simulating a healthy individual; while the second shows the steady
state results for blood glucose, blood lactate and relevant transporter rates in the
green1 model with 5% parasitaemia.
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Table 4.3: Steady state results from the green1 model. Steady
state results for selected metabolites and rates in the green1 model under
two conditions: firstly 0% parasitaemia and secondly 5% parasitaemia.
Metabolite (mM) green1 (with 0 % par) green1 (with 5 % par)
Bgluc 5.1 2.5
Blac 0.79 9.9
Flux (mmol/min)
JvPFvGLCtr 0 3.1 · 10−1
JvPFvLACtr 0 5.8 · 10−1
JvRBCvGLCTRANSPORT 7.3 · 10−2 7.0 · 10−2
JvRBCivGLCTRANSPORT 0 3.2 · 10−1
JvRBCvLACTRANSPORT 1.4 · 10−1 1.4 · 10−1
JvRBCivLACTRANSPORT 0 5.9 · 10−1
Jv_tL1* −5.3 · 10−3 −1.3 · 10−2
Jv_tL2 * 4.2 · 10−2 8.9 · 10−2
* v_tL1 represents the liver glucose transporter (transport from glucose in the
blood into the liver), v_tL2 represents the liver lactate transporter (transport
from lactate in the blood into the liver)
From Table 4.3 it can be seen that the presence of parasites in the green1 model
yields a lower blood glucose and a higher blood lactate steady state concentration.
This effect is brought about by the metabolism of the Plasmodium falciparum para-
sites. In the 0% parasitaemia green1 model the infected red blood cell transporters
for glucose (JvRBCivGLCTRANSPORT) and lactate (JvRBCivLACTRANSPORT) are zero (the
parasitized red blood cell compartment is not active by design). As expected, the
fluxes in the green1 model for the uninfected red blood cell transporters do not
change much with the addition of the parasite model.
As can be seen in Table 4.3 the parasites cause an increase in the utilisation of glucose
and increase in production of lactate in malaria patients. This led us to investigate
the effect of varying levels of parasitaemia on blood glucose and blood lactate. Figure
4.1 and Figure 4.2 shows the simulation result. The model illustrates that increasing
parasitaemia leads to a decrease in blood glucose and increase in blood lactate
(despite the whole body mechanisms for glucose and lactate homeostasis). The data
that can be seen in Figure 4.1 and Figure 4.2 are independent data sets/points
used to validate the model. Longitudinal data (especially of individuals not on
antimalarials) are not readily available and most of the clinical data in literature
consists of one or two points related to the admission data collected for malaria
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patients. Therefore validating the model becomes challenging as it is limited to
the available data and the clinical measurements taken. A literature search was
conducted to obtain as much data available as possible; however the data is not
ideal for model validation, due to large patient variability and absence of longitudinal
data.
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Figure 4.1: Model simulation of the steady state blood glucose concen-
tration with increasing parasitaemia (solid line). The grey region denotes
clinical diagnostic criteria for hypoglycaemia and severe malaria. Published data
for this region has not been found. Data points for malaria patients at admission
are from literature [69].
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Figure 4.2: Model simulation of the steady state blood lactate concen-
tration with increasing parasitaemia (solid line). The grey region denotes
clinical diagnostic criteria for lactic acidosis and severe malaria. Published data for
this region has not been found. Data points for malaria patients at admission are
from literature [69].
4.1.1 Inhibition of the parasites glycolytic flux
Mathematical models are a powerful tool that can be used to predict possible out-
comes of biological systems. We have shown that the increased glycolytic flux of
the parasites cause a decrease in blood glucose and increase in blood lactate levels.
It would be beneficial to know to what extent we could reduce hypoglycaemia and
lactic acidosis through the addition of a glycolytic inhibitor. Cytochalasin B is a
known inhibitor of the glucose-D-transporters [70, 71]. In a similar way to that of
van Niekerk et al. [52] the glucose transporter for the parasite model was altered
to include cytochalasin B by assuming competitive inhibition. An objective func-
tion was used in Mathematica 10.3 to determine the concentration of the inhibitor
cytochalasin that would be required to produce a 50 % inhibition of the parasites’
glycolytic flux (by monitoring vPFvLACtr). It was calculated that 11.58 µM would
be necessary to achieve this amount of inhibition. Figure 4.3 shows a simulation
from the model with 50 % inhibition of the parasites’ glycolytic flux. Here the effect
of inhibiting the parasites’ glycolysis can be seen on the blood glucose and lactate
concentrations.
In Figure 4.3 it can be seen that before the addition of the inhibitor (to the green1
model with 5 % parasitemia) at time zero the blood glucose level is low while the
lactate levels are high. The introduction of the inhibitor leads to a rapid decrease
in blood lactate and an increase in blood glucose concentrations. This investigation
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shows the benefit that reducing the glycolytic flux in the parasites would have on a
malaria patients’ blood glucose and lactate levels.
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Figure 4.3: Effect of a parasite glycolytic inhibitor on whole body glucose
and lactate concentrations. Simulation of blood glucose and blood lactate con-
centrations after the addition of 11.58 µM cytochalasin causing 50% reduction in the
glycolytic flux of Plasmodium falciparum in the green1 model with 5% parasitemia.
The inhibitor is administered at time zero and effects only the parasite glycolytic
transporter.
4.2 Sensitivity, Robustness and Control Analysis
Sensitivity analysis allows for two main outcomes: firstly it provides insights into the
certainty of model predictions in the context of parameter uncertainty. Secondly it
can help in determining the vulnerability of a system to changes in specific reactions
or parameters. A brief introduction to sensitivity analysis can be found in Chapter
2. In the following section we present results for the local and global sensitivity
analysis on the green1 model.
4.2.1 Local sensitivity analysis
In Metabolic Control Analysis there are three different types of coefficients used to
give insights into the effects that parameters or reactions have on a system. The
green1 model was analysed using control (see Table 4.4) and response coefficients
(see Table 4.5). Since the green1 model is so extensive only the rates with the highest
positive and negative controls over reactions, relevant to confirm model reliability
and predict possible drug targets, are considered here.
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4.2.1.1 Control coefficients
Control coefficients show how a perturbation (by 1%) in a rate affects the steady
state concentration of a metabolite or a reaction flux. Table 4.4 shows the control
coefficient results for the green1 model. While the green1 model is limited in molec-
ular detail (despite the detailed descriptions for the parasite and RBC glycolysis)
to accurately predict drug targets, it can give indications or reactions (with control
coefficients) that play a crucial role in achieving a desired model outcome on the
whole body level. In particular, reactions with high control in the parasite (and low
control in the host) are identified as good possibilities for drug targets.
Flux control coefficients
From Table 4.4 it can be seen that the reactions vPFvHK, vPFvPFK and vPFvGLCtr
have the most control on the glucose and lactate transporters of the infected red
blood cells (vRBCivGLCTRANSPORT and vRBCivLACTRANSPORT). This re-
sult was expected since the parasite is responsible for the increased glycolytic flux
after infection and in the isolated parasite model these reactions have the high-
est control. Since these three parasite rates have the largest control over vRB-
CivGLCTRANSPORT and vRBCivLACTRANSPORT they would be good reac-
tions to target i.e. inhibiting vPFvHK, vPFvPFK or vPFvGLCtr would have a
dramatic effect on the glucose transport into the parasitized red blood cells and the
lactate exported out of the infected red blood cells (see Discussion for reference to
previous work done). The homologous enzymes in the RBC have little control on the
uninfected red blood cell fluxes for glucose and lactate indicating that side effects
on the host would be minimal.
Concentration control coefficients
Metabolic Control Analysis showed that the degradation rates for blood glucose and
blood lactate have a negative control on their respective steady state metabolites,
namely CBglucv_d_Bgluc and C
Blac
v_d_Blac. An increase in the rate v_L5r in the liver, re-
sponsible for converting lactate to pyruvate, causes a negative effect on blood lactate
(CBlacvL5r = −0.51) as it feeds blood lactate into the Cori-cycle.
As seen in the control coefficients for the infected transporters the reactions vPFvHK,
vPFvPFK or vPFvGLCtr have a relatively large effect (compared to the other re-
actions) on blood glucose and lactate. The increase in these three parasite enzyme
rates have a negative control on blood glucose and a positive control on blood lactate
due to the increased glycolytic flux in the parasite.
The glucose intake rate v_feed features in almost all of the control coefficients in
Table 4.4 and the fixed value chosen in the model should therefore be carefully
considered.
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Table 4.4: Control coefficients from the green1 model. The highest and lowest control coefficients for relevant
metabolites and rates in the green1 model with 5% parasitaemia.
Reaction C
Bgluc
v C
Blac
v C
JvRBCvGLCTRANS
v C
JvRBCivGLCTRANS
v C
JvRBCvLACTRANS
v C
JvRBCivLACTRANS
v C
JvPFvGLCtr
v C
JCJvPFvLACtr
v
v_d_Bgluc -0.37 - - - - - - -
v_d_Bins -0.13 - - - - - - -
v_d_Blac - -0.94 - - - - - -
v_L5r 0.15 -0.51 - - - - - -
vRBCvHK - - 0.10 - 0.12 - - -
vRBCvBPGSP9 - - 0.18 - 0.19 - - -
vRBCvATPASE - 0.14 0.58 - 0.60 - - -
v_feed 2.0 0.33 - 0.12 - 0.23 0.24 0.24
vPFvGLCtr -0.29 0.31 - 0.26 - 0.27 0.26 0.27
vPFvPFK -0.32 0.35 - 0.29 - 0.30 0.29 0.30
vPFvHK -0.36 0.39 - 0.32 - 0.33 0.33 0.34
* Values not shown were not significant.
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4.2.1.2 Response coefficients
Response coefficients indicate the sensitivity of a system property for a change in
any system parameter. Therefore these coefficients can be used to describe how
perturbing a parameter effects a metabolite concentration or reaction rate at steady
state. Table 4.5 shows some of the important response coefficients for relevant
metabolites and reactions.
Consider the response coefficients RBglucpar and RBlacpar in Table 4.5. A 1% increase in
the parameter par leads to a 1.50% decrease in blood glucose (caused by the parasite
utilising glucose for glycolysis) and a 1.6% increase in blood lactate as a result of the
increased lactate produced by the parasites. These responses show the direct effect
that increasing parasite burden has on blood glucose and lactate concentrations.
The parameter HCT, representative of the hematocrit, has a large effect on many
of the relevant reactions and metabolites that are considered in Table 4.5. A slight
increase in the hematocrit has a considerable negative effect on blood glucose and a
positive effect on blood lactate. These large response coefficients can be explained
by considering the changes in red blood cell volume that occurs. An increase in the
hematocrit results in a greater fraction of total blood volume consisting of red blood
cells. With a greater red blood cell volume (in both the uninfected and infected
compartments), more red blood cells are able to utilise glucose and produce lactate
causing blood glucose to decrease and blood lactate to increase. This is similar to the
effect seen when the red blood cell compartment was added to the Xu model resulting
lower glucose levels and higher lactate levels in the blood. While the hematocrit is
not likely to change much in humans, Metabolic Control Analysis showed it is an
important parameter in the model and therefore its fixed value should be carefully
considered.
In Table 4.5 there are three parameters from the whole body model compartment
that have significant effects on the rates and metabolite concentrations that were
considered. In the liver compartment lactate is converted to pyruvate by the reaction
v_L5r. In this reaction v_L5r is directly proportional to k_L5r and inversely
proportional to k_mL5r. A 1% increase in k_L5r results in this reaction in the
liver to speed up. The increase of conversion of lactate into glucose via the Cori
cycle in the liver creates a demand for lactate which is then fulfilled by the import
of blood lactate into the liver. This accounts for the negative response coefficient
RBlack_L5r (-0.51) and the response of R
Jv_tL2
k_L5r (0.89) which shows an increase of the
flux in v_tL2 that is caused by the increase in the parameter k_L5r. It follows then
that the increase in k_mL5r reduces the rate v_L5r leading to a negative response
coefficient RJv_tL2k_mL5r = -0.10. The rate constant kd_Blac can be found in the equation
for blood lactate degradation described by a simple mass action equation. Therefore
an increase in this constant directly causes a decrease in blood lactate.
The binding constant KglcPFvHK can be found in the hexokinase reaction in the
parasite model while Kf6pPFvPFK is a binding constant in the phosphofructokinase
reaction in the parasite model. In Table 4.5 it can be seen that the responses for
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an increase in either of these parameters has a negative effect on the flux for vR-
BCivGLCTRANSPORT. The increase in either of these binding constants causes
a decrease in the affinity that each respective enzyme (hexokinase or phosphofruc-
tokinase) has for its substrate. For example, a 1% increase in KglcPFvHK results
in hexokinase having a lower affinity for glucose (inside the infected red blood cell).
As a result, in both of these cases, increasing the binding constants in the parasite
results in a inhibitory effect on the glycolytic pathway in the parasite. These lead
to the build up of glucose in the parasite, and in turn the build up of blood glu-
cose. This can be seen as the response coefficients RBglucKglcPFvHK and R
Bgluc
Kf6pPFvPFK are
both positive. Typically, pharmaceuticals are developed to target enzymes through
inhibitory mechanisms therefore targeting the kinetic constants KglcPFvHK and
Kf6pPFvPFK directly does not make sense. However, these response coefficients
suggest that a competitive inhibitor that decreases the affinity that hexokinase and
phosphofructokinase have for their respective substrates could be a possible drug
target solution.
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Table 4.5: Response coefficients from the green1 model. The highest and lowest response coefficients for relevant
metabolites and rates in the green1 model with 5 % parasitaemia.
Parameter R
Bgluc
p R
Blac
p R
JvRBCivGLCTRANSPORT
p R
JvRBCvGLCTRANSPORT
p R
JvRBCivLACTRANSPORT
p R
JvRBCvLACTRANSPORT
p R
Jv_tL2
p
par -1.5 1.6 1.3 - 1.3 - -
HCT -2.7 2.9 1.2 0.22 1.2 0.2 0.32
k_L5r - -0.51 - - - - 0.89
k_mL5r - - - - - - -0.10
kd_Blac - -0.94 - - - - -0.10
Kf6pPFvPFK 0.28 - -0.25 - -0.25 - -
KglcPFvHK 0.30 - -0.27 - -0.27 - -
* Responses of the fluxes and concentrations to the change in reaction rates (i.e. Vmax values) are omitted in this table since
RYv = C
Y
v and these values can be found in Table 4.4. Values not shown were not significant.
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4.2.2 Global sensitivity analysis
Parameter values play a significant role in the results of model predictions. In
some cases they can be experimentally determined while in others they need to
be estimated. Sensitivity analysis allows for the estimation of the propagation of
parameter uncertainty into model predictions.
Global sensitivity, also known as robustness analysis, was performed on the green1
model (with 5%) parasitaemia. This approach involves sampling of parameter val-
ues from the normal distributions with standard deviation of 5% around the mean
values of the parameters. The standard deviation is used as an indication to reflect
experimental error within the parameters. In reality, the experimental error is most
likely higher than the arbitrary chosen 5%, however for our analysis we decided to be
more strict in testing the accuracy of our model predictions. This method was used
to generate 80 000 different parameters sets. These sets were then used to calculate
the frequency of appearance of the blood glucose and blood lactate steady states
in this combined parameter space. The precision of this analysis can be refined
by increasing the number of bins and parameter sets generated. Although when
increasing the number of parameter set simulations from 60000 to 80000 we could
not see differences in the distributions, suggesting that the solutions had converged.
Figure 4.4 shows the range of steady state values obtained for blood glucose resulting
from this procedure. It can be seen that most of the generated parameter sets lead
to a steady state of between 2.17 - 2.95 mM for blood glucose (using 6000 parameter
sets as the selection criteria for the range). The original value used for parasitaemia
was 5 % however during the global sensitivity analysis it can range from 4.75 % to
5.25 %. When parasitaemia was 5 % it was shown in Table 4.3 that green1 had a
steady state value of 2.50 mM which is within the range of the solutions for Bgluc
that most of the parameter sets generated. Therefore model simulations of blood
glucose are not overly sensitive to small perturbations in the parameter values which
is in agreement with what Xu et al. [3] concluded for the original whole body model.
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Figure 4.4: Distribution of blood glucose steady states arising from pa-
rameter uncertainty. Global sensitivity results showing the distribution of blood
glucose steady state using 80 000 different parameter sets. Parameter sets were
determined by random sampling from a normal distribution centered around the
wild type value of the parameters with a 5% standard deviation. Steady states were
determined by using a long time integration.
Global sensitivity analysis showed (Figure 4.5) that for blood lactate the uncertainty
of parameter values lead to most steady state solutions (more than 6000 parameter
sets) being in the range of 7.64 - 10.4 mM. The blood lactate in green1 with 5%
parasitaemia led to a steady state solution of 9.86 mM. In Figure 4.5 the range of
blood lactate steady state values is the same as that of the global sensitivity analysis
for blood glucose in terms of percentage change. This suggests blood lactate, as well
as blood glucose, is not sensitive to small perturbations in the parameter set.
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Figure 4.5: Distribution of blood lactate steady states arising from pa-
rameter uncertainty. Global sensitivity results showing the distribution of blood
lactate steady state using 80 000 different parameter sets. Parameter sets were de-
termined by random sampling from a normal distribution centered around the wild
type value of the parameters with a 5% standard deviation. Steady states were
determined by using a long time integration.
In both histograms, global sensitivity analysis results showed some unexpected be-
haviour. Some parameter sets lead to steady state blood glucose values ranging
between 4.68 - 5.78 mM (Figure 4.4) and lactate levels falling within the range
0.058 - 0.6 mM (Figure 4.5). This could be a result of numerical precision error in
Mathematica but most likely it is due to the implementation of calculation of steady
state values. To reduce computational power required for the sensitivity analysis,
steady states were calculated by running time courses of metabolites for what was
thought to be a sufficient amount of time. It is possible that the model had not yet
reached steady state for those outlying parameter sets. We investigated one such
parameter set and found that the system is very sensitive to changes in the parame-
ter KmPFvATPASE (in the parasite model). Furthermore setting KmPFvATPASE
to it’s wild type value caused blood glucose to change from 5 mM to around 2.7 mM
suggesting that the cause of the unexpected behaviour could be parameter sets that
impede parasite glycolysis.
Sensitivity analysis has shown that the green1 model is not very sensitive to small
perturbations in the parameter sets. In the next chapter we will present a discussion
on the summarised results, model limitations and some concluding remarks.
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Chapter 5
Discussion and Conclusion
5.1 Summary
An important part of Systems biology is to share and combine existing mathemat-
ical models. Models are usually independently constructed to describe particular
biological or physical phenomenon, therefore the integration of them would allow
for the description of larger complex biological systems. As we illustrated in this
thesis, merging models is not a trivial task as they are often constructed in different
frameworks and unit descriptions. This can lead to numerical problems or unex-
pected model behaviour after merging the models. Furthermore it is necessary to
validate the merged models to justify the accuracy of model predictions. This has
encouraged the development of software packages, specification standards and tools
that allow for the reuse or automated merging of mathematical models (see Section
2.4).
In a previous study by Snoep et al. [72] a similar modelling approach, as used
in this thesis, was used to combine pathway models for glyoxalase, glycolysis and
extending the glycolytic pathway to include a glycerol branch. Their work addresses
the importance of integrating the knowledge of individual molecular mechanism-
based models to describe larger metabolism effects.
Initiatives such as the Virtual Physiological Human (VPH) [27], Virtual Physiolog-
ical Rat [73] and Virtual Liver Project [67] have been developed to study organs
and tissues through merged mathematical models. The models, at different levels
of biological organisation, are integrated through multi-level and multi-scale mod-
elling approaches. While these initiatives employ the same idea of linking models to
form hierarchical frameworks by building descriptions of emergent phenomena from
underlying mechanisms, we are unaware of any other models that have been merged
to explain clinical features of parasite burden in malaria patients.
Ultimately, this study aimed to determine through model simulation to what extent
accelerated glycolytic flux in malaria-infected red blood cells contributes to hypo-
glycemia and lactic acidosis associated with the malaria disease state. This was
achieved by linking existing models for whole body glucose metabolism in humans
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with detailed kinetic models for Plasmodium glycolysis and human erythrocyte gly-
colysis into a hierarchical framework (green1 model). Our framework allows for the
investigation of metabolic pathologies in malaria infected or healthy individuals in
whom the presence of malaria parasites could have a dramatic effect on blood glu-
cose and lactate. To our knowledge, to date there are no mathematical models that
can describe malaria disease states from the combination of sub-models with varying
levels of complexity (see Appendix B for manuscript publication).
In a previous study [2] the red blood cell model (Mulquiney & Kuchel [9–11]) had
to be altered to be linked with the parasite model. This involved changing the
units of the model and adding a glucose transporter to the red blood cell model.
Once the models were compatible in terms of units the parasite model was linked
with the red blood cell model. In the current study, the Plasmodium infected red
blood cell model’s glucose transporter was replaced and it was extended with the
model for the uninfected red blood cell (Mulquiney & Kuchel [9–11]) to represent a
malaria infected red blood cell culture with varying levels of parasitemia (called the
dutoit3 model). Splitting the total red blood cell modelling structure into infected
and uninfected compartments was required for the subsequent scaling up of the red
blood cell volumes to represent the blood compartment (consisting of infected and
uninfected red blood cells) of the whole body level. It was decided to use the Xu
et al. [3] model to describe whole body glucose metabolism. This model lacks a
red blood cell compartment and the dutoit3 model would provide exactly that with
a high level of mechanistic detail. To use the Xu model, it was coded from the
published Matlab files and curated on JWS Online. After an unsuccessful initial
attempt to convert the units of the whole body model to fmol amounts, it was
decided to keep the whole body model in units of concentration and link it with the
dutoit3 model which was adapted from fmol to mmol amounts. In implementing
this unit difference a conversion factor was created and used in duplicated transport
rates between the whole body and red blood cell compartment.
During the linking, certain adaptations had to be made to avoid numerical insta-
bility and address unexpected behaviour produced by the whole body model that
now included a detailed red blood cell compartment. Model adaptations included
changing the fixed values for free fatty acids in the fat tissue, alanine in the mus-
cle compartment and the glucose feeding rate such that blood glucose level for a
healthy individual was physiologically realistic. Another important adaptation was
the changing of the liver lactate transporter to a reversible Michaelis Menten equa-
tion to avoid the unrealistic build up of lactate in the liver compartment. Despite
the presence of the parasites, physiologically it is unlikely that the liver would be
overwhelmed at only 5% parasitaemia. Furthermore for steady state analysis it
was essential to change the phenomenologically modelled liver lactate transport of
the Xu et al. [3] model. Thereafter the model was numerically stable and showed
realistic steady state predictions for physiologically relevant levels of parasitemia.
In Chapter 4 we showed model validations, simulations and sensitivity analysis re-
sults. It was necessary to confirm that the addition of the red blood cell compartment
did not lead to unexpected behaviour when linked to the whole body model. The
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whole body fluxes indicated changes with the added RBC compartment could be
physiologically plausible. Verification of duplicated transporters in the same units
(using the conversion factor) proved that mass was still conserved within the system.
Model predictions showed that the presence of the parasite (5% parasitemia) lead
to a blood glucose steady state decrease to 2.5 mM (from 5.1 mM) and an increase
in the blood lactate steady state to 9.9 mM (from 0.79 mM).
Further simulations showed good qualitative and quantitative agreement with clin-
ical data of blood glucose and lactate in malaria infected individuals (by increasing
parasitaemia). While the trend seen in blood glucose and blood lactate due to
accelerated glycolytic flux is promising, a proper validation would require clinical
longitudinal data of patients (i.e. data that shows a change in blood glucose and
lactate over time in malaria infected hosts). In a model simulation it was shown
that with the addition of a known inhibitor of the parasite glucose transporter (and
therefore its glycolytic flux), namely cytochalasin, a 50% reduction in the parasite
glycolytic flux causes a dramatic partial restoration of blood glucose and lactate.
Results from local sensitivity analysis showed that the rates vPFvHK, vPFvPFK and
vPFvGLCtr in the parasite model have a large control over vRBCivGLCTRANS-
PORT and vRBCivLACTRANSPORT (i.e. the glucose and lactate fluxes across the
membrane of the infected red blood cells). We suggest that these enzymes should
be considered as good candidates for possible drug targets as an inhibition of these
reactions leads to a concomitant decrease in the glycolytic flux of the infected red
blood cells and restoration of blood glucose and lactate while having minimal effects
in the non-infected red blood cell. In addition, studying the response coefficients in
the green1 model showed that increasing either KglcPFvHK or Kf6pPFvPFK would
lead to a restoration of blood glucose and decrease in blood lactate. A drug acting
as a competitive inhibitor for fructose-6-phosphate on the phosphofructokinase en-
zyme or intracellular glucose on hexokinase, would therefore lead to a rise in blood
glucose levels and malaria symptoms such as hypoglycemia and lactic acidosis could
be avoided. It has been shown, in a single infected red blood cell, by van Niekerk
et al. [52] that the glucose transporter of the parasite might be a good target for
competitive inhibition.
Global sensitivity analysis showed that with a normal distribution around the mean
value of each parameter (standard deviation of 5%) and considering 80 000 different
parameter sets we can expect a steady state value for blood glucose in an infected in-
dividual with 5% parasitemia to most likely be between 2.17 - 2.85 mM. Considering
that the physiological reference state for glucose in a healthy individual is around
5 mM, the decreased glucose levels would have severe consequences on whole body
metabolism in malaria infected individuals. Similarly, most blood lactate steady
state solutions were found to be in the range of 7.64 - 10.4 mM. A patient is consid-
ered to have lactic acidosis when blood lactate > 5 mmol/L [12] suggesting that the
malaria parasite burden contributes significantly to this. Global sensitivity analysis
also showed that model simulations are not overly sensitive to small perturbations
in the parameter values for blood glucose and blood lactate steady state predictions.
Although sensitivity analysis gives insights into parameter uncertainty, the quality
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of the prediction is limited to accuracy of the descriptions of biological phenomena
in the model.
5.2 Shortcomings
Making assumptions in the modelling of biological systems is essential to reduce the
complexity of systems as underlying mechanisms are not always fully understood. In
addition it minimizes the computation power required to perform simulations. This
creates limitations in the accuracy of predictions and in this study the mechanistic
interpretation of the pathophysiology of the disease state in malaria patients. One
such limitation is from the Xu et. al. [3] model which by extension can also be found
in the green1 model. During this project we discovered that the original whole body
model was described in terms of concentration with the assumption that all com-
partments (e.g. muscle, liver, etc.) are of the same volume. It would be beneficial
to have described these separate components with explicit volumes or at least vol-
umes that are proportional to the expected size of each organ which would allow for
the combined model to be in units of amount per time. This would allow for more
realistic modelling of molecular transport between different compartments. Further
investigation into the possible use of allometric equations to scale compartment sizes
with respect to absolute body weight should be done (as well as the relationship be-
tween body mass and metabolic rate). In the process of combining of the models it
was also discovered that the Mulquiney and Kuchel model created many numerical
problems. This red blood cell model is very detailed and it is questionable if such
level of detail is required for the description of glucose metabolism and pathology in
the disease states on the whole body level. A possible solution to reduce the model
complexity is to lump pathways, equilibrium reactions, or eliminate reactions and
whole branches with low fluxes in a suitable way.
After linking the models it was seen that model adaptations had to be made to the
fixed parameters for free fatty acids in the fat tissue compartment and alanine in the
muscle compartment in combination with the glucose intake rate in the whole body
model. Fixing these parameters places limitations on the accuracy of metabolic
prediction as realistically these substances will vary with changing blood glucose
concentrations. In addition, model applicability is limited to the values these pa-
rameters are fixed at which are not necessary physiologically plausible. For example
the feeding rate was fixed at 0.2 mM/min, but a simple calculation on the average
calories consumed by an individual in a day equated to 0.63 mM/min if all calories
were taken up as glucose.
We suggest more research should also be done on the lactate metabolism in the whole
body model. Even though the wildtype prediction for blood lactate is within the
frequently occurring range for steady state lactate, it is suggested that the lactate
metabolism in the whole body should be further investigated for two main reasons.
Firstly, Xu et al. [3] did not conduct a sensitivity analysis (in terms of response
coefficients) for blood lactate on the original whole body model and therefore it
would be beneficial to know how precise the whole body model is in predicting
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lactate metabolism. Secondly, with the change made to the lactate transporter in
the liver some validation is required to verify the effect of this model adaptation on
lactate metabolism.
Possible causes for hypoglyceamia and lactic acidosis include reduced perfusion,
anaemia, or accelerated glycolytic flux caused by the Plasmodium falciparum par-
asite. Increased lactate production is often associated with severe malaria and is
correlated to patient death [13]. This model only includes the effect of accelerated
glycolytic flux on hypoglycemia and lactic acidosis and in future should be extending
to include the other possible causes.
Lastly, this model is limited to only one phase in the erythrocytic stage of malaria
in the human host and should be expanded by considering how the parasite grows
over time, how its metabolism changes, and how it proliferates in the body as a
result of asexual reproduction.
5.3 Conclusion
The aims of this thesis were to: 1) construct a multi-level model of human glucose
metabolism that contains the molecular mechanisms of erythrocyte and Plasmodium
glycolysis and 2) simulate to what extent an increased parasitaemia leads to an
increased utilisation of glucose and production of lactate, taking into account the
homeostatic mechanisms for glucose and lactate at the whole body level. These aims
were achieved by completing the following objectives.
Firstly, three existing mathematical models for the P. falciparum metabolism, ery-
throcyte metabolism and whole body glucose metabolism were identified. These
independent models were extended and modified as was necessary to merge them to
form the green1 model. Secondly, comparisons of simulations from the green1 model
with clinical data showed that increased glycolytic flux, caused by the presence of
the parasites, could be sufficient to explain the clinical symptoms of hypoglycemia
and lactic acidosis seen in malaria patients. These model predictions should be fur-
ther validated with sets of longitudinal data. The effect of reducing the glycolytic
flux of the parasites with an inhibitor showed a significant improvement to blood
glucose and lactate levels. Lastly, local and global sensitivity analysis identified re-
actions and parameters in the Plasmodium glycolysis pathway that could guide the
development of possible drug targets. Uncertainty analysis showed model simula-
tions of blood glucose and lactate are not overly sensitive to small perturbations in
the parameter values.
In future, we suggest emphasis should be placed on addressing model limitations
specifically for the whole body model, made for the simplification of the model con-
struction process, and validating the model simulations with experimental or clinical
data. In conclusion, we succeeded in estimating the contribution that Plasmodium
falciparum activity has on the clinical symptoms hypoglycemia and lactic acidosis
associated with malaria patients.
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Appendix A
Model description for the green1
model
This appendix contains the full model description of the green1 model. This includes
the combined extended P. falciparum infected erythrocyte model (dutoit3) and the
whole body model (Xu et al.[3]) with the modifications made to the respective
models to link them (see Section 3.3.3).
A.1 Naming conventions
A parasite metabolite or enzyme reaction is represented with the letters PF e.g.
glcPF (parasite glucose). The red blood cell compartment consists of an uninfected
and P. falciparum infected part. We denote the infected red blood cell metabolites
and reactions with the abbreviation RBCi while for the uninfected red blood cell
compartment we have RBC. The respective volumes for each compartment are given
by Vrbci (infected RBC volume) and Vrbcu (uninfected RBC volume) with the total
red blood cell volume as Vrbc. For the dutoit3 model the metabolites are modelled
in mmol and reaction rates in mmol/min. Metabolites and rates that do not contain
the compartment specification of PF or RBC/RBCi belong to the whole body model
(Xu et al.[3]). These variables are present in various compartments of the whole
body model as is described in the original model (see Section 3.1.3). The whole
body metabolites have units of mM and reactions are modelled in units of mM/min.
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A.2 Initial Values:
B_alan(0) = 0.312 (A.2.1)
B_ffa(0) = 0.936 (A.2.2)
B_gluc(0) = 12.48 (A.2.3)
B_glucgn(0) = 0. (A.2.4)
B_ins(0) = 0. (A.2.5)
B_ket(0) = 0.2496 (A.2.6)
B_lac(0) = 0.624 (A.2.7)
Cvar(0) = 0. (A.2.8)
F_TG(0) = 0. (A.2.9)
F_acyl(0) = 0. (A.2.10)
F_g6p(0) = 0. (A.2.11)
GPa(0) = 0.1092 (A.2.12)
GSa(0) = 0.00468 (A.2.13)
M_g6p(0) = 24.96 (A.2.14)
M_glycgn(0) = 1. (A.2.15)
M_ket(0) = 0.312 (A.2.16)
M_lac(0) = 0.624 (A.2.17)
M_pyr(0) = 0.624 (A.2.18)
PKa(0) = 0. (A.2.19)
PP1(0) = 0.00078 (A.2.20)
PP1_GPa(0) = 0. (A.2.21)
R2C2(0) = 0.00078 (A.2.22)
R2_C_cAMP2(0) = 0. (A.2.23)
R2_cAMP4(0) = 0. (A.2.24)
aK(0) = 3.12 (A.2.25)
acet_c(0) = 18.72 (A.2.26)
acet_m(0) = 21.84 (A.2.27)
adpPF(0) = 0.0339733 (A.2.28)
adpRBC(0) = 0.643188 (A.2.29)
adpRBCi(0) = 0.033852 (A.2.30)
alan(0) = 0.312 (A.2.31)
ampRBC(0) = 0.062244 (A.2.32)
ampRBCi(0) = 0.003276 (A.2.33)
atpPF(0) = 0.0679467 (A.2.34)
atpRBC(0) = 4.35708 (A.2.35)
atpRBCi(0) = 0.22932 (A.2.36)
b13pgPF(0) = 0.00339733 (A.2.37)
b13pgRBC(0) = 0.00145236 (A.2.38)
b13pgRBCi(0) = 0.00007644 (A.2.39)
b23pgRBC(0) = 13.9012 (A.2.40)
b23pgRBCi(0) = 0.73164 (A.2.41)
bpgspRBC(0) = 0.00788424 (A.2.42)
71
Stellenbosch University  https://scholar.sun.ac.za
bpgspRBCi(0) = 0.00041496 (A.2.43)
bpgspb13pgRBC(0) = 0. (A.2.44)
bpgspb13pgRBCi(0) = 0. (A.2.45)
bpgspb23pgRBC(0) = 0. (A.2.46)
bpgspb23pgRBCi(0) = 0. (A.2.47)
bpgsppRBC(0) = 0. (A.2.48)
bpgsppRBCi(0) = 0. (A.2.49)
bpgsppp2gRBC(0) = 0. (A.2.50)
bpgsppp2gRBCi(0) = 0. (A.2.51)
bpgsppp3gRBC(0) = 0. (A.2.52)
bpgsppp3gRBCi(0) = 0. (A.2.53)
bpgsppphosRBC(0) = 0. (A.2.54)
bpgsppphosRBCi(0) = 0. (A.2.55)
cAMP(0) = 0. (A.2.56)
citrate(0) = 1.56 (A.2.57)
dhapPF(0) = 0.00339733 (A.2.58)
dhapRBC(0) = 0.0394212 (A.2.59)
dhapRBCi(0) = 0.0020748 (A.2.60)
ery4pRBC(0) = 0.020748 (A.2.61)
ery4pRBCi(0) = 0.001092 (A.2.62)
f16bpPF(0) = 0.00339733 (A.2.63)
f16p2RBC(0) = 0.00560196 (A.2.64)
f16p2RBCi(0) = 0.00029484 (A.2.65)
f6pPF(0) = 0.00339733 (A.2.66)
f6pRBC(0) = 0.0269724 (A.2.67)
f6pRBCi(0) = 0.0014196 (A.2.68)
g16p2RBC(0) = 0.253126 (A.2.69)
g16p2RBCi(0) = 0.0133224 (A.2.70)
g3pPF(0) = 0.00339733 (A.2.71)
g6p(0) = 0.624 (A.2.72)
g6pPF(0) = 0.00339733 (A.2.73)
g6pRBC(0) = 0.082992 (A.2.74)
g6pRBCi(0) = 0.004368 (A.2.75)
gapPF(0) = 0.00339733 (A.2.76)
gapRBC(0) = 0.0118264 (A.2.77)
gapRBCi(0) = 0.00062244 (A.2.78)
glcPF(0) = 0.00339733 (A.2.79)
glcRBC(0) = 10.374 (A.2.80)
glcRBCi(0) = 0.546 (A.2.81)
gluc(0) = 15.6 (A.2.82)
glutamate(0) = 0.312 (A.2.83)
glycgn(0) = 31.2 (A.2.84)
gshRBC(0) = 6.63936 (A.2.85)
gshRBCi(0) = 0.34944 (A.2.86)
gssgRBC(0) = 0.000186732 (A.2.87)
gssgRBCi(0) = 9.828× 10−6 (A.2.88)
hbRBC(0) = 14.5236 (A.2.89)
hbRBCi(0) = 0.7644 (A.2.90)
hbadpRBC(0) = 0. (A.2.91)
hbadpRBCi(0) = 0. (A.2.92)
hbatpRBC(0) = 0. (A.2.93)
(A.2.94)
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hbatpRBCi(0) = 0. (A.2.95)
hbb13pgRBC(0) = 0. (A.2.96)
hbb13pgRBCi(0) = 0. (A.2.97)
hbb23pgRBC(0) = 0. (A.2.98)
hbb23pgRBCi(0) = 0. (A.2.99)
hbmgatpRBC(0) = 0. (A.2.100)
hbmgatpRBCi(0) = 0. (A.2.101)
ket(0) = 0.2496 (A.2.102)
lac(0) = 3.12 (A.2.103)
lacPF(0) = 0.00339733 (A.2.104)
lacRBC(0) = 2.90472 (A.2.105)
lacRBCi(0) = 0.15288 (A.2.106)
malate(0) = 9.36 (A.2.107)
malonyl(0) = 0.936 (A.2.108)
mgRBC(0) = 6.2244 (A.2.109)
mgRBCi(0) = 0.3276 (A.2.110)
mgadpRBC(0) = 0. (A.2.111)
mgadpRBCi(0) = 0. (A.2.112)
mgatpRBC(0) = 0. (A.2.113)
mgatpRBCi(0) = 0. (A.2.114)
mgb13pgRBC(0) = 0. (A.2.115)
mgb13pgRBCi(0) = 0. (A.2.116)
mgb23pgRBC(0) = 0. (A.2.117)
mgb23pgRBCi(0) = 0. (A.2.118)
mgf16p2RBC(0) = 0. (A.2.119)
mgf16p2RBCi(0) = 0. (A.2.120)
mgg16p2RBC(0) = 0. (A.2.121)
mgg16p2RBCi(0) = 0. (A.2.122)
mgphosRBC(0) = 0. (A.2.123)
mgphosRBCi(0) = 0. (A.2.124)
nadPF(0) = 0.0849333 (A.2.125)
nadRBC(0) = 0.124488 (A.2.126)
nadRBCi(0) = 0.006552 (A.2.127)
nadhPF(0) = 0.0169867 (A.2.128)
nadhRBC(0) = 0.000290472 (A.2.129)
nadhRBCi(0) = 0.000015288 (A.2.130)
nadpRBC(0) = 0.00025935 (A.2.131)
nadpRBCi(0) = 0.00001365 (A.2.132)
nadphRBC(0) = 0.132787 (A.2.133)
nadphRBCi(0) = 0.0069888 (A.2.134)
oa_c(0) = 0.001248 (A.2.135)
oa_m(0) = 0.000624 (A.2.136)
p2gPF(0) = 0.00339733 (A.2.137)
p2gRBC(0) = 0.020748 (A.2.138)
p2gRBCi(0) = 0.001092 (A.2.139)
p3gPF(0) = 0.00339733 (A.2.140)
p3gRBC(0) = 0.132787 (A.2.141)
p3gRBCi(0) = 0.0069888 (A.2.142)
p6gRBC(0) = 0.000290472 (A.2.143)
p6gRBCi(0) = 0.000015288 (A.2.144)
p6glRBC(0) = 2.90472× 10−7 (A.2.145)
p6glRBCi(0) = 1.5288× 10−8 (A.2.146)
palm(0) = 0.936 (A.2.147)
(A.2.148)
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palmCoA(0) = 0.936 (A.2.149)
pep(0) = 0.00312 (A.2.150)
pepPF(0) = 0.00339733 (A.2.151)
pepRBC(0) = 0.0477204 (A.2.152)
pepRBCi(0) = 0.0025116 (A.2.153)
phosRBC(0) = 2.0748 (A.2.154)
phosRBCi(0) = 0.1092 (A.2.155)
pyr(0) = 9.36 (A.2.156)
pyrPF(0) = 0.00339733 (A.2.157)
pyrRBC(0) = 0.124488 (A.2.158)
pyrRBCi(0) = 0.006552 (A.2.159)
rib5pRBC(0) = 0.020748 (A.2.160)
rib5pRBCi(0) = 0.001092 (A.2.161)
ru5pRBC(0) = 0.020748 (A.2.162)
ru5pRBCi(0) = 0.001092 (A.2.163)
sed7pRBC(0) = 0.020748 (A.2.164)
sed7pRBCi(0) = 0.001092 (A.2.165)
tkRBC(0) = 0.000684684 (A.2.166)
tkRBCi(0) = 0.000036036 (A.2.167)
tkgRBC(0) = 0. (A.2.168)
tkgRBCi(0) = 0. (A.2.169)
tkgery4pRBC(0) = 0. (A.2.170)
tkgery4pRBCi(0) = 0. (A.2.171)
tkgrib5pRBC(0) = 0. (A.2.172)
tkgrib5pRBCi(0) = 0. (A.2.173)
tkxu5pRBC(0) = 0. (A.2.174)
tkxu5pRBCi(0) = 0. (A.2.175)
xu5pRBC(0) = 0.0020748 (A.2.176)
xu5pRBCi(0) = 0.0001092 (A.2.177)
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A.3 Parameter Values:
AlphaCellWaterFraction = 0.7 (A.3.1)
AlphaRBCvGLCTRANSPORT = 0.54 (A.3.2)
CRBCvMGADP = 0.00062 (A.3.3)
CRBCvMGATP = 0.000084 (A.3.4)
CRBCvMGB13PG = 0.0032 (A.3.5)
CRBCvMGB23PG = 0.0032 (A.3.6)
CRBCvMGF16P2 = 0.0083 (A.3.7)
CRBCvMGG16P2 = 0.0083 (A.3.8)
CRBCvMGPHOS = 40800. (A.3.9)
ConcADPRBC = 0.00031 M (A.3.10)
ConcAMPRBC =
3
100000
M (A.3.11)
ConcATPRBC = 0.0021 M (A.3.12)
ConcAdpPF = 0.001 M (A.3.13)
ConcAtpPF = 0.002 M (A.3.14)
ConcB13PGRBC =
7
10000000
M (A.3.15)
ConcB13pgPF = 0.0001 M (A.3.16)
ConcB23PGRBC = 0.0067 M (A.3.17)
ConcBPGSPB13PGRBC = 0. M (A.3.18)
ConcBPGSPB23PGRBC = 0. M (A.3.19)
ConcBPGSPPP2GRBC = 0. M (A.3.20)
ConcBPGSPPP3GRBC = 0. M (A.3.21)
ConcBPGSPPRBC = 0. M (A.3.22)
ConcBPGSPRBC = 3.8× 10−6 M (A.3.23)
ConcBpgsppphosRBC = 0. M (A.3.24)
ConcCo2RBC = 0.0012 M (A.3.25)
ConcDhapPF = 0.0001 M (A.3.26)
ConcDhapRBC = 0.000019 M (A.3.27)
ConcEry4PRBC =
1
100000
M (A.3.28)
ConcF16P2RBC = 2.7× 10−6 M (A.3.29)
ConcF16bpPF = 0.0001 M (A.3.30)
ConcF6PRBC = 0.000013 M (A.3.31)
ConcF6pPF = 0.0001 M (A.3.32)
ConcG16P2RBC = 0.000122 M (A.3.33)
ConcG6PRBC =
1
25000
M (A.3.34)
ConcG6pPF = 0.0001 M (A.3.35)
ConcGSHRBC = 0.0032 M (A.3.36)
ConcGapPF = 0.0001 M (A.3.37)
ConcGapRBC = 5.7× 10−6 M (A.3.38)
ConcGlcEXT = 0.005 M (A.3.39)
ConcGlcPF = 0.0001 M (A.3.40)
ConcGlcRBC = 0.001 M (A.3.41)
ConcGly3pPF = 0.0001 M (A.3.42)
ConcGssgRBC =
9
100000000
M (A.3.43)
ConcHbADPRBC = 0. M (A.3.44)
ConcHbATPRBC = 0. M (A.3.45)
ConcHbB13PGRBC = 0. M (A.3.46)
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ConcHbB23PGRBC = 0. M (A.3.47)
ConcHbRBC = 0.007 M (A.3.48)
ConcHbmgatpRBC = 0. M (A.3.49)
ConcLacEXT = 0.00182 M (A.3.50)
ConcLacPF = 0.0001 M (A.3.51)
ConcLacRBC = 0.0014 M (A.3.52)
ConcMgADPRBC = 0. M (A.3.53)
ConcMgB13PGRBC = 0. M (A.3.54)
ConcMgB23PGRBC = 0. M (A.3.55)
ConcMgF16P2RBC = 0. M (A.3.56)
ConcMgRBC = 0.003 M (A.3.57)
ConcMgatpRBC = 0. M (A.3.58)
ConcMgg16p2RBC = 0. M (A.3.59)
ConcMgphosRBC = 0. M (A.3.60)
ConcNADPRBC = 1.25× 10−7 M (A.3.61)
ConcNADRBC =
3
50000
M (A.3.62)
ConcNadPF = 0.0025 M (A.3.63)
ConcNadhPF = 0.0005 M (A.3.64)
ConcNadhRBC = 1.4× 10−7 M (A.3.65)
ConcNadphRBC = 0.000064 M (A.3.66)
ConcP2GARBC =
1
100000
M (A.3.67)
ConcP2gPF = 0.0001 M (A.3.68)
ConcP3GARBC = 0.000064 M (A.3.69)
ConcP3gPF = 0.0001 M (A.3.70)
ConcP6GLRBC = 1.4× 10−10 M (A.3.71)
ConcP6GRBC = 1.4× 10−7 M (A.3.72)
ConcPEPRBC = 0.000023 M (A.3.73)
ConcPepPF = 0.0001 M (A.3.74)
ConcPhosEXT = 0.00192 M (A.3.75)
ConcPhosRBC = 0.001 M (A.3.76)
ConcPyrEXT = 0.000085 M (A.3.77)
ConcPyrPF = 0.0001 M (A.3.78)
ConcPyrRBC =
3
50000
M (A.3.79)
ConcRib5PRBC =
1
100000
M (A.3.80)
ConcRu5PRBC =
1
100000
M (A.3.81)
ConcSed7PRBC =
1
100000
M (A.3.82)
ConcTKGEry4PRBC = 0. M (A.3.83)
ConcTKGRBC = 0. M (A.3.84)
ConcTKGRib5PRBC = 0. M (A.3.85)
ConcTKRBC = 3.3× 10−7 M (A.3.86)
ConcTkxu5pRBC = 0. M (A.3.87)
ConcXu5PRBC =
1
1000000
M (A.3.88)
ConvPF = 0.214133 M (A.3.89)
ERBCvHK = 2.5× 10−8 M (A.3.90)
ERBCvPGI = 2.18× 10−7 M (A.3.91)
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Gmax =
1
20000000
mM (A.3.92)
Gmin =
3
100000000
mM (A.3.93)
HCT = 0.5 (A.3.94)
Imax = 1.3× 10−6 mM (A.3.95)
Imin =
7
10000000
mM (A.3.96)
K10RBCvBPGSP6 = 1979. s−1 (A.3.97)
K10RBCvG6PDH = 1.4× 109 M−1s−1 (A.3.98)
K10RBCvGSSGR = 5.× 107 M−1s−1 (A.3.99)
K10RBCvP6GDH = 225000. M−1s−1 (A.3.100)
K10RBCvTK5 = 175. s−1 (A.3.101)
K11RBCvBPGSP6 = 0.01 s−1 (A.3.102)
K11RBCvGSSGR = 7000. s−1 (A.3.103)
K11RBCvP6GDH = 300. s−1 (A.3.104)
K11RBCvTK6 = 40. s−1 (A.3.105)
K12RBCvBPGSP7 = 1000. s−1 (A.3.106)
K12RBCvGSSGR = 1.× 108 M−1s−1 (A.3.107)
K12RBCvP6GDH = 4.95× 106 M−1s−1 (A.3.108)
K12RBCvTK6 = 21300. M−1s−1 (A.3.109)
K13RBCvBPGSP7 = 1.8× 106 M−1s−1 (A.3.110)
K14RBCvBPGSP8 = 1.× 109 M−1s−1 (A.3.111)
K15RBCvBPGSP8 = 610000. s−1 (A.3.112)
K16RBCvBPGSP9 = 0.19 s−1 (A.3.113)
K1RBCvAK = 4300. M−1s−1 (A.3.114)
K1RBCvBPGSP1 = 8.× 107 M−1s−1 (A.3.115)
K1RBCvG6PDH = 1.1× 108 M−1s−1 (A.3.116)
K1RBCvGSSGR = 8.5× 107 M−1s−1 (A.3.117)
K1RBCvP6GDH = 2.4× 106 M−1s−1 (A.3.118)
K1RBCvR5PI = 60900. M−1s−1 (A.3.119)
K1RBCvRu5PE = 3.91× 106 M−1s−1 (A.3.120)
K1RBCvTA = 580000. M−1s−1 (A.3.121)
K1RBCvTK1 = 216000. M−1s−1 (A.3.122)
K2RBCvAK = 1400. M−1s−1 (A.3.123)
K2RBCvBPGSP1 = 400. s−1 (A.3.124)
K2RBCvG6PDH = 870. s−1 (A.3.125)
K2RBCvGSSGR = 510. s−1 (A.3.126)
K2RBCvP6GDH = 410. s−1 (A.3.127)
K2RBCvR5PI = 33.3 s−1 (A.3.128)
K2RBCvRu5PE = 438. s−1 (A.3.129)
K2RBCvTA = 45.3 s−1 (A.3.130)
K2RBCvTK1 = 38. s−1 (A.3.131)
K3RBCvBPGSP2 = 9.9 s−1 (A.3.132)
K3RBCvG6PDH = 2.6× 107 M−1s−1 (A.3.133)
K3RBCvGSSGR = 1.× 109 M−1s−1 (A.3.134)
K3RBCvP6GDH = 2.× 109 M−1s−1 (A.3.135)
K3RBCvR5PI = 14.2 s−1 (A.3.136)
K3RBCvRu5PE = 305. s−1 (A.3.137)
K3RBCvTA = 16.3 s−1 (A.3.138)
K3RBCvTK2 = 34. s−1 (A.3.139)
K4RBCvBPGSP3 = 1.85× 108 M−1s−1 (A.3.140) 77
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K4RBCvG6PDH = 300. s−1 (A.3.141)
K4RBCvGSSGR = 72000. s−1 (A.3.142)
K4RBCvP6GDH = 26000. s−1 (A.3.143)
K4RBCvR5PI = 21600. M−1s−1 (A.3.144)
K4RBCvRu5PE = 1.49× 106 M−1s−1 (A.3.145)
K4RBCvTA = 1.01× 106 M−1s−1 (A.3.146)
K4RBCvTK2 = 156000. M−1s−1 (A.3.147)
K5RBCvBPGSP3 = 1.× 108 s−1 (A.3.148)
K5RBCvG6PDH = 750. s−1 (A.3.149)
K5RBCvGSSGR = 810. s−1 (A.3.150)
K5RBCvP6GDH = 48. s−1 (A.3.151)
K5RBCvTA = 490000. M−1s−1 (A.3.152)
K5RBCvTK3 = 329000. M−1s−1 (A.3.153)
K6RBCvBPGSP4 = 1000. M−1s−1 (A.3.154)
K6RBCvG6PDH = 2000. s−1 (A.3.155)
K6RBCvGSSGR = 1000. s−1 (A.3.156)
K6RBCvP6GDH = 30. s−1 (A.3.157)
K6RBCvTA = 60. s−1 (A.3.158)
K6RBCvTK3 = 175. s−1 (A.3.159)
K7RBCvBPGSP4 = 1000. s−1 (A.3.160)
K7RBCvG6PDH = 220000. s−1 (A.3.161)
K7RBCvGSSGR = 1.× 106 s−1 (A.3.162)
K7RBCvP6GDH = 630. s−1 (A.3.163)
K7RBCvTA = 17. s−1 (A.3.164)
K7RBCvTK4 = 40. s−1 (A.3.165)
K8RBCvBPGSP5 = 10000. s−1 (A.3.166)
K8RBCvG6PDH = 1.1× 109 M−1s−1 (A.3.167)
K8RBCvGSSGR = 5.× 107 M−1s−1 (A.3.168)
K8RBCvP6GDH = 36000. M−1s−1 (A.3.169)
K8RBCvTA = 79000. M−1s−1 (A.3.170)
K8RBCvTK4 = 44800. M−1s−1 (A.3.171)
K9RBCvBPGSP5 = 0.55 s−1 (A.3.172)
K9RBCvG6PDH = 10000. s−1 (A.3.173)
K9RBCvGSSGR = 1.× 106 s−1 (A.3.174)
K9RBCvP6GDH = 800. s−1 (A.3.175)
K9RBCvTK5 = 2.24× 106 M−1s−1 (A.3.176)
KPFvGLCtr = 0.000213 M (A.3.177)
KRBCvATPASE = 0.000585 s−1 (A.3.178)
KRBCvMGADP = 3290. L.mol−1 (A.3.179)
KRBCvMGATP = 43200. L.mol−1 (A.3.180)
KRBCvMGB13PG = 7410. L.mol−1 (A.3.181)
KRBCvMGB23PG = 7410. L.mol−1 (A.3.182)
KRBCvMGF16P2 = 363. L.mol−1 (A.3.183)
KRBCvMGG16P2 = 363. L.mol−1 (A.3.184)
KRBCvOX = 0.000034 s−1 (A.3.185)
KRBCvOXNADH = 0.0163 s−1 (A.3.186)
KaRBCvHBADP = 300000. M−1s−1 (A.3.187)
KaRBCvHBATP = 432000. M−1s−1 (A.3.188)
KaRBCvHBB13PG = 380000. M−1s−1 (A.3.189)
KaRBCvHBBPG = 300000. M−1s−1 (A.3.190)
KaRBCvHBMGATP = 46800. M−1s−1 (A.3.191)
KaRBCvMGADP = 2.76× 106 M−1s−1 (A.3.192)
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KaRBCvMGATP = 3.12× 107 M−1s−1 (A.3.193)
KaRBCvMGB13PG = 228000. M−1s−1 (A.3.194)
KaRBCvMGB23PG = 804000. M−1s−1 (A.3.195)
KaRBCvMGF16P2 = 480000. M−1s−1 (A.3.196)
KaRBCvMGG16P2 = 480000. M−1s−1 (A.3.197)
KaRBCvMGPHOS = 40800. M−1s−1 (A.3.198)
KaRBCvPFK = 8.91251× 10−8 M (A.3.199)
KadpPFvHK = 0.000846735 M (A.3.200)
KadpPFvPFK = 0.00074176 M (A.3.201)
KadpPFvPGK = 0.00015 M (A.3.202)
KadpPFvPK = 0.000317 M (A.3.203)
KahbRBC = 2.51189× 10−7 M (A.3.204)
KatpPFvHK = 0.00069647 M (A.3.205)
KatpPFvPFK = 0.0007862 M (A.3.206)
KatpPFvPGK = 0.00077 M (A.3.207)
Kb13pgPFvGAPDH = 0.00002359 M (A.3.208)
Kb13pgPFvPGK = 0.0000134 M (A.3.209)
KcatfRBCvALD = 68. s−1 (A.3.210)
KcatfRBCvENO = 190. s−1 (A.3.211)
KcatfRBCvGAPDH = 695.304 s−1 (A.3.212)
KcatfRBCvHK = 299.16 s−1 (A.3.213)
KcatfRBCvLDH = 458. s−1 (A.3.214)
KcatfRBCvPFK = 822. s−1 (A.3.215)
KcatfRBCvPGI = 1470. s−1 (A.3.216)
KcatfRBCvPGK = 2290. s−1 (A.3.217)
KcatfRBCvPGM = 795. s−1 (A.3.218)
KcatfRBCvPK = 1386. s−1 (A.3.219)
KcatfRBCvTIM = 14560. s−1 (A.3.220)
KcatrRBCvALD = 234. s−1 (A.3.221)
KcatrRBCvENO = 50. s−1 (A.3.222)
KcatrRBCvGAPDH = 512.487 s−1 (A.3.223)
KcatrRBCvHK = 1.92792 s−1 (A.3.224)
KcatrRBCvLDH = 115. s−1 (A.3.225)
KcatrRBCvPFK = 36. s−1 (A.3.226)
KcatrRBCvPGI = 1760. s−1 (A.3.227)
KcatrRBCvPGK = 917. s−1 (A.3.228)
KcatrRBCvPGM = 714. s−1 (A.3.229)
KcatrRBCvPK = 3.26 s−1 (A.3.230)
KcatrRBCvTIM = 1280. s−1 (A.3.231)
KdPFvLACtr = 0.005 min−1 (A.3.232)
KdPFvPYRtr = 0.0007 min−1 (A.3.233)
KdRBCvHBADP = 1200. s−1 (A.3.234)
KdRBCvHBATP = 1200. s−1 (A.3.235)
KdRBCvHBB13PG = 1200. s−1 (A.3.236)
KdRBCvHBBPG = 1200. s−1 (A.3.237)
KdRBCvHBMGATP = 1200. s−1 (A.3.238)
KdRBCvMGADP = 1200. s−1 (A.3.239)
KdRBCvMGATP = 1200. s−1 (A.3.240)
KdRBCvMGB13PG = 1200. s−1 (A.3.241)
KdRBCvMGB23PG = 1200. s−1 (A.3.242)
KdRBCvMGF16P2 = 1200. s−1 (A.3.243)
KdRBCvMGG16P2 = 1200. s−1 (A.3.244)
KdRBCvMGPHOS = 1200. s−1 (A.3.245)
KdhapPFvALD = 0.00011 M (A.3.246)
KdhapPFvG3PDH = 0.00034 M (A.3.247)
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KdhapPFvTPI = 0.001954 M (A.3.248)
KdibpgRBCvHK = 0.004 M (A.3.249)
Kdig16p2RBCvHK =
3
100000
M (A.3.250)
Kdig6pRBCvHK =
1
100000
M (A.3.251)
KdigshRBCvHK = 0.003 M (A.3.252)
KeqPFvALD =
9
100000
M−1 (A.3.253)
KeqPFvENO = 4.6 (A.3.254)
KeqPFvG3PDH = 32600. (A.3.255)
KeqPFvHK = 1310. (A.3.256)
KeqPFvPGI = 0.33 (A.3.257)
KeqPFvPGK = 3200. (A.3.258)
KeqPFvPGM = 0.19 (A.3.259)
KeqPFvTPI = 0.04545 (A.3.260)
KeqRBCvGLCTRANSPORT = 1. (A.3.261)
Kf16bpPFvALD = 0.0000684 M (A.3.262)
Kf16bpPFvPFK = 0.003626 M (A.3.263)
Kf6pPFvPFK = 0.00109454 M (A.3.264)
Kf6pPFvPGI = 0.000096651 M (A.3.265)
KfRBCvLDHP = 0.00346 s−1 (A.3.266)
Kg3pPFvG3PDH = 0.000398 M (A.3.267)
Kg6pPFvHK = 0.000043 M (A.3.268)
Kg6pPFvPGI = 0.00100774 M (A.3.269)
KgapPFvALD = 0.000046 M (A.3.270)
KgapPFvGAPDH = 0.000917 M (A.3.271)
KgapPFvTPI = 0.000337 M (A.3.272)
KglcPFvHK = 0.000168613 M (A.3.273)
Kh2bpgRBCvMGB13PG = 4.27× 106 L.mol−1 (A.3.274)
Kh2bpgRBCvMGB23PG = 4.27× 106 L.mol−1 (A.3.275)
Kh2fRBCvMGF16P2 = 1.12× 106 L.mol−1 (A.3.276)
Kh2fRBCvMGG16P2 = 1.12× 106 L.mol−1 (A.3.277)
KhadpRBCvAK = 5.42× 106 L.mol−1 (A.3.278)
KhadpRBCvMGADP = 5.42× 106 L.mol−1 (A.3.279)
KhampRBCvAK = 3.09× 106 L.mol−1 (A.3.280)
KhatpRBCvMGATP = 9.07× 106 L.mol−1 (A.3.281)
KhbpgRBCvMGB13PG = 1.62× 108 L.mol−1 (A.3.282)
KhbpgRBCvMGB23PG = 1.62× 108 L.mol−1 (A.3.283)
KhfRBCvMGF16P2 = 7.56× 106 L.mol−1 (A.3.284)
KhfRBCvMGG16P2 = 7.56× 106 L.mol−1 (A.3.285)
KhphosRBCvMGPHOS = 5.68× 106 L.mol−1 (A.3.286)
KhydrolRBCvPGLHYDROLYSIS = 0.00071 L.mol−1 (A.3.287)
KiRBCvGLCTRANSPORT = 0.0069 M (A.3.288)
KiRBCvLACTRANSPORT = 0.0036 s−1 (A.3.289)
KiRBCvPHOSTRANSPORT = 0.00056 s−1 (A.3.290)
KiRBCvPYRTRANSPORT = 0.018 s−1 (A.3.291)
KiadpPFvPK = 0.002 M (A.3.292)
KiatpPFvHK = 0.026 M (A.3.293)
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KiatpPFvPK = 0.00182 M (A.3.294)
Kib13pgRBCvGAPDH = 4.55544× 10−21 M (A.3.295)
Kib13pgRBCvPGK = 1.6× 10−6 M (A.3.296)
Kib23pgRBCvALD = 0.0015 M (A.3.297)
Kidb13pgRBCvGAPDH =
1
1000000
M (A.3.298)
KidgapRBCvGAPDH = 0.000031 M (A.3.299)
KidhapRBCvALD = 0.000011 M (A.3.300)
KidpyrRBCvLDH = 0.000101 M (A.3.301)
Kif16p2RBCvALD = 0.0000198 M (A.3.302)
Kig6pRBCvHK = 0.000047 M (A.3.303)
KigapRBCvGAPDH = 4.76523× 10−19 M (A.3.304)
KiglcRBCvHK = 0.000047 M (A.3.305)
KilacPFvPYRtr = 0.000358 M (A.3.306)
KilacRBCvLDH = 0.00733 M (A.3.307)
KimgRBCvENO = 0.000046 M (A.3.308)
KimgadpRBCvHK = 0.001 M (A.3.309)
KimgadpRBCvPGK =
1
12500
M (A.3.310)
KimgatpRBCvHK = 0.001 M (A.3.311)
KimgatpRBCvPGK = 0.000186 M (A.3.312)
KinadRBCvGAPDH = 0.000045 M (A.3.313)
KinadRBCvLDH = 0.000503 M (A.3.314)
KinadhRBCvGAPDH =
1
100000
M (A.3.315)
KinadhRBCvLDH = 2.45× 10−6 M (A.3.316)
Kip2gRBCvENO = 0.00014 M (A.3.317)
Kip3gRBCvPGK = 0.000205 M (A.3.318)
KipepPFvPK = 0.00292 M (A.3.319)
KipepPFvTPI = 0.0000159 M (A.3.320)
KipepRBCvENO = 0.0001105 M (A.3.321)
KiphosRBCvGAPDH = 0.00316 M (A.3.322)
KipyrPFvLACtr = 0.00163 M (A.3.323)
KipyrPFvPK = 0.105 M (A.3.324)
KipyrRBCvLDH = 0.000228 M (A.3.325)
KkadpRBCvAK = 4.8 L.mol−1 (A.3.326)
KkadpRBCvMGADP = 4.8 L.mol−1 (A.3.327)
KkampRBCvAK = 1.8 L.mol−1 (A.3.328)
KkatpRBCvMGATP = 14. L.mol−1 (A.3.329)
KkbpgRBCvMGB13PG = 85.1 L.mol−1 (A.3.330)
KkbpgRBCvMGB23PG = 85.1 L.mol−1 (A.3.331)
KkfRBCvMGF16P2 = 10.7 L.mol−1 (A.3.332)
KkfRBCvMGG16P2 = 10.7 L.mol−1 (A.3.333)
KkhbpgRBCvMGB13PG = 8.9 L.mol−1 (A.3.334)
KkhbpgRBCvMGB23PG = 8.9 L.mol−1 (A.3.335)
KkhfRBCvMGF16P2 = 3.3 L.mol−1 (A.3.336)
KkhfRBCvMGG16P2 = 3.3 L.mol−1 (A.3.337)
KkphosRBCvMGPHOS = 3. L.mol−1 (A.3.338)
KlacPFvLACtr = 0.0038 M (A.3.339)
KlacPFvLDH = 0.003611 M (A.3.340)
Klactonase1RBCvPGLHYDROLYSIS = 1.3× 107 M−1s−1 (A.3.341)
Klactonase2RBCvPGLHYDROLYSIS = 1000. s−1 (A.3.342)
Klactonase3RBCvPGLHYDROLYSIS = 29. s−1 (A.3.343)
81
Stellenbosch University  https://scholar.sun.ac.za
KmPFvATPASE = 0.0045 M (A.3.344)
Kmb13pgRBCvGAPDH = 6.71× 10−7 M (A.3.345)
Kmb13pgRBCvPGK =
1
500000
M (A.3.346)
KmdhapRBCvALD = 0.000035 M (A.3.347)
KmdhapRBCvTIM = 0.0001624 M (A.3.348)
Kmf16p2RBCvALD = 7.1× 10−6 M (A.3.349)
Kmf16p2RBCvPFK = 0.0005 M (A.3.350)
Kmf6pRBCvPFK = 0.000075 M (A.3.351)
Kmf6pRBCvPGI = 0.000071 M (A.3.352)
Kmg6pRBCvPGI = 0.000181 M (A.3.353)
KmgapRBCvALD = 0.000189 M (A.3.354)
KmgapRBCvGAPDH = 0.000095 M (A.3.355)
KmgapRBCvTIM = 0.000446 M (A.3.356)
KmghadpRBCvMGADP = 107. L.mol−1 (A.3.357)
KmghatpRBCvMGATP = 748. L.mol−1 (A.3.358)
KmghbpgRBCvMGB13PG = 513. L.mol−1 (A.3.359)
KmghbpgRBCvMGB23PG = 513. L.mol−1 (A.3.360)
KmghfRBCvMGF16P2 = 89. L.mol−1 (A.3.361)
KmghfRBCvMGG16P2 = 89. L.mol−1 (A.3.362)
KmlacRBCvLDH = 0.00107 M (A.3.363)
KmlacRBCvLDHP = 0.000414 M (A.3.364)
KmmgRBCvENO = 0.000046 M (A.3.365)
KmmgadpRBCvHK = 0.001 M (A.3.366)
KmmgadpRBCvPFK = 0.00054 M (A.3.367)
KmmgadpRBCvPGK = 0.0001 M (A.3.368)
KmmgatpRBCvHK = 0.001 M (A.3.369)
KmmgatpRBCvPFK = 0.000068 M (A.3.370)
KmmgatpRBCvPGK = 0.001 M (A.3.371)
KmnadRBCvGAPDH = 0.000045 M (A.3.372)
KmnadRBCvLDH = 0.000107 M (A.3.373)
KmnadhRBCvGAPDH = 3.3× 10−6 M (A.3.374)
KmnadhRBCvLDH = 8.44× 10−6 M (A.3.375)
Kmp2gRBCvENO = 0.00014 M (A.3.376)
Kmp2gRBCvPGM = 0.0000256 M (A.3.377)
Kmp3gRBCvPGK = 0.0011 M (A.3.378)
Kmp3gRBCvPGM = 0.000168 M (A.3.379)
KmpepRBCvENO = 0.0001105 M (A.3.380)
KmphosRBCvGAPDH = 0.00316 M (A.3.381)
KmpyrRBCvLDH = 0.000137 M (A.3.382)
KmpyrRBCvLDHP = 0.000414 M (A.3.383)
KmtL2 = 0.8 mM (A.3.384)
KnadPFvG3PDH = 0.00051 M (A.3.385)
KnadPFvGAPDH = 0.0000287 M (A.3.386)
KnadPFvLDH = 0.000234 M (A.3.387)
KnadhPFvG3PDH =
9
100000
M (A.3.388)
KnadhPFvGAPDH = 0.00002719 M (A.3.389)
KnadhPFvLDH = 0.000046 M (A.3.390)
KoRBCvGLCTRANSPORT = 0.0017 M (A.3.391)
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Kp2gPFvENO = 0.000521 M (A.3.392)
Kp2gPFvPGM = 0.000318 M (A.3.393)
Kp3gPFvPGK = 0.000267 M (A.3.394)
Kp3gPFvPGM = 0.00173 M (A.3.395)
KpepPFvENO = 0.00129 M (A.3.396)
KpepPFvPK = 0.000406 M (A.3.397)
KpyrPFvLDH = 0.000133 M (A.3.398)
KpyrPFvPYRtr = 0.0157 M (A.3.399)
KrRBCvLDHP = 5.43× 10−7 s−1 (A.3.400)
KrampRBCvPFK = 0.0003 M (A.3.401)
Krf16p2RBCvPK =
1
200000
M (A.3.402)
Krg16p2RBCvPFK = 0.01 M (A.3.403)
Krg16p2RBCvPK = 0.0001 M (A.3.404)
KrmgadpRBCvPK = 0.000474 M (A.3.405)
KrmgatpRBCvPK = 0.003 M (A.3.406)
KrpepRBCvPK = 0.000225 M (A.3.407)
KrphosRBCvPFK = 0.03 M (A.3.408)
KrpyrRBCvPK = 0.002 M (A.3.409)
KtatpRBCvPFK = 0.0001 M (A.3.410)
KtatpRBCvPK = 0.00339 M (A.3.411)
Ktb23pgRBCvPFK = 0.005 M (A.3.412)
KtmgRBCvPFK = 0.004 M (A.3.413)
LPFvPK = 0.255 (A.3.414)
PP1t = 0.00025 mM (A.3.415)
RtvRBC = 0.69 (A.3.416)
TsRBC = 60. s.min−1 (A.3.417)
VPFvALD = 0.0569593 M.min−1 (A.3.418)
VPFvATPASE = 0.345 M.min−1 (A.3.419)
VPFvENO = 0.286296 M.min−1 (A.3.420)
VPFvGAPDH = 0.656263 M.min−1 (A.3.421)
VPFvGLCtr = 0.0469 M.min−1 (A.3.422)
VPFvHK = 0.083 M.min−1 (A.3.423)
VPFvLACtr = 0.598 M.min−1 (A.3.424)
VPFvPFK = 0.41 M.min−1 (A.3.425)
VPFvPGI = 0.800428 M.min−1 (A.3.426)
VPFvPGM = 0.186938 M.min−1 (A.3.427)
VPFvPK = 0.762 M.min−1 (A.3.428)
VPFvPYRtr = 0.216 M.min−1 (A.3.429)
VPFvTPI = 1.506 M.min−1 (A.3.430)
VRBCvALD = 3.7× 10−7 M (A.3.431)
VRBCvENO = 2.2× 10−7 M (A.3.432)
VRBCvG6PDH = 9.3× 10−8 M (A.3.433)
VRBCvGAPDH = 7.66× 10−6 M (A.3.434)
VRBCvGLCTRANSPORT = 0.047 M (A.3.435)
VRBCvGSSGR = 1.25× 10−7 M (A.3.436)
VRBCvLDH = 3.43× 10−6 M (A.3.437)
VRBCvP6GDH = 2.1× 10−6 M (A.3.438)
VRBCvPFK = 1.1× 10−7 M (A.3.439)
VRBCvPGK = 2.74× 10−6 M (A.3.440)
VRBCvPGLHYDROLYSIS = 0.000014 M (A.3.441)
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VRBCvPGM = 4.1× 10−7 M (A.3.442)
VRBCvPK = 8.7× 10−8 M (A.3.443)
VRBCvR5PI = 0.0000142 M (A.3.444)
VRBCvRu5PE = 4.22× 10−6 M (A.3.445)
VRBCvTA = 6.9× 10−7 M (A.3.446)
VRBCvTIM = 1.14× 10−6 M (A.3.447)
VfPFvG3PDH = 0.012 M.min−1 (A.3.448)
VfPFvLDH = 0.542612 M.min−1 (A.3.449)
VmtL2 = 0.4125 mM.min−1 (A.3.450)
VrPFvGAPDH = 0.243199 M.min−1 (A.3.451)
VrPFvLDH = 0.290792 M.min−1 (A.3.452)
VrPFvPGK = 0.353533 M.min−1 (A.3.453)
alphaPFvGLCtr = 0.91 (A.3.454)
c0 = 5. (A.3.455)
capkt = 0.00025 mM (A.3.456)
cmax = 0.0032 mM (A.3.457)
cmin =
1
500000
mM (A.3.458)
cyt = 0. M (A.3.459)
en1 = 10. (A.3.460)
en10 = 10. (A.3.461)
en11 = 10. (A.3.462)
en12 = 10. (A.3.463)
en2 = 10. (A.3.464)
en3 = 10. (A.3.465)
en4 = 10. (A.3.466)
en5 = 10. (A.3.467)
en6 = 10. (A.3.468)
en7 = 10. (A.3.469)
en8 = 10. (A.3.470)
en9 = 20. (A.3.471)
ep1 = 10. (A.3.472)
ep10 = 10. (A.3.473)
ep11 = 10. (A.3.474)
ep12 = 10. (A.3.475)
ep13 = 10. (A.3.476)
ep14 = 10. (A.3.477)
ep15 = 10. (A.3.478)
ep2 = 10. (A.3.479)
ep3 = 10. (A.3.480)
ep4 = 10. (A.3.481)
ep5 = 10. (A.3.482)
ep6 = 10. (A.3.483)
ep7 = 10. (A.3.484)
ep8 = 10. (A.3.485)
ep9 = 10. (A.3.486)
glc_alpha = 0.36 (A.3.487)
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h = 4. (A.3.488)
index = 5. (A.3.489)
k11 = 0.000043 mM (A.3.490)
k22 = 0.0007 mM (A.3.491)
kPFvGLYtr = 2. min−1 (A.3.492)
kRBC = 0.15 M (A.3.493)
k_Dglucgn =
1
25000000
mM (A.3.494)
k_Dins =
1
1000000
mM (A.3.495)
k_Dins2 = 7.5× 10−7 mM (A.3.496)
k_L10 = 0.1 min−1 (A.3.497)
k_L11f = 0.6 min−1 (A.3.498)
k_L11r = 0.01 min−1 (A.3.499)
k_L12 = 0.6 min−1 (A.3.500)
k_L13 = 0.5 min−1 (A.3.501)
k_L14 = 0.01 min−1 (A.3.502)
k_L15 = 0.01 min−1 (A.3.503)
k_L16 = 0.01 mM−7min−1 (A.3.504)
k_L17 = 0.01 mM.min−1 (A.3.505)
k_L18 = 0.01 min−1 (A.3.506)
k_L19 = 0.01 mM−1min−1 (A.3.507)
k_L1f = 3. mM.min−1 (A.3.508)
k_L1r = 4. mM.min−1 (A.3.509)
k_L20 = 0.2 min−1 (A.3.510)
k_L21f = 0.001 mM.min−1 (A.3.511)
k_L21r = 0.2 min−1 (A.3.512)
k_L22 = 0.01 min−1 (A.3.513)
k_L2f = 200. min−1 (A.3.514)
k_L2r = 20. min−1 (A.3.515)
k_L3f = 0.1 mM.min−1 (A.3.516)
k_L3r = 0.3 mM.min−1 (A.3.517)
k_L4 = 2. mM.min−1 (A.3.518)
k_L5f = 0. (A.3.519)
k_L5r = 0.1 (A.3.520)
k_L6 = 1. mM.min−1 (A.3.521)
k_L7 = 1. mM.min−1 (A.3.522)
k_L8 = 0.1 mM−1min−1 (A.3.523)
k_L9 = 0.1 min−1 (A.3.524)
k_a = 60. (A.3.525)
k_alpha = 0.0083 M (A.3.526)
k_beta = 0.007 M (A.3.527)
k_dcAMP = 3.16227× 10−6 mM (A.3.528)
k_f1 = 0.1 min−1 (A.3.529)
k_f3 = 0.2 min−1 (A.3.530)
k_f4 = 0.1 min−1 (A.3.531)
k_f5 = 0.1 mM−2min−1 (A.3.532)
k_gc1 = 60000. mM−2min−1 (A.3.533)
k_gc2 = 60000. mM2min−1 (A.3.534)
k_i1 = 0.1 mM (A.3.535)
k_i13 = 2. mM (A.3.536)
k_i2 = 1. mM (A.3.537)
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k_i4 = 3. mM (A.3.538)
k_i5 = 1. mM (A.3.539)
k_i8 = 2. mM (A.3.540)
k_mGlgn = 8. mM (A.3.541)
k_mIns = 8. mM (A.3.542)
k_mL1f = 7.7 mM (A.3.543)
k_mL1r = 1.3 mM (A.3.544)
k_mL21a = 21. mM (A.3.545)
k_mL21g = 4.3 mM (A.3.546)
k_mL21k = 0.22 mM (A.3.547)
k_mL21p = 0.4 mM (A.3.548)
k_mL2f = 0.57 mM (A.3.549)
k_mL2r = 1.4 mM (A.3.550)
k_mL3f = 0.01 mM (A.3.551)
k_mL3r = 0.0034 mM (A.3.552)
k_mL4 = 0.18 mM (A.3.553)
k_mL5f = 0.03 mM (A.3.554)
k_mL5r = 0.8 mM (A.3.555)
k_mL6 = 0.22 mM (A.3.556)
k_mL7 = 0.0204 mM (A.3.557)
k_p1 = 0.5 mM (A.3.558)
k_p2 = 2. mM (A.3.559)
k_s1f = 0. min−1 (A.3.560)
k_s1r = 0. min−1 (A.3.561)
k_s2 = 0.02 min−1 (A.3.562)
k_s3f = 0.01 min−1 (A.3.563)
k_s3r = 0.01 min−1 (A.3.564)
k_s4f = 0.07 min−1 (A.3.565)
k_s4r = 0. min−1 (A.3.566)
k_tF1 = 0.01 min−1 (A.3.567)
k_tF3 = 0.008 mM−2min−1 (A.3.568)
k_tL1 = 100. min−1 (A.3.569)
k_tL2 = 0.1 min−1 (A.3.570)
k_tL3 = 0.1 min−1 (A.3.571)
k_tL5 = 0.1 min−1 (A.3.572)
k_tL6 = 1. min−1 (A.3.573)
k_tS1 = 0.01 min−1 (A.3.574)
k_tS2 = 1. min−1 (A.3.575)
k_tS3 = 0.01 min−1 (A.3.576)
k_tS4 = 3. min−1 (A.3.577)
kc1 = 1. min−1 (A.3.578)
kcm1 =
1
25000000
mM (A.3.579)
kcm2 =
1
1000000
mM (A.3.580)
kd_Balan = 0.015 min−1 (A.3.581)
kd_Bffa = 0.015 min−1 (A.3.582)
kd_Bgluc = 0.015 min−1 (A.3.583)
kd_Bglucgn = 0.015 min−1 (A.3.584)
kd_Bins = 0.015 min−1 (A.3.585)
kd_Bket = 0.015 min−1 (A.3.586)
kd_Blac = 0.015 min−1 (A.3.587)
kf = 0.5 min−1 (A.3.588)
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kg2 = 0.5 mM (A.3.589)
kg3 = 1200. min−1 (A.3.590)
kg4 = 300. min−1 (A.3.591)
kg5 = 1200. min−1 (A.3.592)
kg6 = 300. min−1 (A.3.593)
kg7 = 1200. min−1 (A.3.594)
kg8 = 300. min−1 (A.3.595)
kgi = 10. mM (A.3.596)
ki1 = 9.26558× 10−8 M (A.3.597)
ki2 = 0.0000156304 M (A.3.598)
kmg3 = 0.0004 mM (A.3.599)
kmg4 = 0.0011 mM (A.3.600)
kmg5 = 0.01 mM (A.3.601)
kmg6 = 0.005 mM (A.3.602)
kmg7 = 0.015 mM (A.3.603)
kmg8 = 0.00012 mM (A.3.604)
kresume = 1.4 mM.min−1 (A.3.605)
ks_dket = 0.01 min−1 (A.3.606)
kt = 0.0025 mM (A.3.607)
nRBCvPFK = 5. (A.3.608)
ng = 10. (A.3.609)
ni = 10. (A.3.610)
p1 = 1. (A.3.611)
p2 = 1. (A.3.612)
pHConversionFactor = 1. (A.3.613)
par = 0.05 (A.3.614)
parMulti = 1. (A.3.615)
phPF = 7.2 (A.3.616)
phRBC = 7.1 (A.3.617)
pt = 0.07 mM (A.3.618)
s1 = 100. (A.3.619)
s2 = 0.001 (A.3.620)
st = 0.003 mM (A.3.621)
tresume = 20250. min (A.3.622)
v_totblood = 6.24 L (A.3.623)
PKb = 0.0078 mM (A.3.624)
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A.4 Kinetic rates or reaction processes:
Jg10 = kgc1 · cAMP(t)2 · R2C2(t)− k_gc1 · Cvar(t) · R2_C_cAMP2(t) (A.4.1)
Jg11 = kgc2 · cAMP(t)2 · R2_C_cAMP2(t)− k_gc2 · Cvar(t) · R2_cAMP4(t) (A.4.2)
Jg3 =
kg3 · Cvar(t) · (kt− PKa(t))
kmg3 + kt− PKa(t) (A.4.3)
Jg4 =
kg4 · PKa(t) · (PP1(t) + PP1_GPa(t))
kmg4 + PKa(t)
(A.4.4)
Jg5 =
kg5 · (pt−GPa(t)) · PKa(t)
kmg5s + pt−GPa(t) (A.4.5)
Jg6 =
kg6 ·GPa(t) · (PP1(t) + PP1_GPa(t))
kmg6s + GPa(t)
(A.4.6)
Jg7 =
kg7 ·GSa(t) · (Cvar(t) + PKa(t))
kmg7s + GSa(t)
(A.4.7)
Jg8 =
kg8 · (st−GSa(t)) · PP1(t)
kmg8s + st−GSa(t) (A.4.8)
Jg9 = ka ·GPa(t) · PP1(t)− k_a · PP1_GPa(t) (A.4.9)
vPFvALD =
parMulti ·VPFvALD · f16bpPF(t) ·
(
1− dhapPF(t)·gapPF(t)
KeqPFvALD·Vpf·f16bpPF(t)
)
Kf16bpPFvALD ·
(
gapPF(t)·dhapPF(t)
KdhapPFvALD·KgapPFvALD·Vpf2 +
dhapPF(t)
KdhapPFvALD·Vpf +
f16bpPF(t)
Kf16bpPFvALD·Vpf +
gapPF(t)
KgapPFvALD·Vpf + 1
) (A.4.10)
vPFvATPASE =
parMulti ·VPFvATPASE · atpPF(t)5
KmPFvATPASE5 ·Vpf4 ·
(
atpPF(t)5
KmPFvATPASE5·Vpf5 + 1
) (A.4.11)
vPFvENO =
parMulti ·VPFvENO · p2gPF(t) ·
(
1− pepPF(t)
KeqPFvENO·p2gPF(t)
)
Kp2gPFvENO ·
(
p2gPF(t)
Kp2gPFvENO·Vpf +
pepPF(t)
KpepPFvENO·Vpf + 1
) (A.4.12)
vPFvG3PDH =
parMulti ·VfPFvG3PDH · dhapPF(t) · nadhPF(t) ·
(
1− g3pPF(t)·nadPF(t)
KeqPFvG3PDH·dhapPF(t)·nadhPF(t)
)
KdhapPFvG3PDH ·KnadhPFvG3PDH ·Vpf ·
(
dhapPF(t)
KdhapPFvG3PDH·Vpf +
g3pPF(t)
Kg3pPFvG3PDH·Vpf + 1
)
·
(
nadhPF(t)
KnadhPFvG3PDH·Vpf +
nadPF(t)
KnadPFvG3PDH·Vpf + 1
) (A.4.13)
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vPFvGAPDH =
parMulti ·
(
VPFvGAPDH·gapPF(t)·nadPF(t)
KgapPFvGAPDH·KnadPFvGAPDH·Vpf −
VrPFvGAPDH·b13pgPF(t)·nadhPF(t)
Kb13pgPFvGAPDH·KnadhPFvGAPDH·Vpf
)
(
b13pgPF(t)
Kb13pgPFvGAPDH·Vpf +
gapPF(t)
KgapPFvGAPDH·Vpf + 1
)
·
(
nadhPF(t)
KnadhPFvGAPDH·Vpf +
nadPF(t)
KnadPFvGAPDH·Vpf + 1
) (A.4.14)
vPFvGLCtr =
parMulti ·
(
Vpf·VPFvGLCtr·glcRBCi(t)(
cyt
ki1
+1
)
·KPFvGLCtr·Vrbci
− VPFvGLCtr·glcPF(t)(
cyt
ki1
+1
)
·KPFvGLCtr
)
alphaPFvGLCtr·glcRBCi(t)·glcPF(t)(
cyt
ki1
+1
)
·KPFvGLCtr2·Vpf·Vrbci
+
(
cyt
ki2
+1
)
·glcPF(t)(
cyt
ki1
+1
)
·KPFvGLCtr·Vpf
+
(
cyt
ki2
+1
)
·glcRBCi(t)(
cyt
ki1
+1
)
·KPFvGLCtr·Vrbci
+ 1
(A.4.15)
vPFvGLYtr = kPFvGLYtr · parMulti ·Vpf ·
(
g3pPF(t)
Vpf
− glyEXT
vBld
)
(A.4.16)
vPFvHK =
parMulti ·VPFvHK · atpPF(t) ·
(
1− adpPF(t)·g6pPF(t)
KeqPFvHK·atpPF(t)·glcPF(t)
)
· glcPF(t)
KatpPFvHK ·KglcPFvHK ·Vpf ·
(
adpPF(t)
KadpPFvHK·Vpf +
atpPF(t)
KatpPFvHK·Vpf + 1
)
·
(
atpPF(t)
KiatpPFvHK·Vpf + 1
)
·
(
g6pPF(t)
Kg6pPFvHK·Vpf +
glcPF(t)
KglcPFvHK·Vpf + 1
) (A.4.17)
vPFvLACtr = KdPFvLACtr · parMulti · lacPF(t) ·
(
1− hRBC ·Vpf · lacRBCi(t)
hPF ·Vrbci · lacPF(t)
)
(A.4.18)
+
VPFvLACtr · lacPF(t) ·
(
1− hRBC·Vpf·lacRBCi(t)
hPF·Vrbci·lacPF(t)
)
KlacPFvLACtr ·
(
lacPF(t)
KlacPFvLACtr·Vpf +
lacRBCi(t)
KlacPFvLACtr·Vrbci +
pyrPF(t)
KipyrPFvLACtr·Vpf +
pyrRBCi(t)
KipyrPFvLACtr·Vrbci + 1
) (A.4.19)
vPFvLDH =
parMulti ·
(
VfPFvLDH·nadhPF(t)·pyrPF(t)
KnadhPFvLDH·KpyrPFvLDH·Vpf −
VrPFvLDH·lacPF(t)·nadPF(t)
KlacPFvLDH·KnadPFvLDH·Vpf
)
(
nadhPF(t)
KnadhPFvLDH·Vpf +
nadPF(t)
KnadPFvLDH·Vpf + 1
)
·
(
lacPF(t)
KlacPFvLDH·Vpf +
pyrPF(t)
KpyrPFvLDH·Vpf + 1
) (A.4.20)
vPFvPFK =
parMulti ·VPFvPFK · atpPF(t) · f6pPF(t)
KatpPFvPFK ·Kf6pPFvPFK ·Vpf ·
(
atpPF(t)
KatpPFvPFK·Vpf + 1
)
·
(
adpPF(t)
KadpPFvPFK·Vpf +
atpPF(t)
KatpPFvPFK·Vpf + 1
)
·
(
f16bpPF(t)
Kf16bpPFvPFK·Vpf +
f6pPF(t)
Kf6pPFvPFK·Vpf + 1
) (A.4.21)
vPFvPGI =
parMulti ·VPFvPGI ·
(
1− f6pPF(t)
KeqPFvPGI·g6pPF(t)
)
· g6pPF(t)
Kg6pPFvPGI ·
(
f6pPF(t)
Kf6pPFvPGI·Vpf +
g6pPF(t)
Kg6pPFvPGI·Vpf + 1
) (A.4.22)
vPFvPGK =
KadpPFvPGK ·Kb13pgPFvPGK ·KeqPFvPGK · parMulti ·VrPFvPGK · atpPF(t) ·
(
KeqPFvPGK·adpPF(t)·b13pgPF(t)
atpPF(t)·p3gPF(t) − 1
)
· p3gPF(t)
KatpPFvPGK2 ·Kp3gPFvPGK2 ·Vpf ·
(
adpPF(t)
KadpPFvPGK·Vpf +
atpPF(t)
KatpPFvPGK·Vpf + 1
)
·
(
b13pgPF(t)
Kb13pgPFvPGK·Vpf +
p3gPF(t)
Kp3gPFvPGK·Vpf + 1
) (A.4.23)
vPFvPGM =
parMulti ·VPFvPGM ·
(
1− p2gPF(t)
KeqPFvPGM·p3gPF(t)
)
· p3gPF(t)
Kp3gPFvPGM ·
(
p2gPF(t)
Kp2gPFvPGM·Vpf +
p3gPF(t)
Kp3gPFvPGM·Vpf + 1
) (A.4.24)
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vPFvPK =
parMulti ·VPFvPK · adpPF(t) · pepPF(t)
KadpPFvPK ·KpepPFvPK ·Vpf ·
(
adpPF(t)
KadpPFvPK·Vpf + 1
)
·
(
pepPF(t)
KpepPFvPK·Vpf + 1
)
·
(
LPFvPK ·
((
adpPF(t)
KiadpPFvPK·Vpf +
atpPF(t)
KiatpPFvPK·Vpf
)h
+ 1
)
1 ·
((
pepPF(t)
KipepPFvPK·Vpf +
pyrPF(t)
KipyrPFvPK·Vpf
)h
+ 1
)
+ 1
)
(A.4.25)
vPFvPYRtr = KdPFvPYRtr · parMulti · pyrPF(t) ·
(
1− hRBC ·Vpf · pyrRBCi(t)
hPF ·Vrbci · pyrPF(t)
)
(A.4.26)
+
VPFvPYRtr · pyrPF(t) ·
(
1− hRBC·Vpf·pyrRBCi(t)
hPF·Vrbci·pyrPF(t)
)
KpyrPFvPYRtr ·
(
lacPF(t)
KilacPFvPYRtr·Vpf +
lacRBCi(t)
KilacPFvPYRtr·Vrbci +
pyrPF(t)
KpyrPFvPYRtr·Vpf +
pyrRBCi(t)
KpyrPFvPYRtr·Vrbci + 1
) (A.4.27)
vPFvTPI =
parMulti ·VPFvTPI · dhapPF(t) ·
(
1− gapPF(t)
KeqPFvTPI·dhapPF(t)
)
KdhapPFvTPI ·
(
dhapPF(t)
KdhapPFvTPI·Vpf +
gapPF(t)
KgapPFvTPI·Vpf +
pepPF(t)
KipepPFvTPI·Vpf + 1
) (A.4.28)
vRBCivAK = parMulti · TsRBC ·Vrbci ·
(
K1appRBCvAK · adpRBCi(t) ·mgadpRBCi(t)
Vrbci2
− K2appRBCvAK · ampRBCi(t) ·mgatpRBCi(t)
Vrbci2
)
(A.4.29)
vRBCivALD =
parMulti · TsRBC ·Vrbci ·VRBCvALD ·
(
KcatfRBCvALD·f16p2RBCi(t)
Kmf16p2RBCvALD·Vrbci −
KcatrRBCvALD·dhapRBCi(t)·gapRBCi(t)
KidhapRBCvALD·KmgapRBCvALD·Vrbci2
)
gapRBCi(t)·dhapRBCi(t)
KidhapRBCvALD·KmgapRBCvALD·Vrbci2 +
dhapRBCi(t)
KidhapRBCvALD·Vrbci +
f16p2RBCi(t)
Kmf16p2RBCvALD·Vrbci +
KmdhapRBCvALD·f16p2RBCi(t)·gapRBCi(t)
KidhapRBCvALD·Kif16p2RBCvALD·KmgapRBCvALD·Vrbci2
1 +
b23pgRBCi(t)
Vrbci
+
mgb23pgRBCi(t)
Vrbci
Kib23pgRBCvALD
+
KmdhapRBCvALD·gapRBCi(t)·
(
b23pgRBCi(t)
Vrbci
+
mgb23pgRBCi(t)
Vrbci
Kib23pgRBCvALD
+1
)
KidhapRBCvALD·KmgapRBCvALD·Vrbci + 1
(A.4.30)
vRBCivATPASE = KRBCvATPASE · parMulti · TsRBC ·mgatpRBCi(t) (A.4.31)
vRBCivBPGSP1 = parMulti · TsRBC ·Vrbci ·
(
K1appRBCvBPGSP1 · b13pgRBCi(t) · bpgspRBCi(t)
Vrbci2
− K2RBCvBPGSP1 · bpgspb13pgRBCi(t)
Vrbci
)
(A.4.32)
vRBCivBPGSP2 = K3appRBCvBPGSP2 · parMulti · TsRBC · bpgspb13pgRBCi(t) (A.4.33)
vRBCivBPGSP3 = parMulti · TsRBC ·Vrbci ·
(
K4appRBCvBPGSP3 · bpgsppRBCi(t) · p3gRBCi(t)
Vrbci2
− K5RBCvBPGSP3 · bpgsppp3gRBCi(t)
Vrbci
)
(A.4.34)
vRBCivBPGSP4 = parMulti · TsRBC ·Vrbci ·
(
K6appRBCvBPGSP4 · bpgsppRBCi(t) · p2gRBCi(t)
Vrbci2
− K7RBCvBPGSP4 · bpgsppp2gRBCi(t)
Vrbci
)
(A.4.35)
vRBCivBPGSP5 = parMulti · TsRBC ·Vrbci ·
(
K8RBCvBPGSP5 · bpgsppp3gRBCi(t)
Vrbci
− K9RBCvBPGSP5 · bpgspb23pgRBCi(t)
Vrbci
)
(A.4.36)
vRBCivBPGSP6 = parMulti · TsRBC ·Vrbci ·
(
K10RBCvBPGSP6 · bpgsppp2gRBCi(t)
Vrbci
− K11RBCvBPGSP6 · bpgspb23pgRBCi(t)
Vrbci
)
(A.4.37)
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vRBCivBPGSP7 = parMulti · TsRBC ·Vrbci ·
(
K12RBCvBPGSP7 · bpgspb23pgRBCi(t)
Vrbci
− K13appRBCvBPGSP7 · b23pgRBCi(t) · bpgspRBCi(t)
Vrbci2
)
(A.4.38)
vRBCivBPGSP8 = parMulti · TsRBC ·Vrbci ·
(
K14RBCvBPGSP8 · bpgsppRBCi(t) · phosRBCi(t)
Vrbci2
− K15RBCvBPGSP8 · bpgsppphosRBCi(t)
Vrbci
)
(A.4.39)
vRBCivBPGSP9 = K16RBCvBPGSP9 · parMulti · TsRBC · bpgsppphosRBCi(t) (A.4.40)
vRBCivENO =
parMulti · TsRBC ·Vrbci ·VRBCvENO ·
(
KcatfRBCvENO·mgRBCi(t)·p2gRBCi(t)
KimgRBCvENO·Kmp2gRBCvENO·Vrbci2 −
KcatrRBCvENO·mgRBCi(t)·pepRBCi(t)
KipepRBCvENO·KmmgRBCvENO·Vrbci2
)
p2gRBCi(t)·mgRBCi(t)
KimgRBCvENO·Kmp2gRBCvENO·Vrbci2 +
pepRBCi(t)·mgRBCi(t)
KipepRBCvENO·KmmgRBCvENO·Vrbci2 +
mgRBCi(t)
KimgRBCvENO·Vrbci +
p2gRBCi(t)
Kip2gRBCvENO·Vrbci
1 +
pepRBCi(t)
KipepRBCvENO·Vrbci + 1
(A.4.41)
vRBCivG6PDH = [parMulti · TsRBC ·Vrbci ·VRBCvG6PDH· (A.4.42)(
K1RBCvG6PDH ·K3RBCvG6PDH ·K5RBCvG6PDH ·K7RBCvG6PDH ·K9RBCvG6PDH · g6pRBCi(t) · nadpRBCi(t)
Vrbci2
(A.4.43)
−K10RBCvG6PDH ·K2RBCvG6PDH ·K4RBCvG6PDH ·K6RBCvG6PDH ·K8RBCvG6PDH · nadphRBCi(t) · p6glRBCi(t)
Vrbci2
)]
/ (A.4.44)
[K2RBCvG6PDH ·K9RBCvG6PDH (A.4.45)
· (K4RBCvG6PDH ·K6RBCvG6PDH + K4RBCvG6PDH ·K7RBCvG6PDH + K5RBCvG6PDH ·K7RBCvG6PDH) (A.4.46)
+
K3RBCvG6PDH ·K5RBCvG6PDH ·K7RBCvG6PDH · g6pRBCi(t) ·K9RBCvG6PDH
Vrbci
(A.4.47)
+
K1RBCvG6PDH · nadpRBCi(t) ·K9RBCvG6PDH
1 · (K4RBCvG6PDH ·K6RBCvG6PDH + K4RBCvG6PDH ·K7RBCvG6PDH + K5RBCvG6PDH ·K7RBCvG6PDH)
Vrbci
(A.4.48)
+
K10RBCvG6PDH ·K3RBCvG6PDH ·K5RBCvG6PDH ·K7RBCvG6PDH · g6pRBCi(t) · nadphRBCi(t)
Vrbci2
(A.4.49)
+
K10RBCvG6PDH ·K2RBCvG6PDH · (K4RBCvG6PDH ·K6RBCvG6PDH
1 + K5RBCvG6PDH ·K6RBCvG6PDH + K5RBCvG6PDH ·K7RBCvG6PDH) · nadphRBCi(t)
Vrbci
(A.4.50)
(A.4.51)
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+K1RBCvG6PDH ·K3RBCvG6PDH · (K5RBCvG6PDH ·K7RBCvG6PDH + K9RBCvG6PDH ·K7RBCvG6PDH + K5RBCvG6PDH
1 ·K9RBCvG6PDH + K6RBCvG6PDH ·K9RBCvG6PDH) · g6pRBCi(t) · nadpRBCi(t)
Vrbci2
(A.4.52)
+
K10RBCvG6PDH ·K3RBCvG6PDH · (K5RBCvG6PDH + K6RBCvG6PDH) ·K8RBCvG6PDH · g6pRBCi(t) · nadphRBCi(t) · p6glRBCi(t)
Vrbci3
(A.4.53)
+
K10RBCvG6PDH · (K2RBCvG6PDH ·K4RBCvG6PDH + K6RBCvG6PDH ·K4RBCvG6PDH
+K2RBCvG6PDH ·K5RBCvG6PDH + K2RBCvG6PDH ·K6RBCvG6PDH) ·K8RBCvG6PDH · nadphRBCi(t) · p6glRBCi(t) Vrbci
2 (A.4.54)
+
K1RBCvG6PDH ·K3RBCvG6PDH · (K5RBCvG6PDH + K6RBCvG6PDH) ·K8RBCvG6PDH · g6pRBCi(t) · nadpRBCi(t) · p6glRBCi(t)
Vrbci3
(A.4.55)
+
K1RBCvG6PDH ·K4RBCvG6PDH ·K6RBCvG6PDH ·K8RBCvG6PDH · nadpRBCi(t) · p6glRBCi(t)
Vrbci2
(A.4.56)
+
K2RBCvG6PDH ·K4RBCvG6PDH ·K6RBCvG6PDH ·K8RBCvG6PDH · p6glRBCi(t)
Vrbci
]
(A.4.57)
vRBCivGAPDH =
[
parMulti · TsRBC ·Vrbci ·VRBCvGAPDH ·
(
KcatfappRBCvGAPDH · gapRBCi(t) · nadRBCi(t) · phosRBCi(t)
KiappgapRBCvGAPDH ·KiphosRBCvGAPDH ·KmnadRBCvGAPDH ·Vrbci3 (A.4.58)
− KcatrappRBCvGAPDH · b13pgRBCi(t) · nadhRBCi(t)
Kiappb13pgRBCvGAPDH ·KmappnadhRBCvGAPDH ·Vrbci2
)]
/ (A.4.59)
b13pgRBCi(t) ·
(
gapRBCi(t)
KidgapRBCvGAPDH·Vrbci + 1
)
Kiappb13pgRBCvGAPDH ·Vrbci +
gapRBCi(t) ·
(
gapRBCi(t)
KidgapRBCvGAPDH·Vrbci + 1
)
KiappgapRBCvGAPDH ·Vrbci (A.4.60)
+
gapRBCi(t) · phosRBCi(t) ·
(
gapRBCi(t)
KidgapRBCvGAPDH·Vrbci + 1
)
KiappgapRBCvGAPDH ·KiphosRBCvGAPDH ·Vrbci2 +
b13pgRBCi(t) · nadhRBCi(t)
Kiappb13pgRBCvGAPDH ·KmappnadhRBCvGAPDH ·Vrbci2 (A.4.61)
+
gapRBCi(t) · nadhRBCi(t)
KiappgapRBCvGAPDH ·KiappnadhRBCvGAPDH ·Vrbci2 +
Kmb13pgRBCvGAPDH · nadhRBCi(t)
Kiappb13pgRBCvGAPDH ·KmappnadhRBCvGAPDH ·Vrbci (A.4.62)
+
b13pgRBCi(t) · nadRBCi(t)
Kiappb13pgRBCvGAPDH ·KinadRBCvGAPDH ·Vrbci2 +
gapRBCi(t) · nadRBCi(t)
KiappgapRBCvGAPDH ·KinadRBCvGAPDH ·Vrbci2 (A.4.63)
+
Kmb13pgRBCvGAPDH · b13pgRBCi(t) · nadhRBCi(t) · phosRBCi(t)
Kiappb13pgRBCvGAPDH ·Kidb13pgRBCvGAPDH ·KiphosRBCvGAPDH ·KmappnadhRBCvGAPDH ·Vrbci3 (A.4.64)
(A.4.65)
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+
gapRBCi(t) · nadhRBCi(t) · phosRBCi(t)
KiappgapRBCvGAPDH ·KiappnadhRBCvGAPDH ·KiphosRBCvGAPDH ·Vrbci3 (A.4.66)
+
Kmb13pgRBCvGAPDH · nadhRBCi(t) · phosRBCi(t)
Kiappb13pgRBCvGAPDH ·KiphosRBCvGAPDH ·KmappnadhRBCvGAPDH ·Vrbci2 (A.4.67)
+
KmgapRBCvGAPDH · b13pgRBCi(t) · nadRBCi(t) · phosRBCi(t)
KiappgapRBCvGAPDH ·Kidb13pgRBCvGAPDH ·KiphosRBCvGAPDH ·KmnadRBCvGAPDH ·Vrbci3 (A.4.68)
+
gapRBCi(t) · nadRBCi(t) · phosRBCi(t)
KiappgapRBCvGAPDH ·KiphosRBCvGAPDH ·KmnadRBCvGAPDH ·Vrbci3 (A.4.69)
+
KmgapRBCvGAPDH · nadRBCi(t) · phosRBCi(t)
KiappgapRBCvGAPDH ·KiphosRBCvGAPDH ·KmnadRBCvGAPDH ·Vrbci2
]
(A.4.70)
vRBCivGLCTRANSPORT = parMulti · TsRBC ·Vrbci ·
 glc_alpha ·VRBCvGLCTRANSPORT · B_gluc(t)
1000 ·
(
(1−glc_alpha)·B_gluc(t)·k_alpha
1000·k_beta + k_alpha +
glc_alpha·B_gluc(t)
1000
) (A.4.71)
+
(1− glc_alpha) ·VRBCvGLCTRANSPORT · B_gluc(t)
1000 ·
(
glc_alpha·B_gluc(t)·k_beta
1000·k_alpha + k_beta +
(1−glc_alpha)·B_gluc(t)
1000
) (A.4.72)
− glc_alpha ·VRBCvGLCTRANSPORT · glcRBCi(t)
Vrbci ·
(
(1−glc_alpha)·glcRBCi(t)·k_alpha
k_beta·Vrbci + k_alpha +
glc_alpha·glcRBCi(t)
Vrbci
) (A.4.73)
− (1− glc_alpha) ·VRBCvGLCTRANSPORT · glcRBCi(t)
Vrbci ·
(
glc_alpha·glcRBCi(t)·k_beta
k_alpha·Vrbci + k_beta +
(1−glc_alpha)·glcRBCi(t)
Vrbci
)
 (A.4.74)
vRBCivGSSGR = [parMulti · TsRBC ·Vrbci ·VRBCvGSSGR· (A.4.75) K11RBCvGSSGR ·K1RBCvGSSGR ·K3RBCvGSSGR ·K5RBCvGSSGR ·K7RBCvGSSGR1 ·K9RBCvGSSGR · gssgRBCi(t) · nadphRBCi(t)
Vrbci2
(A.4.76)
−
K10RBCvGSSGR ·K12RBCvGSSGR ·K2RBCvGSSGR ·K4RBCvGSSGR ·K6RBCvGSSGR
1 ·K8RBCvGSSGR · gshRBCi(t)2 · nadpRBCi(t)
Vrbci3

 / (A.4.77)

K10RBCvGSSGR ·K1RBCvGSSGR ·K3RBCvGSSGR · (K5RBCvGSSGR + K6RBCvGSSGR)
1 ·K8RBCvGSSGR · gssgRBCi(t) · nadphRBCi(t) · gshRBCi(t)2
Vrbci4
(A.4.78)
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+
K10RBCvGSSGR ·K1RBCvGSSGR ·K4RBCvGSSGR ·K6RBCvGSSGR ·K8RBCvGSSGR · nadphRBCi(t) · gshRBCi(t)2
Vrbci3
(A.4.79)
+
K10RBCvGSSGR ·K12RBCvGSSGR ·K3RBCvGSSGR · (K5RBCvGSSGR + K6RBCvGSSGR) ·K8RBCvGSSGR · gssgRBCi(t) · nadpRBCi(t) · gshRBCi(t)2
Vrbci4
(A.4.80)
+
K10RBCvGSSGR ·K12RBCvGSSGR · (K2RBCvGSSGR ·K4RBCvGSSGR + K6RBCvGSSGR ·K4RBCvGSSGR + K2RBCvGSSGR ·K5RBCvGSSGR
1 + K2RBCvGSSGR ·K6RBCvGSSGR) ·K8RBCvGSSGR · nadpRBCi(t) · gshRBCi(t)2
Vrbci3
(A.4.81)
+
K10RBCvGSSGR ·K2RBCvGSSGR ·K4RBCvGSSGR ·K6RBCvGSSGR ·K8RBCvGSSGR · gshRBCi(t)2
Vrbci2
(A.4.82)
+
K10RBCvGSSGR ·K1RBCvGSSGR ·K3RBCvGSSGR ·K5RBCvGSSGR ·K7RBCvGSSGR · gssgRBCi(t) · nadphRBCi(t) · gshRBCi(t)
Vrbci3
(A.4.83)
+
K11RBCvGSSGR ·K1RBCvGSSGR ·K3RBCvGSSGR · (K5RBCvGSSGR + K6RBCvGSSGR) ·K8RBCvGSSGR · gssgRBCi(t) · nadphRBCi(t) · gshRBCi(t)
Vrbci3
(A.4.84)
+
K11RBCvGSSGR ·K1RBCvGSSGR ·K4RBCvGSSGR ·K6RBCvGSSGR ·K8RBCvGSSGR · nadphRBCi(t) · gshRBCi(t)
Vrbci2
(A.4.85)
+
K10RBCvGSSGR ·K12RBCvGSSGR ·K3RBCvGSSGR ·K5RBCvGSSGR ·K7RBCvGSSGR · gssgRBCi(t) · nadpRBCi(t) · gshRBCi(t)
Vrbci3
(A.4.86)
+
K10RBCvGSSGR ·K12RBCvGSSGR ·K2RBCvGSSGR · (K4RBCvGSSGR ·K6RBCvGSSGR + K4RBCvGSSGR ·K7RBCvGSSGR
1 + K5RBCvGSSGR ·K7RBCvGSSGR) · nadpRBCi(t) · gshRBCi(t)
Vrbci2
(A.4.87)
+
K12RBCvGSSGR ·K2RBCvGSSGR ·K4RBCvGSSGR ·K6RBCvGSSGR ·K8RBCvGSSGR · nadpRBCi(t) · gshRBCi(t)
Vrbci2
(A.4.88)
+
K11RBCvGSSGR ·K2RBCvGSSGR ·K4RBCvGSSGR ·K6RBCvGSSGR ·K8RBCvGSSGR · gshRBCi(t)
Vrbci
(A.4.89)
+ K11RBCvGSSGR ·K2RBCvGSSGR ·K9RBCvGSSGR (A.4.90)
· (K4RBCvGSSGR ·K6RBCvGSSGR + K4RBCvGSSGR ·K7RBCvGSSGR + K5RBCvGSSGR ·K7RBCvGSSGR) (A.4.91)
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+
K11RBCvGSSGR ·K3RBCvGSSGR ·K5RBCvGSSGR ·K7RBCvGSSGR ·K9RBCvGSSGR · gssgRBCi(t)
Vrbci
(A.4.92)
+
K1RBCvGSSGR ·K3RBCvGSSGR · (K11RBCvGSSGR ·K5RBCvGSSGR ·K7RBCvGSSGR + K11RBCvGSSGR ·K9RBCvGSSGR ·K7RBCvGSSGR
1
+K5RBCvGSSGR ·K9RBCvGSSGR ·K7RBCvGSSGR + K11RBCvGSSGR ·K5RBCvGSSGR ·K9RBCvGSSGR
1 + K11RBCvGSSGR ·K6RBCvGSSGR ·K9RBCvGSSGR) · gssgRBCi(t) · nadphRBCi(t)
Vrbci2
(A.4.93)
+
K11RBCvGSSGR ·K1RBCvGSSGR · (K4RBCvGSSGR ·K6RBCvGSSGR + K4RBCvGSSGR ·K7RBCvGSSGR
1 + K5RBCvGSSGR ·K7RBCvGSSGR) ·K9RBCvGSSGR · nadphRBCi(t)
Vrbci
(A.4.94)
+
K12RBCvGSSGR ·K3RBCvGSSGR ·K5RBCvGSSGR ·K7RBCvGSSGR ·K9RBCvGSSGR · gssgRBCi(t) · nadpRBCi(t)
Vrbci2
(A.4.95)
+
K12RBCvGSSGR ·K2RBCvGSSGR · (K4RBCvGSSGR ·K6RBCvGSSGR + K4RBCvGSSGR ·K7RBCvGSSGR + K5RBCvGSSGR ·K7RBCvGSSGR)
1 ·K9RBCvGSSGR · nadpRBCi(t)
Vrbci
 (A.4.96)
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vRBCivHBADP = parMulti · TsRBC ·Vrbci ·
(
KaappRBCvHBADP · adpRBCi(t) · hbRBCi(t)
Vrbci2
− KdRBCvHBADP · hbadpRBCi(t)
Vrbci
)
(A.4.97)
vRBCivHBATP = parMulti · TsRBC ·Vrbci ·
(
KaappRBCvHBATP · atpRBCi(t) · hbRBCi(t)
Vrbci2
− KdRBCvHBATP · hbatpRBCi(t)
Vrbci
)
(A.4.98)
vRBCivHBB13PG = parMulti · TsRBC ·Vrbci ·
(
KaappRBCvHBB13PG · b13pgRBCi(t) · hbRBCi(t)
Vrbci2
− KdRBCvHBB13PG · hbb13pgRBCi(t)
Vrbci
)
(A.4.99)
vRBCivHBB23PG = parMulti · TsRBC ·Vrbci ·
(
KaappRBCvHBBPG · b23pgRBCi(t) · hbRBCi(t)
Vrbci2
− KdRBCvHBBPG · hbb23pgRBCi(t)
Vrbci
)
(A.4.100)
vRBCivHBMGATP = parMulti · TsRBC ·Vrbci ·
(
KaappRBCvHBMGATP · hbRBCi(t) ·mgatpRBCi(t)
Vrbci2
− KdRBCvHBMGATP · hbmgatpRBCi(t)
Vrbci
)
(A.4.101)
vRBCivHK =
[
parMulti · TsRBC ·Vrbci ·
(
ERBCvHK ·KcatfappRBCvHK · glcRBCi(t) ·mgatpRBCi(t)
KiglcRBCvHK ·KmmgatpRBCvHK ·Vrbci2 (A.4.102)
−ERBCvHK ·KcatrappRBCvHK · g6pRBCi(t) ·mgadpRBCi(t)
Kig6pRBCvHK ·KmmgadpRBCvHK ·Vrbci2
)]
/ (A.4.103)
[
glcRBCi(t) · g6pRBCi(t)
Kdig6pRBCvHK ·KiglcRBCvHK ·Vrbci2 +
mgadpRBCi(t) · g6pRBCi(t)
Kig6pRBCvHK ·KmmgadpRBCvHK ·Vrbci2 +
g6pRBCi(t)
Kig6pRBCvHK ·Vrbci (A.4.104)
+
b23pgRBCi(t) · glcRBCi(t)
KdibpgRBCvHK ·KiglcRBCvHK ·Vrbci2 +
g16p2RBCi(t) · glcRBCi(t)
Kdig16p2RBCvHK ·KiglcRBCvHK ·Vrbci2 +
glcRBCi(t)
KiglcRBCvHK ·Vrbci (A.4.105)
+
glcRBCi(t) · gshRBCi(t)
KdigshRBCvHK ·KiglcRBCvHK ·Vrbci2 +
mgadpRBCi(t)
KimgadpRBCvHK ·Vrbci +
glcRBCi(t) ·mgatpRBCi(t)
KiglcRBCvHK ·KmmgatpRBCvHK ·Vrbci2 (A.4.106)
+
mgatpRBCi(t)
KimgatpRBCvHK ·Vrbci + 1
]
(A.4.107)
vRBCivLACTRANSPORT = 20 · parMulti · TsRBC ·Vrbci ·
(
KoRBCvLACTRANSPORT · lacRBCi(t)
Vrbci
− KiRBCvLACTRANSPORT · B_lac(t)
1000
)
(A.4.108)
Stellenbosch University  https://scholar.sun.ac.za
Stellenbosch University  https://scholar.sun.ac.za
vRBCivLDH =
[
parMulti · TsRBC ·Vrbci ·VRBCvLDH ·
(
KcatfRBCvLDH · nadhRBCi(t) · pyrRBCi(t)
KinadhRBCvLDH ·KmapppyrRBCvLDH ·Vrbci2 (A.4.109)
− KcatrRBCvLDH · lacRBCi(t) · nadRBCi(t)
KinadRBCvLDH ·KmapplacRBCvLDH ·Vrbci2
)]
/ (A.4.110)
[
KmnadRBCvLDH · lacRBCi(t) · nadhRBCi(t)
KinadhRBCvLDH ·KinadRBCvLDH ·KmapplacRBCvLDH ·Vrbci2 +
lacRBCi(t) · pyrRBCi(t) · nadhRBCi(t)
KiapplacRBCvLDH ·KinadhRBCvLDH ·KmapppyrRBCvLDH ·Vrbci3 (A.4.111)
+
pyrRBCi(t) · nadhRBCi(t)
KinadhRBCvLDH ·KmapppyrRBCvLDH ·Vrbci2 +
nadhRBCi(t)
KinadhRBCvLDH ·Vrbci +
lacRBCi(t) · nadRBCi(t)
KinadRBCvLDH ·KmapplacRBCvLDH ·Vrbci2 (A.4.112)
+
nadRBCi(t)
KinadRBCvLDH ·Vrbci +
lacRBCi(t) · nadRBCi(t) · pyrRBCi(t)
KiapppyrRBCvLDH ·KinadRBCvLDH ·KmapplacRBCvLDH ·Vrbci3 (A.4.113)
+
KmnadhRBCvLDH · nadRBCi(t) · pyrRBCi(t)
KinadhRBCvLDH ·KinadRBCvLDH ·KmapppyrRBCvLDH ·Vrbci2 (A.4.114)
+
(
pyrRBCi(t)
KidpyrRBCvLDH ·Vrbci + 1
)
·
(
KmnadRBCvLDH · lacRBCi(t)
KinadRBCvLDH ·KmapplacRBCvLDH ·Vrbci +
KmnadhRBCvLDH · pyrRBCi(t)
KinadhRBCvLDH ·KmapppyrRBCvLDH ·Vrbci + 1
)]
(A.4.115)
vRBCivLDHP =
parMulti · TsRBC ·Vrbci ·
(
KfRBCvLDHP·nadphRBCi(t)·pyrRBCi(t)
KmpyrRBCvLDHP·Vrbci2 −
KrRBCvLDHP·lacRBCi(t)·nadpRBCi(t)
KmlacRBCvLDHP·Vrbci2
)
lacRBCi(t)
KmlacRBCvLDHP·Vrbci +
pyrRBCi(t)
KmpyrRBCvLDHP·Vrbci + 1
(A.4.116)
vRBCivMGADP = parMulti · TsRBC ·Vrbci ·
(
KaappRBCvMGADP · adpRBCi(t) ·mgRBCi(t)
Vrbci2
− KdRBCvMGADP ·mgadpRBCi(t)
Vrbci
)
(A.4.117)
vRBCivMGATP = parMulti · TsRBC ·Vrbci ·
(
KaappRBCvMGATP · atpRBCi(t) ·mgRBCi(t)
Vrbci2
− KdRBCvMGATP ·mgatpRBCi(t)
Vrbci
)
(A.4.118)
vRBCivMGB13PG = parMulti · TsRBC ·Vrbci ·
(
KaappRBCvMGB13PG · b13pgRBCi(t) ·mgRBCi(t)
Vrbci2
− KdRBCvMGB13PG ·mgb13pgRBCi(t)
Vrbci
)
(A.4.119)
vRBCivMGB23PG = parMulti · TsRBC ·Vrbci ·
(
KaappRBCvMGB23PG · b23pgRBCi(t) ·mgRBCi(t)
Vrbci2
− KdRBCvMGB23PG ·mgb23pgRBCi(t)
Vrbci
)
(A.4.120)
vRBCivMGF16P2 = parMulti · TsRBC ·Vrbci ·
(
KaappRBCvMGF16P2 · f16p2RBCi(t) ·mgRBCi(t)
Vrbci2
− KdRBCvMGF16P2 ·mgf16p2RBCi(t)
Vrbci
)
(A.4.121)
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vRBCivMGG16P2 = parMulti · TsRBC ·Vrbci ·
(
KaappRBCvMGG16P2 · g16p2RBCi(t) ·mgRBCi(t)
Vrbci2
− KdRBCvMGG16P2 ·mgg16p2RBCi(t)
Vrbci
)
(A.4.122)
vRBCivMGPHOS = parMulti · TsRBC ·Vrbci ·
(
KaappRBCvMGPHOS ·mgRBCi(t) · phosRBCi(t)
Vrbci2
− KdRBCvMGPHOS ·mgphosRBCi(t)
Vrbci
)
(A.4.123)
vRBCivOX = KRBCvOX · parMulti · TsRBC · gshRBCi(t) (A.4.124)
vRBCivOXNADH = KRBCvOXNADH · parMulti · TsRBC · nadhRBCi(t) (A.4.125)
vRBCivP6GDH = [parMulti · TsRBC ·Vrbci ·VRBCvP6GDH (A.4.126)
·
 K11RBCvP6GDH ·K1RBCvP6GDH ·K3RBCvP6GDH ·K5RBCvP6GDH ·K7RBCvP6GDH ·K9RBCvP6GDH1 · nadpRBCi(t) · p6gRBCi(t)
Vrbci2
(A.4.127)
−
co2RBCi ·K10RBCvP6GDH ·K12RBCvP6GDH ·K2RBCvP6GDH ·K4RBCvP6GDH ·K6RBCvP6GDH ·K8RBCvP6GDH
1 · nadphRBCi(t) · ru5pRBCi(t)
Vrbci3
 / (A.4.128)
[
co2RBCi ·K12RBCvP6GDH ·K2RBCvP6GDH ·K4RBCvP6GDH ·K6RBCvP6GDH · nadphRBCi(t) ·K8RBCvP6GDH
Vrbci2
(A.4.129)
+
co2RBCi ·K11RBCvP6GDH ·K1RBCvP6GDH ·K4RBCvP6GDH ·K6RBCvP6GDH · nadpRBCi(t) ·K8RBCvP6GDH
Vrbci2
(A.4.130)
+
co2RBCi ·K11RBCvP6GDH ·K1RBCvP6GDH ·K3RBCvP6GDH · (K5RBCvP6GDH + K6RBCvP6GDH) · nadpRBCi(t)
1 · p6gRBCi(t) ·K8RBCvP6GDH
Vrbci3
(A.4.131)
+
co2RBCi ·K10RBCvP6GDH ·K12RBCvP6GDH · (K2RBCvP6GDH ·K4RBCvP6GDH + K6RBCvP6GDH ·K4RBCvP6GDH
1 + K2RBCvP6GDH ·K5RBCvP6GDH + K2RBCvP6GDH ·K6RBCvP6GDH) · nadphRBCi(t) · ru5pRBCi(t) ·K8RBCvP6GDH
Vrbci3
(A.4.132)
+
co2RBCi ·K10RBCvP6GDH ·K1RBCvP6GDH ·K4RBCvP6GDH ·K6RBCvP6GDH · nadpRBCi(t) · ru5pRBCi(t) ·K8RBCvP6GDH
Vrbci3
(A.4.133)
+
co2RBCi ·K10RBCvP6GDH ·K12RBCvP6GDH ·K3RBCvP6GDH · (K5RBCvP6GDH
1 + K6RBCvP6GDH) · nadphRBCi(t) · p6gRBCi(t) · ru5pRBCi(t) ·K8RBCvP6GDH
Vrbci4
(A.4.134)
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+co2RBCi ·K10RBCvP6GDH ·K1RBCvP6GDH ·K3RBCvP6GDH · (K5RBCvP6GDH
1 + K6RBCvP6GDH) · nadpRBCi(t) · p6gRBCi(t) · ru5pRBCi(t) ·K8RBCvP6GDH
Vrbci4
(A.4.135)
+
co2RBCi ·K10RBCvP6GDH ·K2RBCvP6GDH ·K4RBCvP6GDH ·K6RBCvP6GDH · ru5pRBCi(t) ·K8RBCvP6GDH
Vrbci2
(A.4.136)
+
co2RBCi ·K11RBCvP6GDH ·K2RBCvP6GDH ·K4RBCvP6GDH ·K6RBCvP6GDH ·K8RBCvP6GDH
Vrbci
(A.4.137)
+ K11RBCvP6GDH ·K2RBCvP6GDH · (K4RBCvP6GDH ·K6RBCvP6GDH + K4RBCvP6GDH ·K7RBCvP6GDH (A.4.138)
+ K5RBCvP6GDH ·K7RBCvP6GDH) ·K9RBCvP6GDH (A.4.139)
+
K12RBCvP6GDH ·K2RBCvP6GDH · (K4RBCvP6GDH ·K6RBCvP6GDH + K4RBCvP6GDH ·K7RBCvP6GDH
1 + K5RBCvP6GDH ·K7RBCvP6GDH) ·K9RBCvP6GDH · nadphRBCi(t)
Vrbci
(A.4.140)
+
K11RBCvP6GDH ·K1RBCvP6GDH · (K4RBCvP6GDH ·K6RBCvP6GDH + K4RBCvP6GDH ·K7RBCvP6GDH
1 + K5RBCvP6GDH ·K7RBCvP6GDH) ·K9RBCvP6GDH · nadpRBCi(t)
Vrbci
(A.4.141)
+
K12RBCvP6GDH ·K3RBCvP6GDH ·K5RBCvP6GDH ·K7RBCvP6GDH ·K9RBCvP6GDH · nadphRBCi(t) · p6gRBCi(t)
Vrbci2
(A.4.142)
+
K1RBCvP6GDH ·K3RBCvP6GDH · (K11RBCvP6GDH ·K5RBCvP6GDH ·K7RBCvP6GDH + K11RBCvP6GDH ·K9RBCvP6GDH ·K7RBCvP6GDH
1
+K5RBCvP6GDH ·K9RBCvP6GDH ·K7RBCvP6GDH + K11RBCvP6GDH ·K5RBCvP6GDH ·K9RBCvP6GDH
1 + K11RBCvP6GDH ·K6RBCvP6GDH ·K9RBCvP6GDH) · nadpRBCi(t) · p6gRBCi(t)
Vrbci2
(A.4.143)
+
K11RBCvP6GDH ·K3RBCvP6GDH ·K5RBCvP6GDH ·K7RBCvP6GDH ·K9RBCvP6GDH · p6gRBCi(t)
Vrbci
(A.4.144)
+
K10RBCvP6GDH ·K12RBCvP6GDH ·K2RBCvP6GDH · (K4RBCvP6GDH ·K6RBCvP6GDH + K4RBCvP6GDH ·K7RBCvP6GDH
1 + K5RBCvP6GDH ·K7RBCvP6GDH) · nadphRBCi(t) · ru5pRBCi(t)
Vrbci2
(A.4.145)
+
K10RBCvP6GDH ·K12RBCvP6GDH ·K3RBCvP6GDH ·K5RBCvP6GDH ·K7RBCvP6GDH · nadphRBCi(t) · p6gRBCi(t) · ru5pRBCi(t)
Vrbci3
(A.4.146)
+
K10RBCvP6GDH ·K1RBCvP6GDH ·K3RBCvP6GDH ·K5RBCvP6GDH ·K7RBCvP6GDH · nadpRBCi(t) · p6gRBCi(t) · ru5pRBCi(t)
Vrbci3
]
(A.4.147)
(A.4.148)
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vRBCivPFK =
[
parMulti · TsRBC ·Vrbci ·VRBCvPFK ·
(
KcatfRBCvPFK · f6pRBCi(t) ·mgatpRBCi(t)
Kmf6pRBCvPFK ·KmmgatpRBCvPFK ·Vrbci2 (A.4.149)
− KcatfRBCvPFK · f16p2RBCi(t) ·mgadpRBCi(t)
Kmf16p2RBCvPFK ·KmmgadpRBCvPFK ·Vrbci2
)]
/ (A.4.150)
[(
mgadpRBCi(t) · f16p2RBCi(t)
Kmf16p2RBCvPFK ·KmmgadpRBCvPFK ·Vrbci2 +
f16p2RBCi(t)
Kmf16p2RBCvPFK ·Vrbci +
f6pRBCi(t)
Kmf6pRBCvPFK ·Vrbci (A.4.151)
+
mgadpRBCi(t)
KmmgadpRBCvPFK ·Vrbci +
f6pRBCi(t) ·mgatpRBCi(t)
Kmf6pRBCvPFK ·KmmgatpRBCvPFK ·Vrbci2 +
mgatpRBCi(t)
KmmgatpRBCvPFK ·Vrbci + 1
)
(A.4.152)
·

(
atpRBCi(t)
KtatpRBCvPFK·Vrbci + 1
)4 · ( b23pgRBCi(t)
Ktb23pgRBCvPFK·Vrbci + 1
)4 · ( mgRBCi(t)
KtmgRBCvPFK·Vrbci + 1
)4 · ( hRBC
KaRBCvPFK
)nRBCvPFK
(
ampRBCi(t)
KrampRBCvPFK·Vrbci + 1
)4 · ( f16p2RBCi(t)
Kmf16p2RBCvPFK·Vrbci +
f6pRBCi(t)
Kmf6pRBCvPFK·Vrbci + 1
)4 · ( g16p2RBCi(t)
Krg16p2RBCvPFK·Vrbci + 1
)4 · ( phosRBCi(t)
KrphosRBCvPFK·Vrbci + 1
)4 + 1


(A.4.153)
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vRBCivPGI =
ERBCvPGI · parMulti · TsRBC ·Vrbci ·
(
KcatfRBCvPGI·g6pRBCi(t)
Kmg6pRBCvPGI·Vrbci −
KcatrRBCvPGI·f6pRBCi(t)
Kmf6pRBCvPGI·Vrbci
)
f6pRBCi(t)
Kmf6pRBCvPGI·Vrbci +
g6pRBCi(t)
Kmg6pRBCvPGI·Vrbci + 1
(A.4.154)
vRBCivPGK =
parMulti · TsRBC ·Vrbci ·VRBCvPGK ·
(
KcatfRBCvPGK·b13pgRBCi(t)·mgadpRBCi(t)
KimgadpRBCvPGK·Kmb13pgRBCvPGK·Vrbci2
1 − KcatrRBCvPGK·mgatpRBCi(t)·p3gRBCi(t)
KimgatpRBCvPGK·Kmp3gRBCvPGK·Vrbci2
)
mgadpRBCi(t)·b13pgRBCi(t)
KimgadpRBCvPGK·Kmb13pgRBCvPGK·Vrbci2 +
b13pgRBCi(t)
Kib13pgRBCvPGK·Vrbci +
mgadpRBCi(t)
KimgadpRBCvPGK·Vrbci +
mgatpRBCi(t)
KimgatpRBCvPGK·Vrbci
1 +
mgatpRBCi(t)·p3gRBCi(t)
KimgatpRBCvPGK·Kmp3gRBCvPGK·Vrbci2 +
p3gRBCi(t)
Kip3gRBCvPGK·Vrbci + 1
(A.4.155)
vRBCivPGLHYDROLYSIS = parMulti · TsRBC ·Vrbci ·
(
KhydrolRBCvPGLHYDROLYSIS · p6glRBCi(t)
Vrbci
(A.4.156)
+
Klactonase3RBCvPGLHYDROLYSIS ·VRBCvPGLHYDROLYSIS · p6glRBCi(t)
Vrbci ·
(
Klactonase2RBCvPGLHYDROLYSIS+Klactonase3RBCvPGLHYDROLYSIS
Klactonase1RBCvPGLHYDROLYSIS
+
p6glRBCi(t)
Vrbci
)
 (A.4.157)
vRBCivPGM =
parMulti · TsRBC ·Vrbci ·VRBCvPGM ·
(
KcatfRBCvPGM·p3gRBCi(t)
Kmp3gRBCvPGM·Vrbci −
KcatrRBCvPGM·p2gRBCi(t)
Kmp2gRBCvPGM·Vrbci
)
p2gRBCi(t)
Kmp2gRBCvPGM·Vrbci +
p3gRBCi(t)
Kmp3gRBCvPGM·Vrbci + 1
(A.4.158)
vRBCivPHOSTRANSPORT = parMulti · TsRBC ·Vrbci ·
(
KoRBCvPHOSTRANSPORT · phosRBCi(t)
Vrbci
− KiRBCvPHOSTRANSPORT · phosEXT
vBld
)
(A.4.159)
(A.4.160)
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vRBCivPK =
[
parMulti · TsRBC ·Vrbci ·VRBCvPK ·
(
KcatfRBCvPK ·mgadpRBCi(t) · pepRBCi(t)
KrmgadpRBCvPK ·KrpepRBCvPK ·Vrbci2 −
KcatrRBCvPK ·mgatpRBCi(t) · pyrRBCi(t)
KrmgatpRBCvPK ·KrpyrRBCvPK ·Vrbci2
)]
/
(A.4.161)[
(LRBCivPK + 1) ·
(
pepRBCi(t) ·mgadpRBCi(t)
KrmgadpRBCvPK ·KrpepRBCvPK ·Vrbci2 +
mgadpRBCi(t)
KrmgadpRBCvPK ·Vrbci +
mgatpRBCi(t)
KrmgatpRBCvPK ·Vrbci (A.4.162)
+
pepRBCi(t)
KrpepRBCvPK ·Vrbci +
mgatpRBCi(t) · pyrRBCi(t)
KrmgatpRBCvPK ·KrpyrRBCvPK ·Vrbci2 +
pyrRBCi(t)
KrpyrRBCvPK ·Vrbci + 1
)
(A.4.163)
vRBCivPYRTRANSPORT = parMulti · TsRBC ·Vrbci ·
(
KoRBCvPYRTRANSPORT · pyrRBCi(t)
Vrbci
− KiRBCvPYRTRANSPORT · pyrEXT
vBld
)
(A.4.164)
vRBCivR5PI =
parMulti · TsRBC ·Vrbci ·VRBCvR5PI ·
(
K1RBCvR5PI·K3RBCvR5PI·ru5pRBCi(t)
(K2RBCvR5PI+K3RBCvR5PI)·Vrbci −
K2RBCvR5PI·K4RBCvR5PI·rib5pRBCi(t)
(K2RBCvR5PI+K3RBCvR5PI)·Vrbci
)
K1RBCvR5PI·ru5pRBCi(t)
(K2RBCvR5PI+K3RBCvR5PI)·Vrbci +
K4RBCvR5PI·xu5pRBCi(t)
(K2RBCvR5PI+K3RBCvR5PI)·Vrbci + 1
(A.4.165)
vRBCivRu5PE =
parMulti · TsRBC ·Vrbci ·VRBCvRu5PE ·
(
K1RBCvRu5PE·K3RBCvRu5PE·ru5pRBCi(t)
(K2RBCvRu5PE+K3RBCvRu5PE)·Vrbci −
K2RBCvRu5PE·K4RBCvRu5PE·xu5pRBCi(t)
(K2RBCvRu5PE+K3RBCvRu5PE)·Vrbci
)
K1RBCvRu5PE·ru5pRBCi(t)
(K2RBCvRu5PE+K3RBCvRu5PE)·Vrbci +
K4RBCvRu5PE·xu5pRBCi(t)
(K2RBCvRu5PE+K3RBCvRu5PE)·Vrbci + 1
(A.4.166)
vRBCivTA =
[
parMulti · TsRBC ·Vrbci ·VRBCvTA ·
(
K1RBCvTA ·K3RBCvTA ·K5RBCvTA ·K7RBCvTA · gapRBCi(t) · sed7pRBCi(t)
Vrbci2
(A.4.167)
−K2RBCvTA ·K4RBCvTA ·K6RBCvTA ·K8RBCvTA · ery4pRBCi(t) · f6pRBCi(t)
Vrbci2
)]
/ (A.4.168)
[
K4RBCvTA · (K2RBCvTA + K6RBCvTA) ·K8RBCvTA · f6pRBCi(t) · ery4pRBCi(t)
Vrbci2
(A.4.169)
+
K1RBCvTA ·K4RBCvTA · (K6RBCvTA + K7RBCvTA) · sed7pRBCi(t) · ery4pRBCi(t)
Vrbci2
(A.4.170)
+
K2RBCvTA ·K4RBCvTA · (K6RBCvTA + K7RBCvTA) · ery4pRBCi(t)
Vrbci
(A.4.171)
+
(K2RBCvTA + K3RBCvTA) ·K6RBCvTA ·K8RBCvTA · f6pRBCi(t)
Vrbci
(A.4.172)
+
(K2RBCvTA + K3RBCvTA) ·K5RBCvTA ·K8RBCvTA · f6pRBCi(t) · gapRBCi(t)
Vrbci2
(A.4.173)
+
(K2RBCvTA + K3RBCvTA) ·K5RBCvTA ·K7RBCvTA · gapRBCi(t)
Vrbci
(A.4.174)
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+
K1RBCvTA ·K5RBCvTA · (K3RBCvTA + K7RBCvTA) · gapRBCi(t) · sed7pRBCi(t)
Vrbci2
(A.4.175)
+
K1RBCvTA ·K3RBCvTA · (K6RBCvTA + K7RBCvTA) · sed7pRBCi(t)
Vrbci
]
(A.4.176)
vRBCivTIM =
parMulti · TsRBC ·Vrbci ·VRBCvTIM ·
(
KcatfRBCvTIM·gapRBCi(t)
KmgapRBCvTIM·Vrbci −
KcatrRBCvTIM·dhapRBCi(t)
KmdhapRBCvTIM·Vrbci
)
dhapRBCi(t)
KmdhapRBCvTIM·Vrbci +
gapRBCi(t)
KmgapRBCvTIM·Vrbci + 1
(A.4.177)
vRBCivTK1 = parMulti · TsRBC ·Vrbci ·
(
K1RBCvTK1 · tkRBCi(t) · xu5pRBCi(t)
Vrbci2
− K2RBCvTK1 · tkxu5pRBCi(t)
Vrbci
)
(A.4.178)
vRBCivTK2 = parMulti · TsRBC ·Vrbci ·
(
K3RBCvTK2 · tkxu5pRBCi(t)
Vrbci
− K4RBCvTK2 · gapRBCi(t) · tkgRBCi(t)
Vrbci2
)
(A.4.179)
vRBCivTK3 = parMulti · TsRBC ·Vrbci ·
(
K5RBCvTK3 · rib5pRBCi(t) · tkgRBCi(t)
Vrbci2
− K6RBCvTK3 · tkgrib5pRBCi(t)
Vrbci
)
(A.4.180)
vRBCivTK4 = parMulti · TsRBC ·Vrbci ·
(
K7RBCvTK4 · tkgrib5pRBCi(t)
Vrbci
− K8RBCvTK4 · sed7pRBCi(t) · tkRBCi(t)
Vrbci2
)
(A.4.181)
vRBCivTK5 = parMulti · TsRBC ·Vrbci ·
(
K9RBCvTK5 · ery4pRBCi(t) · tkgRBCi(t)
Vrbci2
− K10RBCvTK5 · tkgery4pRBCi(t)
Vrbci
)
(A.4.182)
vRBCivTK6 = parMulti · TsRBC ·Vrbci ·
(
K11RBCvTK6 · tkgery4pRBCi(t)
Vrbci
− K12RBCvTK6 · f6pRBCi(t) · tkRBCi(t)
Vrbci2
)
(A.4.183)
vRBCvAK = TsRBC ·Vrbcu ·
(
K1appRBCvAK · adpRBC(t) ·mgadpRBC(t)
Vrbcu2
− K2appRBCvAK · ampRBC(t) ·mgatpRBC(t)
Vrbcu2
)
(A.4.184)
(A.4.185)
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vRBCvALD =
[
TsRBC ·Vrbcu ·VRBCvALD ·
(
KcatfRBCvALD · f16p2RBC(t)
Kmf16p2RBCvALD ·Vrbcu −
KcatrRBCvALD · dhapRBC(t) · gapRBC(t)
KidhapRBCvALD ·KmgapRBCvALD ·Vrbcu2
)]
/ (A.4.186)
[
gapRBC(t) · dhapRBC(t)
KidhapRBCvALD ·KmgapRBCvALD ·Vrbcu2 +
dhapRBC(t)
KidhapRBCvALD ·Vrbcu +
f16p2RBC(t)
Kmf16p2RBCvALD ·Vrbcu (A.4.187)
+
KmdhapRBCvALD · f16p2RBC(t) · gapRBC(t)
KidhapRBCvALD ·Kif16p2RBCvALD ·KmgapRBCvALD ·Vrbcu2 +
b23pgRBC(t)
Vrbcu
+
mgb23pgRBC(t)
Vrbcu
Kib23pgRBCvALD
(A.4.188)
+
KmdhapRBCvALD · gapRBC(t) ·
(
b23pgRBC(t)
Vrbcu
+
mgb23pgRBC(t)
Vrbcu
Kib23pgRBCvALD
+ 1
)
KidhapRBCvALD ·KmgapRBCvALD ·Vrbcu + 1
 (A.4.189)
vRBCvATPASE = KRBCvATPASE · TsRBC ·mgatpRBC(t) (A.4.190)
vRBCvBPGSP1 = TsRBC ·Vrbcu ·
(
K1appRBCvBPGSP1 · b13pgRBC(t) · bpgspRBC(t)
Vrbcu2
− K2RBCvBPGSP1 · bpgspb13pgRBC(t)
Vrbcu
)
(A.4.191)
vRBCvBPGSP2 = K3appRBCvBPGSP2 · TsRBC · bpgspb13pgRBC(t) (A.4.192)
vRBCvBPGSP3 = TsRBC ·Vrbcu ·
(
K4appRBCvBPGSP3 · bpgsppRBC(t) · p3gRBC(t)
Vrbcu2
− K5RBCvBPGSP3 · bpgsppp3gRBC(t)
Vrbcu
)
(A.4.193)
vRBCvBPGSP4 = TsRBC ·Vrbcu ·
(
K6appRBCvBPGSP4 · bpgsppRBC(t) · p2gRBC(t)
Vrbcu2
− K7RBCvBPGSP4 · bpgsppp2gRBC(t)
Vrbcu
)
(A.4.194)
vRBCvBPGSP5 = TsRBC ·Vrbcu ·
(
K8RBCvBPGSP5 · bpgsppp3gRBC(t)
Vrbcu
− K9RBCvBPGSP5 · bpgspb23pgRBC(t)
Vrbcu
)
(A.4.195)
vRBCvBPGSP6 = TsRBC ·Vrbcu ·
(
K10RBCvBPGSP6 · bpgsppp2gRBC(t)
Vrbcu
− K11RBCvBPGSP6 · bpgspb23pgRBC(t)
Vrbcu
)
(A.4.196)
vRBCvBPGSP7 = TsRBC ·Vrbcu ·
(
K12RBCvBPGSP7 · bpgspb23pgRBC(t)
Vrbcu
− K13appRBCvBPGSP7 · b23pgRBC(t) · bpgspRBC(t)
Vrbcu2
)
(A.4.197)
vRBCvBPGSP8 = TsRBC ·Vrbcu ·
(
K14RBCvBPGSP8 · bpgsppRBC(t) · phosRBC(t)
Vrbcu2
− K15RBCvBPGSP8 · bpgsppphosRBC(t)
Vrbcu
)
(A.4.198)
vRBCvBPGSP9 = K16RBCvBPGSP9 · TsRBC · bpgsppphosRBC(t) (A.4.199)
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vRBCvENO =
TsRBC ·Vrbcu ·VRBCvENO ·
(
KcatfRBCvENO·mgRBC(t)·p2gRBC(t)
KimgRBCvENO·Kmp2gRBCvENO·Vrbcu2 −
KcatrRBCvENO·mgRBC(t)·pepRBC(t)
KipepRBCvENO·KmmgRBCvENO·Vrbcu2
)
p2gRBC(t)·mgRBC(t)
KimgRBCvENO·Kmp2gRBCvENO·Vrbcu2 +
pepRBC(t)·mgRBC(t)
KipepRBCvENO·KmmgRBCvENO·Vrbcu2 +
mgRBC(t)
KimgRBCvENO·Vrbcu +
p2gRBC(t)
Kip2gRBCvENO·Vrbcu
1 +
pepRBC(t)
KipepRBCvENO·Vrbcu + 1
(A.4.200)
vRBCvG6PDH = [TsRBC ·Vrbcu ·VRBCvG6PDH· (A.4.201)(
K1RBCvG6PDH ·K3RBCvG6PDH ·K5RBCvG6PDH ·K7RBCvG6PDH ·K9RBCvG6PDH · g6pRBC(t) · nadpRBC(t)
Vrbcu2
(A.4.202)
−K10RBCvG6PDH ·K2RBCvG6PDH ·K4RBCvG6PDH ·K6RBCvG6PDH ·K8RBCvG6PDH · nadphRBC(t) · p6glRBC(t)
Vrbcu2
)]
/ (A.4.203)
[K2RBCvG6PDH ·K9RBCvG6PDH (A.4.204)
· (K4RBCvG6PDH ·K6RBCvG6PDH + K4RBCvG6PDH ·K7RBCvG6PDH + K5RBCvG6PDH ·K7RBCvG6PDH) (A.4.205)
+
K3RBCvG6PDH ·K5RBCvG6PDH ·K7RBCvG6PDH · g6pRBC(t) ·K9RBCvG6PDH
Vrbcu
(A.4.206)
+
K1RBCvG6PDH · nadpRBC(t) ·K9RBCvG6PDH
1 · (K4RBCvG6PDH ·K6RBCvG6PDH + K4RBCvG6PDH ·K7RBCvG6PDH + K5RBCvG6PDH ·K7RBCvG6PDH)
Vrbcu
(A.4.207)
+
K10RBCvG6PDH ·K3RBCvG6PDH ·K5RBCvG6PDH ·K7RBCvG6PDH · g6pRBC(t) · nadphRBC(t)
Vrbcu2
(A.4.208)
+
K10RBCvG6PDH ·K2RBCvG6PDH · (K4RBCvG6PDH ·K6RBCvG6PDH
1 + K5RBCvG6PDH ·K6RBCvG6PDH + K5RBCvG6PDH ·K7RBCvG6PDH) · nadphRBC(t)
Vrbcu
(A.4.209)
+
K1RBCvG6PDH ·K3RBCvG6PDH · (K5RBCvG6PDH ·K7RBCvG6PDH + K9RBCvG6PDH ·K7RBCvG6PDH + K5RBCvG6PDH
1 ·K9RBCvG6PDH + K6RBCvG6PDH ·K9RBCvG6PDH) · g6pRBC(t) · nadpRBC(t)
Vrbcu2
(A.4.210)
+
K10RBCvG6PDH ·K3RBCvG6PDH · (K5RBCvG6PDH + K6RBCvG6PDH) ·K8RBCvG6PDH · g6pRBC(t) · nadphRBC(t) · p6glRBC(t)
Vrbcu3
(A.4.211)
+
K10RBCvG6PDH · (K2RBCvG6PDH ·K4RBCvG6PDH + K6RBCvG6PDH ·K4RBCvG6PDH
+K2RBCvG6PDH ·K5RBCvG6PDH + K2RBCvG6PDH ·K6RBCvG6PDH) ·K8RBCvG6PDH · nadphRBC(t) · p6glRBC(t) Vrbcu
2 (A.4.212)
+
K1RBCvG6PDH ·K3RBCvG6PDH · (K5RBCvG6PDH + K6RBCvG6PDH) ·K8RBCvG6PDH · g6pRBC(t) · nadpRBC(t) · p6glRBC(t)
Vrbcu3
(A.4.213)
+
K1RBCvG6PDH ·K4RBCvG6PDH ·K6RBCvG6PDH ·K8RBCvG6PDH · nadpRBC(t) · p6glRBC(t)
Vrbcu2
(A.4.214)
+
K2RBCvG6PDH ·K4RBCvG6PDH ·K6RBCvG6PDH ·K8RBCvG6PDH · p6glRBC(t)
Vrbcu
]
(A.4.215)
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vRBCvGAPDH =
[
TsRBC ·Vrbcu ·VRBCvGAPDH ·
(
KcatfappRBCvGAPDH · gapRBC(t) · nadRBC(t) · phosRBC(t)
KiappgapRBCvGAPDH ·KiphosRBCvGAPDH ·KmnadRBCvGAPDH ·Vrbcu3 (A.4.216)
− KcatrappRBCvGAPDH · b13pgRBC(t) · nadhRBC(t)
Kiappb13pgRBCvGAPDH ·KmappnadhRBCvGAPDH ·Vrbcu2
)]
/ (A.4.217)
b13pgRBC(t) ·
(
gapRBC(t)
KidgapRBCvGAPDH·Vrbcu + 1
)
Kiappb13pgRBCvGAPDH ·Vrbcu +
gapRBC(t) ·
(
gapRBC(t)
KidgapRBCvGAPDH·Vrbcu + 1
)
KiappgapRBCvGAPDH ·Vrbcu (A.4.218)
+
gapRBC(t) · phosRBC(t) ·
(
gapRBC(t)
KidgapRBCvGAPDH·Vrbcu + 1
)
KiappgapRBCvGAPDH ·KiphosRBCvGAPDH ·Vrbcu2 +
b13pgRBC(t) · nadhRBC(t)
Kiappb13pgRBCvGAPDH ·KmappnadhRBCvGAPDH ·Vrbcu2 (A.4.219)
+
gapRBC(t) · nadhRBC(t)
KiappgapRBCvGAPDH ·KiappnadhRBCvGAPDH ·Vrbcu2 +
Kmb13pgRBCvGAPDH · nadhRBC(t)
Kiappb13pgRBCvGAPDH ·KmappnadhRBCvGAPDH ·Vrbcu (A.4.220)
+
b13pgRBC(t) · nadRBC(t)
Kiappb13pgRBCvGAPDH ·KinadRBCvGAPDH ·Vrbcu2 +
gapRBC(t) · nadRBC(t)
KiappgapRBCvGAPDH ·KinadRBCvGAPDH ·Vrbcu2 (A.4.221)
+
Kmb13pgRBCvGAPDH · b13pgRBC(t) · nadhRBC(t) · phosRBC(t)
Kiappb13pgRBCvGAPDH ·Kidb13pgRBCvGAPDH ·KiphosRBCvGAPDH ·KmappnadhRBCvGAPDH ·Vrbcu3 (A.4.222)
+
gapRBC(t) · nadhRBC(t) · phosRBC(t)
KiappgapRBCvGAPDH ·KiappnadhRBCvGAPDH ·KiphosRBCvGAPDH ·Vrbcu3 (A.4.223)
+
Kmb13pgRBCvGAPDH · nadhRBC(t) · phosRBC(t)
Kiappb13pgRBCvGAPDH ·KiphosRBCvGAPDH ·KmappnadhRBCvGAPDH ·Vrbcu2 (A.4.224)
+
KmgapRBCvGAPDH · b13pgRBC(t) · nadRBC(t) · phosRBC(t)
KiappgapRBCvGAPDH ·Kidb13pgRBCvGAPDH ·KiphosRBCvGAPDH ·KmnadRBCvGAPDH ·Vrbcu3 (A.4.225)
+
gapRBC(t) · nadRBC(t) · phosRBC(t)
KiappgapRBCvGAPDH ·KiphosRBCvGAPDH ·KmnadRBCvGAPDH ·Vrbcu3 (A.4.226)
+
KmgapRBCvGAPDH · nadRBC(t) · phosRBC(t)
KiappgapRBCvGAPDH ·KiphosRBCvGAPDH ·KmnadRBCvGAPDH ·Vrbcu2
]
(A.4.227)
vRBCvGLCTRANSPORT = TsRBC ·Vrbcu ·
 glc_alpha ·VRBCvGLCTRANSPORT · B_gluc(t)
1000 ·
(
(1−glc_alpha)·B_gluc(t)·k_alpha
1000·k_beta + k_alpha +
glc_alpha·B_gluc(t)
1000
) (A.4.228)
+
(1− glc_alpha) ·VRBCvGLCTRANSPORT · B_gluc(t)
1000 ·
(
glc_alpha·B_gluc(t)·k_beta
1000·k_alpha + k_beta +
(1−glc_alpha)·B_gluc(t)
1000
) (A.4.229)
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− glc_alpha ·VRBCvGLCTRANSPORT · glcRBC(t)
Vrbcu ·
(
(1−glc_alpha)·glcRBC(t)·k_alpha
k_beta·Vrbcu + k_alpha +
glc_alpha·glcRBC(t)
Vrbcu
) (A.4.230)
− (1− glc_alpha) ·VRBCvGLCTRANSPORT · glcRBC(t)
Vrbcu ·
(
glc_alpha·glcRBC(t)·k_beta
k_alpha·Vrbcu + k_beta +
(1−glc_alpha)·glcRBC(t)
Vrbcu
)
 (A.4.231)
vRBCvGSSGR = [TsRBC ·Vrbcu ·VRBCvGSSGR· (A.4.232) K11RBCvGSSGR ·K1RBCvGSSGR ·K3RBCvGSSGR ·K5RBCvGSSGR ·K7RBCvGSSGR1 ·K9RBCvGSSGR · gssgRBC(t) · nadphRBC(t)
Vrbcu2
(A.4.233)
−
K10RBCvGSSGR ·K12RBCvGSSGR ·K2RBCvGSSGR ·K4RBCvGSSGR ·K6RBCvGSSGR
1 ·K8RBCvGSSGR · gshRBC(t)2 · nadpRBC(t)
Vrbcu3

 / (A.4.234)

K10RBCvGSSGR ·K1RBCvGSSGR ·K3RBCvGSSGR · (K5RBCvGSSGR + K6RBCvGSSGR)
1 ·K8RBCvGSSGR · gssgRBC(t) · nadphRBC(t) · gshRBC(t)2
Vrbcu4
(A.4.235)
+
K10RBCvGSSGR ·K1RBCvGSSGR ·K4RBCvGSSGR ·K6RBCvGSSGR ·K8RBCvGSSGR · nadphRBC(t) · gshRBC(t)2
Vrbcu3
(A.4.236)
+
K10RBCvGSSGR ·K12RBCvGSSGR ·K3RBCvGSSGR · (K5RBCvGSSGR + K6RBCvGSSGR) ·K8RBCvGSSGR · gssgRBC(t) · nadpRBC(t) · gshRBC(t)2
Vrbcu4
(A.4.237)
+
K10RBCvGSSGR ·K12RBCvGSSGR · (K2RBCvGSSGR ·K4RBCvGSSGR + K6RBCvGSSGR ·K4RBCvGSSGR + K2RBCvGSSGR ·K5RBCvGSSGR
1 + K2RBCvGSSGR ·K6RBCvGSSGR) ·K8RBCvGSSGR · nadpRBC(t) · gshRBC(t)2
Vrbcu3
(A.4.238)
+
K10RBCvGSSGR ·K2RBCvGSSGR ·K4RBCvGSSGR ·K6RBCvGSSGR ·K8RBCvGSSGR · gshRBC(t)2
Vrbcu2
(A.4.239)
+
K10RBCvGSSGR ·K1RBCvGSSGR ·K3RBCvGSSGR ·K5RBCvGSSGR ·K7RBCvGSSGR · gssgRBC(t) · nadphRBC(t) · gshRBC(t)
Vrbcu3
(A.4.240)
+
K11RBCvGSSGR ·K1RBCvGSSGR ·K3RBCvGSSGR · (K5RBCvGSSGR + K6RBCvGSSGR) ·K8RBCvGSSGR · gssgRBC(t) · nadphRBC(t) · gshRBC(t)
Vrbcu3
(A.4.241)
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+
K11RBCvGSSGR ·K1RBCvGSSGR ·K4RBCvGSSGR ·K6RBCvGSSGR ·K8RBCvGSSGR · nadphRBC(t) · gshRBC(t)
Vrbcu2
(A.4.242)
+
K10RBCvGSSGR ·K12RBCvGSSGR ·K3RBCvGSSGR ·K5RBCvGSSGR ·K7RBCvGSSGR · gssgRBC(t) · nadpRBC(t) · gshRBC(t)
Vrbcu3
(A.4.243)
+
K10RBCvGSSGR ·K12RBCvGSSGR ·K2RBCvGSSGR · (K4RBCvGSSGR ·K6RBCvGSSGR + K4RBCvGSSGR ·K7RBCvGSSGR
1 + K5RBCvGSSGR ·K7RBCvGSSGR) · nadpRBC(t) · gshRBC(t)
Vrbcu2
(A.4.244)
+
K12RBCvGSSGR ·K2RBCvGSSGR ·K4RBCvGSSGR ·K6RBCvGSSGR ·K8RBCvGSSGR · nadpRBC(t) · gshRBC(t)
Vrbcu2
(A.4.245)
+
K11RBCvGSSGR ·K2RBCvGSSGR ·K4RBCvGSSGR ·K6RBCvGSSGR ·K8RBCvGSSGR · gshRBC(t)
Vrbcu
(A.4.246)
+ K11RBCvGSSGR ·K2RBCvGSSGR ·K9RBCvGSSGR (A.4.247)
· (K4RBCvGSSGR ·K6RBCvGSSGR + K4RBCvGSSGR ·K7RBCvGSSGR + K5RBCvGSSGR ·K7RBCvGSSGR) (A.4.248)
+
K11RBCvGSSGR ·K3RBCvGSSGR ·K5RBCvGSSGR ·K7RBCvGSSGR ·K9RBCvGSSGR · gssgRBC(t)
Vrbcu
(A.4.249)
+
K1RBCvGSSGR ·K3RBCvGSSGR · (K11RBCvGSSGR ·K5RBCvGSSGR ·K7RBCvGSSGR + K11RBCvGSSGR ·K9RBCvGSSGR ·K7RBCvGSSGR
1
+K5RBCvGSSGR ·K9RBCvGSSGR ·K7RBCvGSSGR + K11RBCvGSSGR ·K5RBCvGSSGR ·K9RBCvGSSGR
1 + K11RBCvGSSGR ·K6RBCvGSSGR ·K9RBCvGSSGR) · gssgRBC(t) · nadphRBC(t)
Vrbcu2
(A.4.250)
+
K11RBCvGSSGR ·K1RBCvGSSGR · (K4RBCvGSSGR ·K6RBCvGSSGR + K4RBCvGSSGR ·K7RBCvGSSGR
1 + K5RBCvGSSGR ·K7RBCvGSSGR) ·K9RBCvGSSGR · nadphRBC(t)
Vrbcu
(A.4.251)
+
K12RBCvGSSGR ·K3RBCvGSSGR ·K5RBCvGSSGR ·K7RBCvGSSGR ·K9RBCvGSSGR · gssgRBC(t) · nadpRBC(t)
Vrbcu2
(A.4.252)
+
K12RBCvGSSGR ·K2RBCvGSSGR · (K4RBCvGSSGR ·K6RBCvGSSGR + K4RBCvGSSGR ·K7RBCvGSSGR + K5RBCvGSSGR ·K7RBCvGSSGR)
1 ·K9RBCvGSSGR · nadpRBC(t)
Vrbcu

(A.4.253)
vRBCvHBADP = TsRBC ·Vrbcu ·
(
KaappRBCvHBADP · adpRBC(t) · hbRBC(t)
Vrbcu2
− KdRBCvHBADP · hbadpRBC(t)
Vrbcu
)
(A.4.254)
vRBCvHBATP = TsRBC ·Vrbcu ·
(
KaappRBCvHBATP · atpRBC(t) · hbRBC(t)
Vrbcu2
− KdRBCvHBATP · hbatpRBC(t)
Vrbcu
)
(A.4.255)
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vRBCvHBB13PG = TsRBC ·Vrbcu ·
(
KaappRBCvHBB13PG · b13pgRBC(t) · hbRBC(t)
Vrbcu2
− KdRBCvHBB13PG · hbb13pgRBC(t)
Vrbcu
)
(A.4.256)
vRBCvHBB23PG = TsRBC ·Vrbcu ·
(
KaappRBCvHBBPG · b23pgRBC(t) · hbRBC(t)
Vrbcu2
− KdRBCvHBBPG · hbb23pgRBC(t)
Vrbcu
)
(A.4.257)
vRBCvHBMGATP = TsRBC ·Vrbcu ·
(
KaappRBCvHBMGATP · hbRBC(t) ·mgatpRBC(t)
Vrbcu2
− KdRBCvHBMGATP · hbmgatpRBC(t)
Vrbcu
)
(A.4.258)
vRBCvHK =
[
mathrmTsRBC ·Vrbcu ·
(
ERBCvHK ·KcatfappRBCvHK · glcRBC(t) ·mgatpRBC(t)
KiglcRBCvHK ·KmmgatpRBCvHK ·Vrbcu2 (A.4.259)
−ERBCvHK ·KcatrappRBCvHK · g6pRBC(t) ·mgadpRBC(t)
Kig6pRBCvHK ·KmmgadpRBCvHK ·Vrbcu2
)]
/ (A.4.260)
[
glcRBC(t) · g6pRBC(t)
Kdig6pRBCvHK ·KiglcRBCvHK ·Vrbcu2 +
mgadpRBC(t) · g6pRBC(t)
Kig6pRBCvHK ·KmmgadpRBCvHK ·Vrbcu2 +
g6pRBC(t)
Kig6pRBCvHK ·Vrbcu (A.4.261)
+
b23pgRBC(t) · glcRBC(t)
KdibpgRBCvHK ·KiglcRBCvHK ·Vrbcu2 +
g16p2RBC(t) · glcRBC(t)
Kdig16p2RBCvHK ·KiglcRBCvHK ·Vrbcu2 +
glcRBC(t)
KiglcRBCvHK ·Vrbcu (A.4.262)
+
glcRBC(t) · gshRBC(t)
KdigshRBCvHK ·KiglcRBCvHK ·Vrbcu2 +
mgadpRBC(t)
KimgadpRBCvHK ·Vrbcu +
glcRBC(t) ·mgatpRBC(t)
KiglcRBCvHK ·KmmgatpRBCvHK ·Vrbcu2 (A.4.263)
+
mgatpRBC(t)
KimgatpRBCvHK ·Vrbcu + 1
]
(A.4.264)
vRBCvLACTRANSPORT = 20 · TsRBC ·Vrbcu ·
(
KoRBCvLACTRANSPORT · lacRBC(t)
Vrbcu
− KiRBCvLACTRANSPORT · B_lac(t)
1000
)
(A.4.265)
vRBCvLDH =
[
TsRBC ·Vrbcu ·VRBCvLDH ·
(
KcatfRBCvLDH · nadhRBC(t) · pyrRBC(t)
KinadhRBCvLDH ·KmapppyrRBCvLDH ·Vrbcu2 (A.4.266)
− KcatrRBCvLDH · lacRBC(t) · nadRBC(t)
KinadRBCvLDH ·KmapplacRBCvLDH ·Vrbcu2
)]
/ (A.4.267)
[
KmnadRBCvLDH · lacRBC(t) · nadhRBC(t)
KinadhRBCvLDH ·KinadRBCvLDH ·KmapplacRBCvLDH ·Vrbcu2 +
lacRBC(t) · pyrRBC(t) · nadhRBC(t)
KiapplacRBCvLDH ·KinadhRBCvLDH ·KmapppyrRBCvLDH ·Vrbcu3
(A.4.268)
+
pyrRBC(t) · nadhRBC(t)
KinadhRBCvLDH ·KmapppyrRBCvLDH ·Vrbcu2 +
nadhRBC(t)
KinadhRBCvLDH ·Vrbcu +
lacRBC(t) · nadRBC(t)
KinadRBCvLDH ·KmapplacRBCvLDH ·Vrbcu2 (A.4.269)
(A.4.270)
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+
nadRBC(t)
KinadRBCvLDH ·Vrbcu +
lacRBC(t) · nadRBC(t) · pyrRBC(t)
KiapppyrRBCvLDH ·KinadRBCvLDH ·KmapplacRBCvLDH ·Vrbcu3 (A.4.271)
+
KmnadhRBCvLDH · nadRBC(t) · pyrRBC(t)
KinadhRBCvLDH ·KinadRBCvLDH ·KmapppyrRBCvLDH ·Vrbcu2 (A.4.272)
+
(
pyrRBC(t)
KidpyrRBCvLDH ·Vrbcu + 1
)
·
(
KmnadRBCvLDH · lacRBC(t)
KinadRBCvLDH ·KmapplacRBCvLDH ·Vrbcu +
KmnadhRBCvLDH · pyrRBC(t)
KinadhRBCvLDH ·KmapppyrRBCvLDH ·Vrbcu + 1
)]
(A.4.273)
vRBCvLDHP =
TsRBC ·Vrbcu ·
(
KfRBCvLDHP·nadphRBC(t)·pyrRBC(t)
KmpyrRBCvLDHP·Vrbcu2 −
KrRBCvLDHP·lacRBC(t)·nadpRBC(t)
KmlacRBCvLDHP·Vrbcu2
)
lacRBC(t)
KmlacRBCvLDHP·Vrbcu +
pyrRBC(t)
KmpyrRBCvLDHP·Vrbcu + 1
(A.4.274)
vRBCvMGADP = TsRBC ·Vrbcu ·
(
KaappRBCvMGADP · adpRBC(t) ·mgRBC(t)
Vrbcu2
− KdRBCvMGADP ·mgadpRBC(t)
Vrbcu
)
(A.4.275)
vRBCvMGATP = TsRBC ·Vrbcu ·
(
KaappRBCvMGATP · atpRBC(t) ·mgRBC(t)
Vrbcu2
− KdRBCvMGATP ·mgatpRBC(t)
Vrbcu
)
(A.4.276)
vRBCvMGB13PG = TsRBC ·Vrbcu ·
(
KaappRBCvMGB13PG · b13pgRBC(t) ·mgRBC(t)
Vrbcu2
− KdRBCvMGB13PG ·mgb13pgRBC(t)
Vrbcu
)
(A.4.277)
vRBCvMGB23PG = TsRBC ·Vrbcu ·
(
KaappRBCvMGB23PG · b23pgRBC(t) ·mgRBC(t)
Vrbcu2
− KdRBCvMGB23PG ·mgb23pgRBC(t)
Vrbcu
)
(A.4.278)
vRBCvMGF16P2 = TsRBC ·Vrbcu ·
(
KaappRBCvMGF16P2 · f16p2RBC(t) ·mgRBC(t)
Vrbcu2
− KdRBCvMGF16P2 ·mgf16p2RBC(t)
Vrbcu
)
(A.4.279)
vRBCvMGG16P2 = TsRBC ·Vrbcu ·
(
KaappRBCvMGG16P2 · g16p2RBC(t) ·mgRBC(t)
Vrbcu2
− KdRBCvMGG16P2 ·mgg16p2RBC(t)
Vrbcu
)
(A.4.280)
vRBCvMGPHOS = TsRBC ·Vrbcu ·
(
KaappRBCvMGPHOS ·mgRBC(t) · phosRBC(t)
Vrbcu2
− KdRBCvMGPHOS ·mgphosRBC(t)
Vrbcu
)
(A.4.281)
vRBCvOX = KRBCvOX · TsRBC · gshRBC(t) (A.4.282)
vRBCvOXNADH = KRBCvOXNADH · TsRBC · nadhRBC(t) (A.4.283)
(A.4.284)
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vRBCvP6GDH = [TsRBC ·Vrbcu ·VRBCvP6GDH (A.4.285)
·
 K11RBCvP6GDH ·K1RBCvP6GDH ·K3RBCvP6GDH ·K5RBCvP6GDH ·K7RBCvP6GDH ·K9RBCvP6GDH1 · nadpRBC(t) · p6gRBC(t)
Vrbcu2
(A.4.286)
−
co2RBC ·K10RBCvP6GDH ·K12RBCvP6GDH ·K2RBCvP6GDH ·K4RBCvP6GDH ·K6RBCvP6GDH ·K8RBCvP6GDH
1 · nadphRBC(t) · ru5pRBC(t)
Vrbcu3
 / (A.4.287)
[
co2RBC ·K12RBCvP6GDH ·K2RBCvP6GDH ·K4RBCvP6GDH ·K6RBCvP6GDH · nadphRBC(t) ·K8RBCvP6GDH
Vrbcu2
(A.4.288)
+
co2RBC ·K11RBCvP6GDH ·K1RBCvP6GDH ·K4RBCvP6GDH ·K6RBCvP6GDH · nadpRBC(t) ·K8RBCvP6GDH
Vrbcu2
(A.4.289)
+
co2RBC ·K11RBCvP6GDH ·K1RBCvP6GDH ·K3RBCvP6GDH · (K5RBCvP6GDH + K6RBCvP6GDH) · nadpRBC(t)
1 · p6gRBC(t) ·K8RBCvP6GDH
Vrbcu3
(A.4.290)
+
co2RBC ·K10RBCvP6GDH ·K12RBCvP6GDH · (K2RBCvP6GDH ·K4RBCvP6GDH + K6RBCvP6GDH ·K4RBCvP6GDH
1 + K2RBCvP6GDH ·K5RBCvP6GDH + K2RBCvP6GDH ·K6RBCvP6GDH) · nadphRBC(t) · ru5pRBC(t) ·K8RBCvP6GDH
Vrbcu3
(A.4.291)
+
co2RBC ·K10RBCvP6GDH ·K1RBCvP6GDH ·K4RBCvP6GDH ·K6RBCvP6GDH · nadpRBC(t) · ru5pRBC(t) ·K8RBCvP6GDH
Vrbcu3
(A.4.292)
+
co2RBC ·K10RBCvP6GDH ·K12RBCvP6GDH ·K3RBCvP6GDH · (K5RBCvP6GDH
1 + K6RBCvP6GDH) · nadphRBC(t) · p6gRBC(t) · ru5pRBC(t) ·K8RBCvP6GDH
Vrbcu4
(A.4.293)
+
co2RBC ·K10RBCvP6GDH ·K1RBCvP6GDH ·K3RBCvP6GDH · (K5RBCvP6GDH
1 + K6RBCvP6GDH) · nadpRBC(t) · p6gRBC(t) · ru5pRBC(t) ·K8RBCvP6GDH
Vrbcu4
(A.4.294)
+
co2RBC ·K10RBCvP6GDH ·K2RBCvP6GDH ·K4RBCvP6GDH ·K6RBCvP6GDH · ru5pRBC(t) ·K8RBCvP6GDH
Vrbcu2
(A.4.295)
+
co2RBC ·K11RBCvP6GDH ·K2RBCvP6GDH ·K4RBCvP6GDH ·K6RBCvP6GDH ·K8RBCvP6GDH
Vrbcu
(A.4.296)
+ K11RBCvP6GDH ·K2RBCvP6GDH · (K4RBCvP6GDH ·K6RBCvP6GDH + K4RBCvP6GDH ·K7RBCvP6GDH (A.4.297)
+ K5RBCvP6GDH ·K7RBCvP6GDH) ·K9RBCvP6GDH (A.4.298)
+
K12RBCvP6GDH ·K2RBCvP6GDH · (K4RBCvP6GDH ·K6RBCvP6GDH + K4RBCvP6GDH ·K7RBCvP6GDH
1 + K5RBCvP6GDH ·K7RBCvP6GDH) ·K9RBCvP6GDH · nadphRBC(t)
Vrbcu
(A.4.299)
(A.4.300)
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+K11RBCvP6GDH ·K1RBCvP6GDH · (K4RBCvP6GDH ·K6RBCvP6GDH + K4RBCvP6GDH ·K7RBCvP6GDH
1 + K5RBCvP6GDH ·K7RBCvP6GDH) ·K9RBCvP6GDH · nadpRBC(t)
Vrbcu
(A.4.301)
+
K12RBCvP6GDH ·K3RBCvP6GDH ·K5RBCvP6GDH ·K7RBCvP6GDH ·K9RBCvP6GDH · nadphRBC(t) · p6gRBC(t)
Vrbcu2
(A.4.302)
+
K1RBCvP6GDH ·K3RBCvP6GDH · (K11RBCvP6GDH ·K5RBCvP6GDH ·K7RBCvP6GDH + K11RBCvP6GDH ·K9RBCvP6GDH ·K7RBCvP6GDH
1
+K5RBCvP6GDH ·K9RBCvP6GDH ·K7RBCvP6GDH + K11RBCvP6GDH ·K5RBCvP6GDH ·K9RBCvP6GDH
1 + K11RBCvP6GDH ·K6RBCvP6GDH ·K9RBCvP6GDH) · nadpRBC(t) · p6gRBC(t)
Vrbcu2
(A.4.303)
+
K11RBCvP6GDH ·K3RBCvP6GDH ·K5RBCvP6GDH ·K7RBCvP6GDH ·K9RBCvP6GDH · p6gRBC(t)
Vrbcu
(A.4.304)
+
K10RBCvP6GDH ·K12RBCvP6GDH ·K2RBCvP6GDH · (K4RBCvP6GDH ·K6RBCvP6GDH + K4RBCvP6GDH ·K7RBCvP6GDH
1 + K5RBCvP6GDH ·K7RBCvP6GDH) · nadphRBC(t) · ru5pRBC(t)
Vrbcu2
(A.4.305)
+
K10RBCvP6GDH ·K12RBCvP6GDH ·K3RBCvP6GDH ·K5RBCvP6GDH ·K7RBCvP6GDH · nadphRBC(t) · p6gRBC(t) · ru5pRBC(t)
Vrbcu3
(A.4.306)
+
K10RBCvP6GDH ·K1RBCvP6GDH ·K3RBCvP6GDH ·K5RBCvP6GDH ·K7RBCvP6GDH · nadpRBC(t) · p6gRBC(t) · ru5pRBC(t)
Vrbcu3
]
(A.4.307)
vRBCvPFK =
[
TsRBC ·Vrbcu ·VRBCvPFK ·
(
KcatfRBCvPFK · f6pRBC(t) ·mgatpRBC(t)
Kmf6pRBCvPFK ·KmmgatpRBCvPFK ·Vrbcu2 (A.4.308)
− KcatfRBCvPFK · f16p2RBC(t) ·mgadpRBC(t)
Kmf16p2RBCvPFK ·KmmgadpRBCvPFK ·Vrbcu2
)]
/ (A.4.309)
[(
mgadpRBC(t) · f16p2RBC(t)
Kmf16p2RBCvPFK ·KmmgadpRBCvPFK ·Vrbcu2 +
f16p2RBC(t)
Kmf16p2RBCvPFK ·Vrbcu +
f6pRBC(t)
Kmf6pRBCvPFK ·Vrbcu (A.4.310)
+
mgadpRBC(t)
KmmgadpRBCvPFK ·Vrbcu +
f6pRBC(t) ·mgatpRBC(t)
Kmf6pRBCvPFK ·KmmgatpRBCvPFK ·Vrbcu2 +
mgatpRBC(t)
KmmgatpRBCvPFK ·Vrbcu + 1
)
(A.4.311)
·

(
atpRBC(t)
KtatpRBCvPFK·Vrbcu + 1
)4 · ( b23pgRBC(t)
Ktb23pgRBCvPFK·Vrbcu + 1
)4 · ( mgRBC(t)
KtmgRBCvPFK·Vrbcu + 1
)4 · ( hRBC
KaRBCvPFK
)nRBCvPFK
(
ampRBC(t)
KrampRBCvPFK·Vrbcu + 1
)4 · ( f16p2RBC(t)
Kmf16p2RBCvPFK·Vrbcu +
f6pRBC(t)
Kmf6pRBCvPFK·Vrbcu + 1
)4 · ( g16p2RBC(t)
Krg16p2RBCvPFK·Vrbcu + 1
)4 · ( phosRBC(t)
KrphosRBCvPFK·Vrbcu + 1
)4 + 1


(A.4.312)
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vRBCvPGI =
ERBCvPGI · TsRBC ·Vrbcu ·
(
KcatfRBCvPGI·g6pRBC(t)
Kmg6pRBCvPGI·Vrbcu −
KcatrRBCvPGI·f6pRBC(t)
Kmf6pRBCvPGI·Vrbcu
)
f6pRBC(t)
Kmf6pRBCvPGI·Vrbcu +
g6pRBC(t)
Kmg6pRBCvPGI·Vrbcu + 1
(A.4.313)
vRBCvPGK =
[
TsRBC ·Vrbcu ·VRBCvPGK ·
(
KcatfRBCvPGK · b13pgRBC(t) ·mgadpRBC(t)
KimgadpRBCvPGK ·Kmb13pgRBCvPGK ·Vrbcu2 (A.4.314)
− KcatrRBCvPGK ·mgatpRBC(t) · p3gRBC(t)
KimgatpRBCvPGK ·Kmp3gRBCvPGK ·Vrbcu2
)]
/ (A.4.315)
[
mgadpRBC(t) · b13pgRBC(t)
KimgadpRBCvPGK ·Kmb13pgRBCvPGK ·Vrbcu2 +
b13pgRBC(t)
Kib13pgRBCvPGK ·Vrbcu +
mgadpRBC(t)
KimgadpRBCvPGK ·Vrbcu (A.4.316)
+
mgatpRBC(t)
KimgatpRBCvPGK ·Vrbcu +
mgatpRBC(t) · p3gRBC(t)
KimgatpRBCvPGK ·Kmp3gRBCvPGK ·Vrbcu2 +
p3gRBC(t)
Kip3gRBCvPGK ·Vrbcu + 1
]
(A.4.317)
vRBCvPGLHYDROLYSIS = TsRBC ·Vrbcu ·
(
KhydrolRBCvPGLHYDROLYSIS · p6glRBC(t)
Vrbcu
(A.4.318)
+
Klactonase3RBCvPGLHYDROLYSIS ·VRBCvPGLHYDROLYSIS · p6glRBC(t)
Vrbcu ·
(
Klactonase2RBCvPGLHYDROLYSIS+Klactonase3RBCvPGLHYDROLYSIS
Klactonase1RBCvPGLHYDROLYSIS
+
p6glRBC(t)
Vrbcu
)
 (A.4.319)
vRBCvPGM =
TsRBC ·Vrbcu ·VRBCvPGM ·
(
KcatfRBCvPGM·p3gRBC(t)
Kmp3gRBCvPGM·Vrbcu −
KcatrRBCvPGM·p2gRBC(t)
Kmp2gRBCvPGM·Vrbcu
)
p2gRBC(t)
Kmp2gRBCvPGM·Vrbcu +
p3gRBC(t)
Kmp3gRBCvPGM·Vrbcu + 1
(A.4.320)
vRBCvPHOSTRANSPORT = TsRBC ·Vrbcu ·
(
KoRBCvPHOSTRANSPORT · phosRBC(t)
Vrbcu
− KiRBCvPHOSTRANSPORT · phosEXT
vBld
)
(A.4.321)
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vRBCvPK =
[
TsRBC ·Vrbcu ·VRBCvPK ·
(
KcatfRBCvPK ·mgadpRBC(t) · pepRBC(t)
KrmgadpRBCvPK ·KrpepRBCvPK ·Vrbcu2 −
KcatrRBCvPK ·mgatpRBC(t) · pyrRBC(t)
KrmgatpRBCvPK ·KrpyrRBCvPK ·Vrbcu2
)]
/ (A.4.322)
[
(LRBCvPK + 1) ·
(
pepRBC(t) ·mgadpRBC(t)
KrmgadpRBCvPK ·KrpepRBCvPK ·Vrbcu2 +
mgadpRBC(t)
KrmgadpRBCvPK ·Vrbcu +
mgatpRBC(t)
KrmgatpRBCvPK ·Vrbcu (A.4.323)
+
pepRBC(t)
KrpepRBCvPK ·Vrbcu +
mgatpRBC(t) · pyrRBC(t)
KrmgatpRBCvPK ·KrpyrRBCvPK ·Vrbcu2 +
pyrRBC(t)
KrpyrRBCvPK ·Vrbcu + 1
)]
(A.4.324)
vRBCvPYRTRANSPORT = TsRBC ·Vrbcu ·
(
KoRBCvPYRTRANSPORT · pyrRBC(t)
Vrbcu
− KiRBCvPYRTRANSPORT · pyrEXT
vBld
)
(A.4.325)
vRBCvR5PI =
TsRBC ·Vrbcu ·VRBCvR5PI ·
(
K1RBCvR5PI·K3RBCvR5PI·ru5pRBC(t)
(K2RBCvR5PI+K3RBCvR5PI)·Vrbcu −
K2RBCvR5PI·K4RBCvR5PI·rib5pRBC(t)
(K2RBCvR5PI+K3RBCvR5PI)·Vrbcu
)
K1RBCvR5PI·ru5pRBC(t)
(K2RBCvR5PI+K3RBCvR5PI)·Vrbcu +
K4RBCvR5PI·xu5pRBC(t)
(K2RBCvR5PI+K3RBCvR5PI)·Vrbcu + 1
(A.4.326)
vRBCvRu5PE =
TsRBC ·Vrbcu ·VRBCvRu5PE ·
(
K1RBCvRu5PE·K3RBCvRu5PE·ru5pRBC(t)
(K2RBCvRu5PE+K3RBCvRu5PE)·Vrbcu −
K2RBCvRu5PE·K4RBCvRu5PE·xu5pRBC(t)
(K2RBCvRu5PE+K3RBCvRu5PE)·Vrbcu
)
K1RBCvRu5PE·ru5pRBC(t)
(K2RBCvRu5PE+K3RBCvRu5PE)·Vrbcu +
K4RBCvRu5PE·xu5pRBC(t)
(K2RBCvRu5PE+K3RBCvRu5PE)·Vrbcu + 1
(A.4.327)
vRBCvTA =
[
TsRBC ·Vrbcu ·VRBCvTA ·
(
K1RBCvTA ·K3RBCvTA ·K5RBCvTA ·K7RBCvTA · gapRBC(t) · sed7pRBC(t)
Vrbcu2
(A.4.328)
−K2RBCvTA ·K4RBCvTA ·K6RBCvTA ·K8RBCvTA · ery4pRBC(t) · f6pRBC(t)
Vrbcu2
)]
/ (A.4.329)
[
K4RBCvTA · (K2RBCvTA + K6RBCvTA) ·K8RBCvTA · f6pRBC(t) · ery4pRBC(t)
Vrbcu2
(A.4.330)
+
K1RBCvTA ·K4RBCvTA · (K6RBCvTA + K7RBCvTA) · sed7pRBC(t) · ery4pRBC(t)
Vrbcu2
(A.4.331)
+
K2RBCvTA ·K4RBCvTA · (K6RBCvTA + K7RBCvTA) · ery4pRBC(t)
Vrbcu
(A.4.332)
+
(K2RBCvTA + K3RBCvTA) ·K6RBCvTA ·K8RBCvTA · f6pRBC(t)
Vrbcu
(A.4.333)
+
(K2RBCvTA + K3RBCvTA) ·K5RBCvTA ·K8RBCvTA · f6pRBC(t) · gapRBC(t)
Vrbcu2
(A.4.334)
+
(K2RBCvTA + K3RBCvTA) ·K5RBCvTA ·K7RBCvTA · gapRBC(t)
Vrbcu
(A.4.335)
+
K1RBCvTA ·K5RBCvTA · (K3RBCvTA + K7RBCvTA) · gapRBC(t) · sed7pRBC(t)
Vrbcu2
(A.4.336)
+
K1RBCvTA ·K3RBCvTA · (K6RBCvTA + K7RBCvTA) · sed7pRBC(t)
Vrbcu
]
(A.4.337)
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vRBCvTIM =
TsRBC ·Vrbcu ·VRBCvTIM ·
(
KcatfRBCvTIM·gapRBC(t)
KmgapRBCvTIM·Vrbcu −
KcatrRBCvTIM·dhapRBC(t)
KmdhapRBCvTIM·Vrbcu
)
dhapRBC(t)
KmdhapRBCvTIM·Vrbcu +
gapRBC(t)
KmgapRBCvTIM·Vrbcu + 1
(A.4.338)
vRBCvTK1 = TsRBC ·Vrbcu ·
(
K1RBCvTK1 · tkRBC(t) · xu5pRBC(t)
Vrbcu2
− K2RBCvTK1 · tkxu5pRBC(t)
Vrbcu
)
(A.4.339)
vRBCvTK2 = TsRBC ·Vrbcu ·
(
K3RBCvTK2 · tkxu5pRBC(t)
Vrbcu
− K4RBCvTK2 · gapRBC(t) · tkgRBC(t)
Vrbcu2
)
(A.4.340)
vRBCvTK3 = TsRBC ·Vrbcu ·
(
K5RBCvTK3 · rib5pRBC(t) · tkgRBC(t)
Vrbcu2
− K6RBCvTK3 · tkgrib5pRBC(t)
Vrbcu
)
(A.4.341)
vRBCvTK4 = TsRBC ·Vrbcu ·
(
K7RBCvTK4 · tkgrib5pRBC(t)
Vrbcu
− K8RBCvTK4 · sed7pRBC(t) · tkRBC(t)
Vrbcu2
)
(A.4.342)
vRBCvTK5 = TsRBC ·Vrbcu ·
(
K9RBCvTK5 · ery4pRBC(t) · tkgRBC(t)
Vrbcu2
− K10RBCvTK5 · tkgery4pRBC(t)
Vrbcu
)
(A.4.343)
vRBCvTK6 = TsRBC ·Vrbcu ·
(
K11RBCvTK6 · tkgery4pRBC(t)
Vrbcu
− K12RBCvTK6 · f6pRBC(t) · tkRBC(t)
Vrbcu2
)
(A.4.344)
vWBivGLCTRANSPORT =
1
ω
parMulti · TsRBC ·Vrbci ·
 glc_alpha ·VRBCvGLCTRANSPORT · B_gluc(t)
1000 ·
(
(1−glc_alpha)·B_gluc(t)·k_alpha
1000·k_beta + k_alpha +
glc_alpha·B_gluc(t)
1000
) (A.4.345)
+
(1− glc_alpha) ·VRBCvGLCTRANSPORT · B_gluc(t)
1000 ·
(
glc_alpha·B_gluc(t)·k_beta
1000·k_alpha + k_beta +
(1−glc_alpha)·B_gluc(t)
1000
) (A.4.346)
− glc_alpha ·VRBCvGLCTRANSPORT · glcRBCi(t)
Vrbci ·
(
(1−glc_alpha)·glcRBCi(t)·k_alpha
k_beta·Vrbci + k_alpha +
glc_alpha·glcRBCi(t)
Vrbci
) (A.4.347)
− (1− glc_alpha) ·VRBCvGLCTRANSPORT · glcRBCi(t)
Vrbci ·
(
glc_alpha·glcRBCi(t)·k_beta
k_alpha·Vrbci + k_beta +
(1−glc_alpha)·glcRBCi(t)
Vrbci
)
 (A.4.348)
vWBivLACTRANSPORT =
1
ω
[
20 · parMulti · TsRBC ·Vrbci ·
(
KoRBCvLACTRANSPORT · lacRBCi(t)
Vrbci
− KiRBCvLACTRANSPORT · B_lac(t)
1000
)]
(A.4.349)
(A.4.350)
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vWBvGLCTRANSPORT =
1
ω
TsRBC ·Vrbcu ·
 glc_alpha ·VRBCvGLCTRANSPORT · B_gluc(t)
1000 ·
(
(1−glc_alpha)·B_gluc(t)·k_alpha
1000·k_beta + k_alpha +
glc_alpha·B_gluc(t)
1000
) (A.4.351)
+
(1− glc_alpha) ·VRBCvGLCTRANSPORT · B_gluc(t)
1000 ·
(
glc_alpha·B_gluc(t)·k_beta
1000·k_alpha + k_beta +
(1−glc_alpha)·B_gluc(t)
1000
) (A.4.352)
− glc_alpha ·VRBCvGLCTRANSPORT · glcRBC(t)
Vrbcu ·
(
(1−glc_alpha)·glcRBC(t)·k_alpha
k_beta·Vrbcu + k_alpha +
glc_alpha·glcRBC(t)
Vrbcu
) (A.4.353)
− (1− glc_alpha) ·VRBCvGLCTRANSPORT · glcRBC(t)
Vrbcu ·
(
glc_alpha·glcRBC(t)·k_beta
k_alpha·Vrbcu + k_beta +
(1−glc_alpha)·glcRBC(t)
Vrbcu
)
 (A.4.354)
vWBvLACTRANSPORT =
1
ω
[
20 · TsRBC ·Vrbcu ·
(
KoRBCvLACTRANSPORT · lacRBC(t)
Vrbcu
− KiRBCvLACTRANSPORT · B_lac(t)
1000
)]
(A.4.355)
(A.4.356)
v_F1 = k_f1 ·
(
B_ins(t)ep14
k_Dinsep14 + B_ins(t)ep14
+ 1
)
· F_g6p(t) (A.4.357)
v_F3 = k_f3 ·
(
B_ins(t)ep15
k_Dinsep15 + B_ins(t)ep15
+ 1
)
· F_acyl(t) (A.4.358)
v_F4 =
k_Dinsen12 · k_f4 · F_TG(t)
k_Dinsen12 + B_ins(t)en12
(A.4.359)
v_F5 = F_ffa3 · k_f5 (A.4.360)
v_Ggluc =
k1glucgn · B_gluc(t)ng
k_mGlgnng + B_gluc(t)ng
(A.4.361)
v_Igluc =
k1ins · B_gluc(t)ni
k_mInsni + B_gluc(t)ni
(A.4.362)
v_L10 = k_L10 · aK(t) (A.4.363)
v_L11f = k_L11f ·
(
B_glucgn(t)ep5
k_Dglucgnep5 + B_glucgn(t)ep5
+ 1
)
· oa_m(t) (A.4.364)
v_L11r = k_L11r ·malate(t) (A.4.365)
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v_L12 =
k_Dinsen4 · k_L12 ·
(
B_glucgn(t)ep6
k_Dglucgnep6+B_glucgn(t)ep6 + 1
)
·malate(t)
k_Dinsen4 + B_ins(t)en4
(A.4.366)
v_L13 =
k_Dinsen5 · k_L13 ·
(
B_glucgn(t)ep7
k_Dglucgnep7+B_glucgn(t)ep7 + 1
)
· oa_c(t)
k_Dinsen5 + B_ins(t)en5
(A.4.367)
v_L14 =
k_Dglucgnen7 · k_L14 ·
(
B_ins(t)ep10
k_Dinsep10+B_ins(t)ep10 + 1
)
· citrate(t)
k_Dglucgnen7 + B_glucgn(t)en7
(A.4.368)
v_L15 =
k_i5 · k_L15 · acet_c(t) ·
(
p1·citrate(t)
k_p1+citrate(t) + 1
)
k_i5 + palmCoA(t)
(A.4.369)
v_L16 = k_L16 · acet_c(t) ·malonyl(t)7 (A.4.370)
v_L17 =
k_i1 · k_L17 · palm(t)
k_i1 + malonyl(t)
(A.4.371)
v_L18 =
k_i2 · k_L18 · palmCoA(t)
k_i2 + malonyl(t)
(A.4.372)
v_L19 =
k_Dinsen8 · k_L19 · acet_m(t)2 ·
(
cAMP(t)ep11
k_dcAMPep11+cAMP(t)ep11 + 1
)
k_Dinsen8 + B_ins(t)en8
(A.4.373)
v_L1f =
k_L1f ·
(
B_ins(t)ep1
k_Dinsep1+B_ins(t)ep1 + 1
)
· gluc(t)
k_mL1f + gluc(t)
(A.4.374)
v_L1r =
k_L1r ·
(
B_glucgn(t)ep9
k_Dglucgnep9+B_glucgn(t)ep9 + 1
)
· g6p(t)
k_mL1r + g6p(t)
(A.4.375)
v_L20 =
k_Dins2en3 · k_L20 · alan(t)
k_Dins2en3 + B_ins(t)en3
(A.4.376)
v_L21f =
k_Dinsen3 · k_L21f · glutamate(t) · pyr(t)(
k_Dinsen3 + B_ins(t)en3
) · (k_mL21g + glutamate(t)) · (k_mL21p + pyr(t)) (A.4.377)
Stellenbosch University  https://scholar.sun.ac.za
Stellenbosch University  https://scholar.sun.ac.za
v_L21r =
k_Dinsen3 · k_L21r · acet_m(t) · aK(t) · alan(t)
(k_mL21k + aK(t)) · (k_mL21a + alan(t)) · (k_Dinsen3 + B_ins(t)en3) (A.4.378)
v_L22 = k_L22 · glutamate(t) (A.4.379)
v_L2f =
k_L2f · g6p(t) ·GSa(t)
k_mL2f + g6p(t)
(A.4.380)
v_L2r =
k_L2r · glycgn(t) ·GPa(t)
k_mL2r + glycgn(t)
(A.4.381)
v_L3f =
k_Dglucgnen1 · k_L3f ·
(
B_ins(t)ep2
k_Dinsep2+B_ins(t)ep2 + 1
)
· g6p(t)(
k_Dglucgnen1 + B_glucgn(t)en1
) · (k_mL3f + g6p(t)) (A.4.382)
v_L3r =
k_Dins2en6 · k_L3r ·
(
B_glucgn(t)ep8
k_Dglucgnep8+B_glucgn(t)ep8 + 1
)
· pep(t)(
k_Dins2en6 + B_ins(t)en6
) · (k_mL3r + pep(t)) (A.4.383)
v_L4 =
k_Dglucgnen2 · k_i13 · k_L4 ·
(
B_ins(t)ep3
k_Dinsep3+B_ins(t)ep3 + 1
)
· pep(t)
(k_i13 + alan(t)) · (k_Dglucgnen2 + B_glucgn(t)en2) · (k_mL4 + pep(t)) (A.4.384)
v_L5f =
k_L5f · pyr(t)
k_mL5f + pyr(t)
(A.4.385)
v_L5r =
k_L5r · lac(t)
k_mL5r + lac(t)
(A.4.386)
v_L6 =
k_L6 ·
(
p2·acet_m(t)
k_p2+acet_m(t) + 1
)
·
(
B_glucgn(t)ep4
k_Dglucgnep4+B_glucgn(t)ep4 + 1
)
· pyr(t)
k_mL6 + pyr(t)
(A.4.387)
v_L7 =
k_i8 · k_L7 · pyr(t)
(k_i8 + acet_m(t)) · (k_mL7 + pyr(t)) (A.4.388)
v_L8 =
k_i4 · k_L8 · acet_m(t) · oa_m(t)
k_i4 + palmCoA(t)
(A.4.389)
v_L9 = k_L9 · citrate(t) (A.4.390)
v_S1f = k_s1f ·M_g6p(t) (A.4.391)
v_S1r = k_s1r ·M_glycgn(t) (A.4.392)
v_S2 = k_s2 ·M_g6p(t) (A.4.393)
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v_S3f = k_s3f ·M_pyr(t) (A.4.394)
v_S3r = k_s3r ·M_lac(t) (A.4.395)
v_S4f = k_s4f ·M_pyr(t) (A.4.396)
v_S4r = k_s4r ·M_alan ·M_ket(t) (A.4.397)
v_c1cAMP =
kc1 · B_glucgn(t)ng
kcm1ng + B_glucgn(t)ng
(A.4.398)
v_c2cAMP =
kc2 · B_ins(t)ni · cAMP(t)
kcm2ni + B_ins(t)ni
(A.4.399)
v_d_Balan = kd_Balan · B_alan(t) (A.4.400)
v_d_Bffa = kd_Bffa · B_ffa(t) (A.4.401)
v_d_Bgluc = kd_Bgluc · B_gluc(t) (A.4.402)
v_d_Bglucgn = kd_Bglucgn · B_glucgn(t) (A.4.403)
v_d_Bins = kd_Bins · B_ins(t) (A.4.404)
v_d_Bket = kd_Bket · B_ket(t) (A.4.405)
v_d_Blac = kd_Blac · B_lac(t) (A.4.406)
v_feed = 2.× ·10−1 (A.4.407)
v_glucgn = k_glucgn (A.4.408)
v_ins = k_ins (A.4.409)
v_s_dket = ks_dket ·M_ket(t) (A.4.410)
v_tF1 = k_tF1 · B_gluc(t) ·
(
B_ins(t)ep12
k_Dinsep12 + B_ins(t)ep12
+ 1
)
(A.4.411)
v_tF3 =
F_ffa8 · k_Dins2en9 · k_tF3
k_Dins2en9 + B_ins(t)en9
(A.4.412)
v_tL1 = k_tL1 · (B_gluc(t)− gluc(t)) (A.4.413)
v_tL2 =
VmtL2 · (B_lac(t)− lac(t))
KmtL2 ·
(
B_lac(t)
KmtL2
+
lac(t)
KmtL2
+ 1
) (A.4.414)
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v_tL3 = k_tL3 · ket(t) (A.4.415)
v_tL5 = k_tL5 · B_ffa(t) (A.4.416)
v_tL6 =
k_Dins2en10 · k_tL6 · B_alan(t)
k_Dins2en10 + B_ins(t)en10
(A.4.417)
v_tS1 = k_tS1 · B_gluc(t) ·
(
B_ins(t)ep13
k_Dinsep13 + B_ins(t)ep13
+ 1
)
(A.4.418)
v_tS2 = k_tS2 · B_ket(t) (A.4.419)
v_tS3 = k_tS3 ·M_lac(t) (A.4.420)
v_tS4 =
k_Dins2en11 · k_tS4 ·M_alan
k_Dins2en11 + B_ins(t)en11
(A.4.421)
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A.5 Assignment rules:
LRBCivPK =
(
1.58489× ·10−7) · pHConversionFactor · ( atpRBCi(t)
KtatpRBCvPK·Vrbci + 1
)4
hRBC ·
(
f16p2RBCi(t)
Krf16p2RBCvPK·Vrbci +
g16p2RBCi(t)
Krg16p2RBCvPK·Vrbci + 1
)4 · ( pepRBCi(t)
KrpepRBCvPK·Vrbci +
pyrRBCi(t)
KrpyrRBCvPK·Vrbci + 1
)4 (A.5.1)
KaappRBCvMGG16P2 =
CRBCvMGG16P2 ·KaRBCvMGG16P2 · (hRBC ·KhfRBCvMGG16P2
1 ·KmghfRBCvMGG16P2 + KRBCvMGG16P2)
Kh2fRBCvMGG16P2 ·KhfRBCvMGG16P2 · hRBC2 + KhfRBCvMGG16P2 · hRBC
1 + KhfRBCvMGG16P2 ·KkhfRBCvMGG16P2 · kRBC · hRBC + KkfRBCvMGG16P2 · kRBC + 1
(A.5.2)
KaappRBCvMGATP =
CRBCvMGATP ·KaRBCvMGATP · (hRBC ·KhatpRBCvMGATP ·KmghatpRBCvMGATP + KRBCvMGATP)
10−phRBC·KhatpRBCvMGATP
pHConversionFactor
+ KkatpRBCvMGATP · kRBC + 1
(A.5.3)
LRBCvPK =
(
1.58489× ·10−7) · pHConversionFactor · ( atpRBC(t)
KtatpRBCvPK·Vrbcu + 1
)4
hRBC ·
(
f16p2RBC(t)
Krf16p2RBCvPK·Vrbcu +
g16p2RBC(t)
Krg16p2RBCvPK·Vrbcu + 1
)4 · ( pepRBC(t)
KrpepRBCvPK·Vrbcu +
pyrRBC(t)
KrpyrRBCvPK·Vrbcu + 1
)4 (A.5.4)
KeqRBCvPHOSTRANSPORT =
1 + 10phRBC−6.75
1
RtvRBC
+ 10
phRBC−6.75
RtvRBC2
(A.5.5)
KiapppyrRBCvLDH =
(
2.84747× ·10−1) · (1 + (1.58489× ·10−7) · 10phRBC) ·KipyrRBCvLDH (A.5.6)
KaappRBCvMGB13PG =
CRBCvMGB13PG ·KaRBCvMGB13PG
1 · (hRBC ·KhbpgRBCvMGB13PG ·KmghbpgRBCvMGB13PG + KRBCvMGB13PG)
Kh2bpgRBCvMGB13PG ·KhbpgRBCvMGB13PG · hRBC2 + KhbpgRBCvMGB13PG · hRBC
1 + KhbpgRBCvMGB13PG ·KkhbpgRBCvMGB13PG · kRBC · hRBC + KkbpgRBCvMGB13PG · kRBC + 1
(A.5.7)
KcatrappRBCvHK =
KcatrRBCvHK
1 + (1.04713× ·107) · 10−phRBC + (2.81838× ·10−10) · 10phRBC (A.5.8)
Kiappb13pgRBCvGAPDH =
Kib13pgRBCvGAPDH
1 + 10phRBC−10 + (3.16228× ·107) · 10−phRBC (A.5.9)
KcatfappRBCvHK =
KcatfRBCvHK
1 + (1.04713× ·107) · 10−phRBC + (2.81838× ·10−10) · 10phRBC (A.5.10)
Vrbc = 1000 ·AlphaCellWaterFraction ·HCT · v_totblood (A.5.11)
K1appRBCvAK = K1RBCvAK ·
(
KkadpRBCvAK · kRBC + 10−phRBC ·KhadpRBCvAK · pHConversionFactor + 1
)
(A.5.12)
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ka =
k_a
kd
(A.5.13)
KmapppyrRBCvLDH =
(
2.84747× ·10−1) · (1 + (1.58489× ·10−7) · 10phRBC) ·KmpyrRBCvLDH (A.5.14)
pyrEXT = ConcPyrEXT · vBld (A.5.15)
hPF = 10−phPF · pHConversionFactor (A.5.16)
kd =
(cmax− cmin) · c0index
c0index + glycgn(t)index
+ cmin (A.5.17)
KaappRBCvMGPHOS =
KaRBCvMGPHOS · (KkphosRBCvMGPHOS · kRBC + (6.30957× ·10−8) ·KhphosRBCvMGPHOS · pHConversionFactor + 1)
hRBC ·KhphosRBCvMGPHOS + KkphosRBCvMGPHOS · kRBC + 1 (A.5.18)
kmg6s =
kmg6
s2·gluc(t)
kgi
+ 1
(A.5.19)
kc2 =
(
3.16228× ·105) · kc1 (A.5.20)
KeqRBCvLACTRANSPORT =
1 + 10phRBC−3.73
1 + 10
phRBC−3.73
RtvRBC
(A.5.21)
KaappRBCvHBMGATP = HbpHRBC ·KaRBCvHBMGATP (A.5.22)
KcatfappRBCvGAPDH =
KcatfRBCvGAPDH
1 + 10phRBC−10 + (3.16228× ·107) · 10−phRBC (A.5.23)
k1ins = (Imax− Imin) · kd_Bins (A.5.24)
KiappgapRBCvGAPDH =
KigapRBCvGAPDH
1 + 10phRBC−10 + (3.16228× ·107) · 10−phRBC (A.5.25)
K6appRBCvBPGSP4 =
1.75858 ·K6RBCvBPGSP4
1 + (4.7863× ·1028) · 10−4·phRBC (A.5.26)
kgc1 =
k_gc1
k11
(A.5.27)
KaappRBCvHBADP = HbpHRBC ·KaRBCvHBADP (A.5.28)
KoRBCvLACTRANSPORT =
KiRBCvLACTRANSPORT
KeqRBCvLACTRANSPORT
(A.5.29)
k_ins = Imin · kd_Bins (A.5.30)
Stellenbosch University  https://scholar.sun.ac.za
Stellenbosch University  https://scholar.sun.ac.za
KmappnadhRBCvGAPDH =
(
6.30957× ·10−8) · 10phRBC ·KmnadhRBCvGAPDH (A.5.31)
KiapplacRBCvLDH =
(
7.15253× ·10−1) · (1 + (6.30957× ·106) · 10−phRBC) ·KilacRBCvLDH (A.5.32)
co2RBCi = ConcCo2RBC ·Vrbci (A.5.33)
K13appRBCvBPGSP7 =
1.75858 ·K13RBCvBPGSP7
1 + (4.7863× ·1028) · 10−4·phRBC (A.5.34)
hRBC = 10−phRBC · pHConversionFactor (A.5.35)
Vrbcu = Vrbc− parMulti ·Vrbci (A.5.36)
Vrbci =
{
·par ·Vrbc· ·par > 0·
·1· ·True (A.5.37)
KoRBCvPYRTRANSPORT =
KiRBCvPYRTRANSPORT
RtvRBC
(A.5.38)
KaappRBCvHBATP = HbpHRBC ·KaRBCvHBATP (A.5.39)
KaappRBCvHBB13PG = HbpHRBC ·KaRBCvHBB13PG (A.5.40)
kmg5s = kmg5 ·
(
s1 · g6p(t)
kg2
+ 1
)
(A.5.41)
KoRBCvPHOSTRANSPORT =
KiRBCvPHOSTRANSPORT
KeqRBCvPHOSTRANSPORT
(A.5.42)
kmg7s = kmg7 ·
(
s1 · g6p(t)
kg2
+ 1
)
(A.5.43)
phosEXT = ConcPhosEXT · vBld (A.5.44)
co2RBC = ConcCo2RBC ·Vrbcu (A.5.45)
GPaPlot =
(
1.42857× ·101) ·GPa(t) (A.5.46)
k_glucgn = Gmax · kd_Bglucgn (A.5.47)
Vpf =
{
·trophToRBC ·Vrbci· ·par > 0·
·1· ·True (A.5.48)
trophToRBC =
14
45
(A.5.49)
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ω = (1−HCT) · v_totblood (A.5.50)
k1glucgn = (Gmax−Gmin) · kd_Bglucgn (A.5.51)
GSaPlot =
(
3.33333× ·102) ·GSa(t) (A.5.52)
kgc2 =
k_gc2
k22
(A.5.53)
K2appRBCvAK = K2RBCvAK · (hRBC ·KhampRBCvAK + KkampRBCvAK · kRBC + 1) (A.5.54)
KiappnadhRBCvGAPDH =
(
6.30957× ·10−8) · 10phRBC ·KinadhRBCvGAPDH (A.5.55)
KaappRBCvMGADP =
CRBCvMGADP ·KaRBCvMGADP · (hRBC ·KhadpRBCvMGADP ·KmghadpRBCvMGADP + KRBCvMGADP)
hRBC ·KhadpRBCvMGADP + KkadpRBCvMGADP · kRBC + 1 (A.5.56)
F_ffa = 2.85138× ·10−2 (A.5.57)
M_alan = 0 (A.5.58)
KcatrappRBCvGAPDH =
KcatrRBCvGAPDH
1 + 10phRBC−10 + (3.16228× ·107) · 10−phRBC (A.5.59)
KmapplacRBCvLDH =
(
7.15253× ·10−1) · (1 + (6.30957× ·106) · 10−phRBC) ·KmlacRBCvLDH (A.5.60)
K1appRBCvBPGSP1 =
3.51189 ·K1RBCvBPGSP1
1 + (1.58489× ·10−7) · 10phRBC (A.5.61)
KaappRBCvHBBPG = HbpHRBC ·KaRBCvHBBPG (A.5.62)
vBld = 1000 · (1−HCT) · v_totblood (A.5.63)
K3appRBCvBPGSP2 =
1.75858 ·K3RBCvBPGSP2
1 + (4.7863× ·1028) · 10−4·phRBC (A.5.64)
kmg8s =
kmg8
s1·g6p(t)
kg2
+ 1
(A.5.65)
K4appRBCvBPGSP3 =
1.75858 ·K4RBCvBPGSP3
1 + (4.7863× ·1028) · 10−4·phRBC (A.5.66)
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HbpHRBC =
(2.51189×·1014)·KahbRBC2
pHConversionFactor2
+
(3.16979×·107)·KahbRBC
pHConversionFactor
+ 1
KahbRBC2
hRBC2
+ 2·KahbRBC
hRBC
+ 1
(A.5.67)
KaappRBCvMGB23PG =
CRBCvMGB23PG ·KaRBCvMGB23PG
1 · (hRBC ·KhbpgRBCvMGB23PG ·KmghbpgRBCvMGB23PG + KRBCvMGB23PG)
Kh2bpgRBCvMGB23PG ·KhbpgRBCvMGB23PG · hRBC2 + KhbpgRBCvMGB23PG · hRBC
1 + KhbpgRBCvMGB23PG ·KkhbpgRBCvMGB23PG · kRBC · hRBC + KkbpgRBCvMGB23PG · kRBC + 1
(A.5.68)
KaappRBCvMGF16P2 =
CRBCvMGF16P2 ·KaRBCvMGF16P2
1 · (hRBC ·KhfRBCvMGF16P2 ·KmghfRBCvMGF16P2 + KRBCvMGF16P2)
Kh2fRBCvMGF16P2 ·KhfRBCvMGF16P2 · hRBC2 + KhfRBCvMGF16P2 · hRBC
1 + KhfRBCvMGF16P2 ·KkhfRBCvMGF16P2 · kRBC · hRBC + KkfRBCvMGF16P2 · kRBC + 1
(A.5.69)
parMulti =
{
·1· ·par > 0·
·0· ·True (A.5.70)
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A.6 Ordinary differential equations:
B_alan′(t) = −1.v_d_Balan− 1.v_tL6 + 1.v_tS4 (A.6.1)
B_ffa′(t) = −1.v_d_Bffa + 1.v_tF3− 1.v_tL5 (A.6.2)
B_gluc′(t) = −1.vRBCivGLCTRANSPORT− 1.vRBCvGLCTRANSPORT− 1.v_d_Bgluc
+ 1.v_feed− 1.v_tF1− 1.v_tL1− 1.v_tS1 (A.6.3)
B_glucgn′(t) = −1.v_d_Bglucgn− 1.v_Ggluc + 1.v_glucgn (A.6.4)
B_ins′(t) = −1.v_d_Bins + 1.v_Igluc + 1.v_ins (A.6.5)
B_ket′(t) = −1.v_d_Bket + 1.v_tL3− 1.v_tS2 (A.6.6)
B_lac′(t) = 1.vRBCivLACTRANSPORT + 1.vRBCvLACTRANSPORT− 1.v_d_Blac
− 1.v_tL2 + 1.v_tS3 (A.6.7)
Cvar′(t) = 1.Jg10 + 1.Jg11 (A.6.8)
F_TG′(t) = 1.v_F3− 1.v_F4 (A.6.9)
F_acyl′(t) = 1.v_F1− 1.v_F3 + 1.v_F5 (A.6.10)
F_g6p′(t) = 1.v_tF1− 1.v_F1 (A.6.11)
GPa′(t) = 1.Jg5− 1.Jg6− 1.Jg9 (A.6.12)
GSa′(t) = 1.Jg8− 1.Jg7 (A.6.13)
M_g6p′(t) = −1.v_S1f + 1.v_S1r− 1.v_S2 + 1.v_tS1 (A.6.14)
M_glycgn′(t) = 1.v_S1f − 1.v_S1r (A.6.15)
M_ket′(t) = 1.v_tS2− 1.v_s_dket (A.6.16)
M_lac′(t) = 1.v_S3f − 1.v_S3r− 1.v_tS3 (A.6.17)
M_pyr′(t) = 2.v_S2− 1.v_S3f + 1.v_S3r− 1.v_S4f + 1.v_S4r (A.6.18)
PKa′(t) = 1.Jg3− 1.Jg4 (A.6.19)
PP1′(t) = −1.Jg9 (A.6.20)
PP1_GPa′(t) = 1.Jg9 (A.6.21)
R2C2′(t) = −1.Jg10 (A.6.22)
R2_C_cAMP2′(t) = 1.Jg10− 1.Jg11 (A.6.23)
R2_cAMP4′(t) = 1.Jg11 (A.6.24)
aK′(t) = −1.v_L10 + 1.v_L21f − 1.v_L21r + 1.v_L9 (A.6.25)
acet_c′(t) = 1.v_L14− 1.v_L15− 1.v_L16 (A.6.26)
acet_m′(t) = 8.v_L18− 2.v_L19 + 1.v_L7− 1.v_L8 (A.6.27)
adpPF′(t) = 1.vPFvATPASE + 1.vPFvHK + 1.vPFvPFK− 1.vPFvPGK− 1.vPFvPK (A.6.28)
adpRBC′(t) = −1.vRBCvAK− 1.vRBCvHBADP− 1.vRBCvMGADP (A.6.29)
adpRBCi′(t) = −1.vRBCivAK− 1.vRBCivHBADP− 1.vRBCivMGADP (A.6.30)
alan′(t) = −1.v_L20 + 1.v_L21f − 1.v_L21r + 1.v_tL6 (A.6.31)
ampRBC′(t) = 1.vRBCvAK (A.6.32)
ampRBCi′(t) = 1.vRBCivAK (A.6.33)
atpPF′(t) = −1.vPFvATPASE− 1.vPFvHK− 1.vPFvPFK + 1.vPFvPGK + 1.vPFvPK (A.6.34)
atpRBC′(t) = −1.vRBCvHBATP− 1.vRBCvMGATP (A.6.35)
atpRBCi′(t) = −1.vRBCivHBATP− 1.vRBCivMGATP (A.6.36)
b13pgPF′(t) = 1.vPFvGAPDH− 1.vPFvPGK (A.6.37)
b13pgRBC′(t) = −1.vRBCvBPGSP1 + 1.vRBCvGAPDH− 1.vRBCvHBB13PG
− 1.vRBCvMGB13PG− 1.vRBCvPGK (A.6.38)
b13pgRBCi′(t) = −1.vRBCivBPGSP1 + 1.vRBCivGAPDH− 1.vRBCivHBB13PG
− 1.vRBCivMGB13PG− 1.vRBCivPGK (A.6.39)
b23pgRBC′(t) = 1.vRBCvBPGSP7− 1.vRBCvHBB23PG− 1.vRBCvMGB23PG (A.6.40)
b23pgRBCi′(t) = 1.vRBCivBPGSP7− 1.vRBCivHBB23PG− 1.vRBCivMGB23PG (A.6.41)
bpgspRBC′(t) = −1.vRBCvBPGSP1 + 1.vRBCvBPGSP7 + 1.vRBCvBPGSP9 (A.6.42)
bpgspRBCi′(t) = −1.vRBCivBPGSP1 + 1.vRBCivBPGSP7 + 1.vRBCivBPGSP9 (A.6.43)
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bpgspb13pgRBC′(t) = 1.vRBCvBPGSP1− 1.vRBCvBPGSP2 (A.6.44)
bpgspb13pgRBCi′(t) = 1.vRBCivBPGSP1− 1.vRBCivBPGSP2 (A.6.45)
bpgspb23pgRBC′(t) = 1.vRBCvBPGSP5 + 1.vRBCvBPGSP6− 1.vRBCvBPGSP7 (A.6.46)
bpgspb23pgRBCi′(t) = 1.vRBCivBPGSP5 + 1.vRBCivBPGSP6− 1.vRBCivBPGSP7 (A.6.47)
bpgsppRBC′(t) = 1.vRBCvBPGSP2− 1.vRBCvBPGSP3
− 1.vRBCvBPGSP4− 1.vRBCvBPGSP8 (A.6.48)
bpgsppRBCi′(t) = 1.vRBCivBPGSP2− 1.vRBCivBPGSP3
− 1.vRBCivBPGSP4− 1.vRBCivBPGSP8 (A.6.49)
bpgsppp2gRBC′(t) = 1.vRBCvBPGSP4− 1.vRBCvBPGSP6 (A.6.50)
bpgsppp2gRBCi′(t) = 1.vRBCivBPGSP4− 1.vRBCivBPGSP6 (A.6.51)
bpgsppp3gRBC′(t) = 1.vRBCvBPGSP3− 1.vRBCvBPGSP5 (A.6.52)
bpgsppp3gRBCi′(t) = 1.vRBCivBPGSP3− 1.vRBCivBPGSP5 (A.6.53)
bpgsppphosRBC′(t) = 1.vRBCvBPGSP8− 1.vRBCvBPGSP9 (A.6.54)
bpgsppphosRBCi′(t) = 1.vRBCivBPGSP8− 1.vRBCivBPGSP9 (A.6.55)
cAMP′(t) = −2.Jg10− 2.Jg11 + 1.v_c1cAMP− 1.v_c2cAMP (A.6.56)
citrate′(t) = −1.v_L14 + 1.v_L8− 1.v_L9 (A.6.57)
dhapPF′(t) = 1.vPFvALD− 1.vPFvG3PDH− 1.vPFvTPI (A.6.58)
dhapRBC′(t) = 1.vRBCvALD + 1.vRBCvTIM (A.6.59)
dhapRBCi′(t) = 1.vRBCivALD + 1.vRBCivTIM (A.6.60)
ery4pRBC′(t) = 1.vRBCvTA− 1.vRBCvTK5 (A.6.61)
ery4pRBCi′(t) = 1.vRBCivTA− 1.vRBCivTK5 (A.6.62)
f16bpPF′(t) = 1.vPFvPFK− 1.vPFvALD (A.6.63)
f16p2RBC′(t) = −1.vRBCvALD− 1.vRBCvMGF16P2 + 1.vRBCvPFK (A.6.64)
f16p2RBCi′(t) = −1.vRBCivALD− 1.vRBCivMGF16P2 + 1.vRBCivPFK (A.6.65)
f6pPF′(t) = 1.vPFvPGI− 1.vPFvPFK (A.6.66)
f6pRBC′(t) = −1.vRBCvPFK + 1.vRBCvPGI + 1.vRBCvTA + 1.vRBCvTK6 (A.6.67)
f6pRBCi′(t) = −1.vRBCivPFK + 1.vRBCivPGI + 1.vRBCivTA + 1.vRBCivTK6 (A.6.68)
g16p2RBC′(t) = −1.vRBCvMGG16P2 (A.6.69)
g16p2RBCi′(t) = −1.vRBCivMGG16P2 (A.6.70)
g3pPF′(t) = 1.vPFvG3PDH− 1.vPFvGLYtr (A.6.71)
g6p′(t) = 1.v_L1f − 1.v_L1r− 1.v_L2f + 1.v_L2r− 1.v_L3f + 1.v_L3r (A.6.72)
g6pPF′(t) = 1.vPFvHK− 1.vPFvPGI (A.6.73)
g6pRBC′(t) = −1.vRBCvG6PDH + 1.vRBCvHK− 1.vRBCvPGI (A.6.74)
g6pRBCi′(t) = −1.vRBCivG6PDH + 1.vRBCivHK− 1.vRBCivPGI (A.6.75)
gapPF′(t) = 1.vPFvALD− 1.vPFvGAPDH + 1.vPFvTPI (A.6.76)
gapRBC′(t) = 1.vRBCvALD− 1.vRBCvGAPDH− 1.vRBCvTA− 1.vRBCvTIM
+ 1.vRBCvTK2 (A.6.77)
gapRBCi′(t) = 1.vRBCivALD− 1.vRBCivGAPDH− 1.vRBCivTA− 1.vRBCivTIM
+ 1.vRBCivTK2 (A.6.78)
glcPF′(t) = 1.vPFvGLCtr− 1.vPFvHK (A.6.79)
glcRBC′(t) = 1.vRBCvGLCTRANSPORT− 1.vRBCvHK (A.6.80)
glcRBCi′(t) = −1.vPFvGLCtr + 1.vRBCivGLCTRANSPORT− 1.vRBCivHK (A.6.81)
gluc′(t) = −1.v_L1f + 1.v_L1r + 1.v_tL1 (A.6.82)
glutamate′(t) = −1.v_L21f + 1.v_L21r− 1.v_L22 (A.6.83)
glycgn′(t) = 1.v_L2f − 1.v_L2r (A.6.84)
gshRBC′(t) = 2.vRBCvGSSGR− 2.vRBCvOX (A.6.85)
gshRBCi′(t) = 2.vRBCivGSSGR− 2.vRBCivOX (A.6.86)
gssgRBC′(t) = 1.vRBCvOX− 1.vRBCvGSSGR (A.6.87)
gssgRBCi′(t) = 1.vRBCivOX− 1.vRBCivGSSGR (A.6.88)
127
Stellenbosch University  https://scholar.sun.ac.za
hbRBC′(t) = −1.vRBCvHBADP− 1.vRBCvHBATP− 1.vRBCvHBB13PG
− 1.vRBCvHBB23PG− 1.vRBCvHBMGATP (A.6.89)
hbRBCi′(t) = −1.vRBCivHBADP− 1.vRBCivHBATP− 1.vRBCivHBB13PG
− 1.vRBCivHBB23PG− 1.vRBCivHBMGATP (A.6.90)
hbadpRBC′(t) = 1.vRBCvHBADP (A.6.91)
hbadpRBCi′(t) = 1.vRBCivHBADP (A.6.92)
hbatpRBC′(t) = 1.vRBCvHBATP (A.6.93)
hbatpRBCi′(t) = 1.vRBCivHBATP (A.6.94)
hbb13pgRBC′(t) = 1.vRBCvHBB13PG (A.6.95)
hbb13pgRBCi′(t) = 1.vRBCivHBB13PG (A.6.96)
hbb23pgRBC′(t) = 1.vRBCvHBB23PG (A.6.97)
hbb23pgRBCi′(t) = 1.vRBCivHBB23PG (A.6.98)
hbmgatpRBC′(t) = 1.vRBCvHBMGATP (A.6.99)
hbmgatpRBCi′(t) = 1.vRBCivHBMGATP (A.6.100)
ket′(t) = 1.v_L19− 1.v_tL3 (A.6.101)
lac′(t) = 1.v_L5f − 1.v_L5r + 1.v_tL2 (A.6.102)
lacPF′(t) = 1.vPFvLDH− 1.vPFvLACtr (A.6.103)
lacRBC′(t) = −1.vRBCvLACTRANSPORT + 1.vRBCvLDH + 1.vRBCvLDHP (A.6.104)
lacRBCi′(t) = 1.vPFvLACtr− 1.vRBCivLACTRANSPORT + 1.vRBCivLDH + 1.vRBCivLDHP (A.6.105)
malate′(t) = 1.v_L10 + 1.v_L11f − 1.v_L11r− 1.v_L12 (A.6.106)
malonyl′(t) = 1.v_L15− 7.v_L16 (A.6.107)
mgRBC′(t) = −1.vRBCvMGADP− 1.vRBCvMGATP− 1.vRBCvMGB13PG
− 1.vRBCvMGB23PG− 1.vRBCvMGF16P2− 1.vRBCvMGG16P2
− 1.vRBCvMGPHOS (A.6.108)
mgRBCi′(t) = −1.vRBCivMGADP− 1.vRBCivMGATP− 1.vRBCivMGB13PG
− 1.vRBCivMGB23PG− 1.vRBCivMGF16P2− 1.vRBCivMGG16P2
− 1.vRBCivMGPHOS (A.6.109)
mgadpRBC′(t) = −1.vRBCvAK + 1.vRBCvATPASE + 1.vRBCvHK + 1.vRBCvMGADP
+ 1.vRBCvPFK− 1.vRBCvPGK− 1.vRBCvPK (A.6.110)
mgadpRBCi′(t) = −1.vRBCivAK + 1.vRBCivATPASE + 1.vRBCivHK + 1.vRBCivMGADP
+ 1.vRBCivPFK− 1.vRBCivPGK− 1.vRBCivPK (A.6.111)
mgatpRBC′(t) = 1.vRBCvAK− 1.vRBCvATPASE− 1.vRBCvHBMGATP
− 1.vRBCvHK + 1.vRBCvMGATP− 1.vRBCvPFK + 1.vRBCvPGK
+ 1.vRBCvPK (A.6.112)
mgatpRBCi′(t) = 1.vRBCivAK− 1.vRBCivATPASE− 1.vRBCivHBMGATP
− 1.vRBCivHK + 1.vRBCivMGATP− 1.vRBCivPFK + 1.vRBCivPGK
+ 1.vRBCivPK (A.6.113)
mgb13pgRBC′(t) = 1.vRBCvMGB13PG (A.6.114)
mgb13pgRBCi′(t) = 1.vRBCivMGB13PG (A.6.115)
mgb23pgRBC′(t) = 1.vRBCvMGB23PG (A.6.116)
mgb23pgRBCi′(t) = 1.vRBCivMGB23PG (A.6.117)
mgf16p2RBC′(t) = 1.vRBCvMGF16P2 (A.6.118)
mgf16p2RBCi′(t) = 1.vRBCivMGF16P2 (A.6.119)
mgg16p2RBC′(t) = 1.vRBCvMGG16P2 (A.6.120)
mgg16p2RBCi′(t) = 1.vRBCivMGG16P2 (A.6.121)
mgphosRBC′(t) = 1.vRBCvMGPHOS (A.6.122)
mgphosRBCi′(t) = 1.vRBCivMGPHOS (A.6.123)
nadPF′(t) = 1.vPFvG3PDH− 1.vPFvGAPDH + 1.vPFvLDH (A.6.124)
nadRBC′(t) = −1.vRBCvGAPDH + 1.vRBCvLDH + 1.vRBCvOXNADH (A.6.125)
nadRBCi′(t) = −1.vRBCivGAPDH + 1.vRBCivLDH + 1.vRBCivOXNADH (A.6.126)
nadhPF′(t) = −1.vPFvG3PDH + 1.vPFvGAPDH− 1.vPFvLDH (A.6.127)
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nadhRBC′(t) = 1.vRBCvGAPDH− 1.vRBCvLDH− 1.vRBCvOXNADH (A.6.128)
nadhRBCi′(t) = 1.vRBCivGAPDH− 1.vRBCivLDH− 1.vRBCivOXNADH (A.6.129)
nadpRBC′(t) = −1.vRBCvG6PDH + 1.vRBCvGSSGR + 1.vRBCvLDHP− 1.vRBCvP6GDH (A.6.130)
nadpRBCi′(t) = −1.vRBCivG6PDH + 1.vRBCivGSSGR + 1.vRBCivLDHP− 1.vRBCivP6GDH (A.6.131)
nadphRBC′(t) = 1.vRBCvG6PDH− 1.vRBCvGSSGR− 1.vRBCvLDHP + 1.vRBCvP6GDH (A.6.132)
nadphRBCi′(t) = 1.vRBCivG6PDH− 1.vRBCivGSSGR− 1.vRBCivLDHP + 1.vRBCivP6GDH (A.6.133)
oa_c′(t) = 1.v_L12− 1.v_L13 + 1.v_L14 (A.6.134)
oa_m′(t) = −1.v_L11f + 1.v_L11r + 1.v_L6− 1.v_L8 (A.6.135)
p2gPF′(t) = 1.vPFvPGM− 1.vPFvENO (A.6.136)
p2gRBC′(t) = −1.vRBCvBPGSP4− 1.vRBCvENO + 1.vRBCvPGM (A.6.137)
p2gRBCi′(t) = −1.vRBCivBPGSP4− 1.vRBCivENO + 1.vRBCivPGM (A.6.138)
p3gPF′(t) = 1.vPFvPGK− 1.vPFvPGM (A.6.139)
p3gRBC′(t) = 1.vRBCvBPGSP2− 1.vRBCvBPGSP3 + 1.vRBCvPGK− 1.vRBCvPGM (A.6.140)
p3gRBCi′(t) = 1.vRBCivBPGSP2− 1.vRBCivBPGSP3 + 1.vRBCivPGK− 1.vRBCivPGM (A.6.141)
p6gRBC′(t) = 1.vRBCvPGLHYDROLYSIS− 1.vRBCvP6GDH (A.6.142)
p6gRBCi′(t) = 1.vRBCivPGLHYDROLYSIS− 1.vRBCivP6GDH (A.6.143)
p6glRBC′(t) = 1.vRBCvG6PDH− 1.vRBCvPGLHYDROLYSIS (A.6.144)
p6glRBCi′(t) = 1.vRBCivG6PDH− 1.vRBCivPGLHYDROLYSIS (A.6.145)
palm′(t) = 1.v_L16− 1.v_L17 + 1.v_tL5 (A.6.146)
palmCoA′(t) = 1.v_L17− 1.v_L18 (A.6.147)
pep′(t) = 1.v_L13 + 2.v_L3f − 2.v_L3r− 1.v_L4 (A.6.148)
pepPF′(t) = 1.vPFvENO− 1.vPFvPK (A.6.149)
pepRBC′(t) = 1.vRBCvENO− 1.vRBCvPK (A.6.150)
pepRBCi′(t) = 1.vRBCivENO− 1.vRBCivPK (A.6.151)
phosRBC′(t) = 1.vRBCvATPASE− 1.vRBCvBPGSP8 + 2.vRBCvBPGSP9− 1.vRBCvGAPDH
− 1.vRBCvMGPHOS− 1.vRBCvPHOSTRANSPORT (A.6.152)
phosRBCi′(t) = 1.vRBCivATPASE− 1.vRBCivBPGSP8 + 2.vRBCivBPGSP9− 1.vRBCivGAPDH
− 1.vRBCivMGPHOS− 1.vRBCivPHOSTRANSPORT (A.6.153)
pyr′(t) = 1.v_L20− 1.v_L21f + 1.v_L21r + 1.v_L4− 1.v_L5f + 1.v_L5r− 1.v_L6
− 1.v_L7 (A.6.154)
pyrPF′(t) = −1.vPFvLDH + 1.vPFvPK− 1.vPFvPYRtr (A.6.155)
pyrRBC′(t) = −1.vRBCvLDH− 1.vRBCvLDHP + 1.vRBCvPK− 1.vRBCvPYRTRANSPORT (A.6.156)
pyrRBCi′(t) = 1.vPFvPYRtr− 1.vRBCivLDH− 1.vRBCivLDHP + 1.vRBCivPK
− 1.vRBCivPYRTRANSPORT (A.6.157)
rib5pRBC′(t) = 1.vRBCvR5PI− 1.vRBCvTK3 (A.6.158)
rib5pRBCi′(t) = 1.vRBCivR5PI− 1.vRBCivTK3 (A.6.159)
ru5pRBC′(t) = 1.vRBCvP6GDH− 1.vRBCvR5PI− 1.vRBCvRu5PE (A.6.160)
ru5pRBCi′(t) = 1.vRBCivP6GDH− 1.vRBCivR5PI− 1.vRBCivRu5PE (A.6.161)
sed7pRBC′(t) = 1.vRBCvTK4− 1.vRBCvTA (A.6.162)
sed7pRBCi′(t) = 1.vRBCivTK4− 1.vRBCivTA (A.6.163)
tkRBC′(t) = −1.vRBCvTK1 + 1.vRBCvTK4 + 1.vRBCvTK6 (A.6.164)
tkRBCi′(t) = −1.vRBCivTK1 + 1.vRBCivTK4 + 1.vRBCivTK6 (A.6.165)
tkgRBC′(t) = 1.vRBCvTK2− 1.vRBCvTK3− 1.vRBCvTK5 (A.6.166)
tkgRBCi′(t) = 1.vRBCivTK2− 1.vRBCivTK3− 1.vRBCivTK5 (A.6.167)
tkgery4pRBC′(t) = 1.vRBCvTK5− 1.vRBCvTK6 (A.6.168)
tkgery4pRBCi′(t) = 1.vRBCivTK5− 1.vRBCivTK6 (A.6.169)
tkgrib5pRBC′(t) = 1.vRBCvTK3− 1.vRBCvTK4 (A.6.170)
tkgrib5pRBCi′(t) = 1.vRBCivTK3− 1.vRBCivTK4 (A.6.171)
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tkxu5pRBC′(t) = 1.vRBCvTK1− 1.vRBCvTK2 (A.6.172)
tkxu5pRBCi′(t) = 1.vRBCivTK1− 1.vRBCivTK2 (A.6.173)
xu5pRBC′(t) = 1.vRBCvRu5PE− 1.vRBCvTK1 (A.6.174)
xu5pRBCi′(t) = 1.vRBCivRu5PE− 1.vRBCivTK1 (A.6.175)
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Appendix B
Publication
The paper in this Appendix has been accepted for publication in the Biochemical
Society Transactions journal.
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Abstract
We propose a hierarchical modelling approach to construct models for disease states at the whole-body
level. Such models can simulate effects of drug-induced inhibition of reaction steps on the whole-body
physiology. We illustrate the approach for glucose metabolism in malaria patients, by merging two detailed
kinetic models for glucose metabolism in the parasite Plasmodium falciparum and the human red blood
cell with a coarse-grained model for whole-body glucose metabolism. In addition we use a genome-scale
metabolic model for the parasite to predict amino acid production proﬁles by the malaria parasite that can
be used as a complex biomarker.
Multi-scale hierarchical modelling of
disease states
Diseases manifest as phenotypic changes in whole-body
physiology that are experienced as illness and can be caused
by external factors (e.g. infectious diseases caused by bacteria)
or by internal dysfunction (e.g. type II diabetes, cancer).
Medical treatment of a disease can be in the form of
medication, such as a pharmaceutical drug that affects specific
reactions in target cells. In the case of a so-called ‘magic
bullet’ drug, displaying complete specificity and complete
inhibition of an essential reaction in a parasite or diseased
cell, the outcome of the drug effect is direct and simple to
predict and no detailed analysis is required. However, most
drugs affect more than one reaction step, do not lead to
complete inhibition and have side effects [1]. The response
to such a drug is more complicated and a quantitative analysis
of the combined effects on the whole-body physiology is
necessary to evaluate the treatment. Analysis of whole-body
responses to partial inhibition of one or more reaction steps
is challenging; typically, mathematical models at the whole-
body level are not fine-grained and do not include individual
chemical reaction steps. We propose a hierarchical approach
where parts of a system are resolved with sufficient detail to
analyse drug effects at the individual reaction step, whereas
for other parts of the system coarse-grained models are used.
This approach is illustrated with a multi-scale hierarchical
model for glucose metabolism in malaria patients (Figure 1).
Key words: glucose metabolism, malaria, multi-scale hierarchical model, Plasmodium
falciparum.
1 To whom correspondence should be addressed (email jls@sun.ac.za).
From diagnosis to drug
Medical treatment usually starts with a diagnosis and
classification of a disease. Typically these are initially made
on the basis of simple phenotypic descriptions. Relating these
symptoms to amechanistic interpretation of the disease is not
a trivial task and will involve a systems based approach [2],
especially when multiple molecular aetiologies with patient-
dependent contributions are involved. Biomarkers play an
important role in such a diagnosis and are likely to be found
at the metabolomics level [3]. A mechanistic, systems level
interpretation of a disease could point to multiple drug
targets, moving away from the single drug single target
paradigm [4]. Such systems approaches to pharmacology
[5] and toxicology [6] could lead to more effective drug
development strategies [7].
Genome-scale network analysis of
metabolism
Metabolomics andmetabolicmodelling are important tools in
following and predicting disease progress and understanding
drug efficacy and mode of action [3,8]. In the last decade,
enormous progress has been made in the genome-scale
analysis of metabolic networks for a large number of
species ranging from bacteria (e.g. E. coli [9]), to eukaryotes
(e.g. S. cerevisiae [10]) to humans [11,12] and includes
important human pathogens (e.g. Haemophilus influenzae
[13], Mycobacterium tuberculosis [14] and Plasmodium
falciparum [15–18]). These networks are very large, up to
several thousands of reactions and the analyses are restricted
to topological and constraint based modelling techniques,
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Figure 1 Hierarchical multi-scale model for malaria patients
The whole-body model consists of several modules at the organ level, each described with input-output functions. The red
blood cell compartment is modelled at the cellular and detailed metabolic level, including P. falciparum metabolism.
such as flux balance analysis [19,20]. Such models have
been very useful for calculating metabolic phenotypes [21],
such as the prediction of changes in metabolite biomarkers
for inborn errors of metabolism [12] or, for instance, in
analysing medium composition requirements for bacterial
growth [22]. The models are typically analysed for steady
state conditions and optimization criteria (e.g. growth rate)
are used to minimize the solution space. Choosing suitable
constraints on exchange reactions, biomass composition and
maintenance reactions can have important effects on model
predictions and should be done carefully.
Why study metabolism in malaria
patients?
Malaria is a dreaded disease that is widespread across tropical
and sub-tropical regions and responsible for the death of
between 500000 and 1000000 people per year,mostly children
in sub-Saharan countries. One might not immediately think
of malaria as a metabolic disease; the classic symptom of
48-h cyclical fever attacks and diagnosis via blood smears has
no relation to metabolism. However, the key-diagnostics for
poor chances of survival, lactic acidosis and hypoglycaemia
[23] are clearly linked to metabolism. In addition, in malaria
patients, blood concentrations of glycerol [24] and alanine
are increased and arginine concentration is decreased [25],
indicating more general metabolic changes [26].
To what extent can these metabolic changes be related
to metabolic activity of the parasite? Plasmodium cannot
synthesize its own amino acids and is dependent on the
host’s haemoglobin for protein biosynthesis and on the host’s
glucose for its free energy production. As such, the metabolic
activity of the parasite has a direct effect on the host, but, in
addition, the parasites cause indirect damage by lysis of red
C©2015 Authors; published by Portland Press Limited 133
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blood cells and sequestration of parasitized red blood cells in
the vasculature leading to reduced blood perfusion [27].
Although the pathophysiologyused to be attributed to two
main syndromes, cerebralmalaria and severe anaemiamalaria,
it has become clear that severe malaria is complicated and
involves several syndromes [27–29]. Ultimately, the goal is to
delineate the individual contributions of these syndromes to
the pathophysiology ofmalaria. Such an analysis would point
at the best points of intervention to relieve the burden of the
disease. In an attempt to estimate the direct contribution of
Plasmodium activity we set out to analyse its amino acid and
carbohydrate metabolism.
Plasmodium biomass production from
haemoglobin
The genome of P. falciparum was sequenced in 2002
and several genome-scale metabolic maps have been
reconstructed [30]. Plasmodium is severely limited in its
biosynthetic reactions and is largely dependent on the host’s
supply of amino acids for protein synthesis, for which the
parasite degrades almost all haemoglobin in the red blood
cell during its 48-h growth cycle. The specific condition
of Plasmodium growing in the red blood cell and using
the available haemoglobin for protein synthesis, leads to
an elegant set of constraints that can be used in a genome-
scale analysis. We used an existing genome-scale model [18]
with a set rate of haemoglobin consumption (assuming a
75% consumption of total haemoglobin in 48-h [31]) and
optimized for biomass production, only allowing uptake of
the amino acids isoleucine and arginine. Isoleucine is not
present in haemoglobin andmust be taken up from the blood.
P. falciparum is known to convert arginine to ornithine [32],
leading to hypoargininaemia [25]. Under these conditions,
a specific growth rate of 0.049 h− 1 was calculated for P.
falciparum, which is close to the expected value of 0.058 h− 1
(calculated on the basis of 16 merozoites formed in 48-h).
A glucose consumption rate of 1.6 mmol·h− 1·gDW− 1 was
obtained which is somewhat lower than the experimentally
measured value of 2.1 mmol·h− 1·gDW− 1 [33].
The complete set of reactions for the genome-scale
network is shown in Figure 2(A), where the red lines
indicate the fluxes through the reactions. In Figure 2(B),
a subset of reactions involved in amino acid metabolism is
shown. These reactions fall in three classes: (1) degradation
of haemoglobin, (2) the synthesis of biomass and (3) export
and inter-conversion of amino acids. The export fluxes for
the amino acids are indicated in Figure 2(C).
The relative amino acidproduction rates comparewellwith
rates observed in P. falciparum culture [32]. Note that the
arginine to ornithine conversion was part of the objective
and is therefore not a validation for the model. One cannot
immediately compare these amino acid product formation
rates to changes in blood amino acid concentrations inmalaria
patients since these concentrations are also dependent on the
consumption rates in the body. However, the high capacity
of the network to consume arginine and the high alanine
production rates are in good agreement with the observed
hypoargininaemia and high alanine blood concentrations
in malaria patients. Interestingly, a high alanine blood
concentration in malaria patients is usually attributed to a
reduced alanine to glucose conversion in the liver [26], but
our network analysis shows that a high alanine production
by Plasmodium could contribute to this symptom. For an
accurate prediction of blood concentration changes of amino
acids a full body implementation of a model is required.
However, high production rates (e.g. alanine) or consumption
rates (e.g. arginine) due to Plasmodium activity can point to
potential metabolic biomarkers for malaria progression. In
addition, one can simulate the effect of a drug by setting
a constraint on a metabolic flux in the network. If such
an inhibition is complete then the network analysis can be
accurate and the effect is dependent on whether the inhibited
step is essential or not. If the inhibition is not complete, which
is the likely scenario, it is better to analyse the effect in a
kinetic model.
Kinetic modelling of Plasmodium glucose
metabolism in malaria patients
Currently no detailed kinetic models exist for genome-
scale networks, mostly due to limited kinetic informa-
tion. Kinetic models do exist for smaller systems, such
as central carbon metabolism and in a more coarse-
grained form for organ and organism level metabolism.
To analyse the effect of increased glycolytic activity of
Plasmodium infected red blood cells in malaria patients,
we merged three existing kinetic models: a detailed
kinetic model for glycolysis of P. falciparum [34], a
detailed kinetic model for central carbon metabolism of the
red blood cell [35–37] and a coarse grained kinetic model
for whole-body glucose metabolism [38]. The models were
obtained from the JWSOnline [39] andBiomodels [40]model
repositories, corrected for units and shared-variable-names
inconsistencies and integrated. No adaptations were made to
the P. falciparum and red blood cell model and for the whole-
body model only the fixed metabolites alanine and non-
esterified fatty acids were changed. A detailed description
of the merged model will be published elsewhere (K. Green,
D.C. Palm, F. du Toit and D.D. van Niekerk and Snoep,
manuscript in preparation).
Figure 3(A) shows a schema for the combined model
with the compartmentalized whole-body model and the
added Plasmodium infected red blood model. A simulation
of the effect of increased parasitaemia on blood glucose
concentration is given in Figure 3(B), together with patient
data (and rat model data) obtained from the literature.
The patient data show a lot of scatter, which is indicative
of large intermittent variance (no longitudinal data for a
patient followed over time was available). Most papers make
reference to hypoglycaemia in severe malaria patients, but
then donot report both parasitaemia and blood glucose levels.
The model prediction does simulate the reference state and
the few patient data with hypoglycaemia, for which data were
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Figure 2 P. falciparum genome-scale network analysis
The steady state solution space for the genome-scale metabolic network for P. falciparum [18] with a set inﬂux rate of
0.83 μmol haemoglobin·h− 1·gDW− 1 was optimized for biomass formation and ornithine production. Fluxes are indicated in
red on the complete network structure in (A). A subset of reactions for amino acid metabolism, indicating the haemoglobin
degradation, biomass formation and the amino acid inter-conversion and export are indicated in (B). The export ﬂuxes of
the different amino acids are indicated in (C).
available, quite well. Similarly, the lactate data for malaria
patients shows a lot of scatter (Figure 3C) and much more
consistent data for the longitudinal rat study was obtained.
The model prediction of lactate is low for the reference
state but seems to follow the trend of lactate increase (and
the rat data) reasonably well. In Figure 3(D), the results of
an inhibition of the glucose transporter (to 50% of non-
inhibited lactate flux) in P. falciparum are simulated.
Discussion and conclusion
To understand the pathophysiology of complex diseases,
whole-body mathematical models can be strong tools to
integrate and analyse the numerous effects that lead to
the disease state. Specifically, when personal parameters
can be added to such a model, they can be instrumental
in choosing a correct treatment. Currently only very few
molecularly informed models exist for the whole-body level
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Figure 3 Modelling glucose and lactate metabolism in malaria patients
(A) kinetic model for whole-body glucose metabolism [38] was merged with two detailed kinetic models for glucose
metabolism in P. falciparum [34] and the red blood cell [35–37] (A). The effect of increasing levels of parasitaemia on
steady state blood glucose and lactate concentrations was analysed and shown in (B and C) respectively, together with
concentrations measured in malaria patients (black symbols, calculated from [41–52]) and rat data (red symbols, calculated
from [53]). The shaded boxes indicate the severe malaria (> 5% parasitaemia) and hypoglycaemia (<2 mM glucose, B)
and lactic acidosis (>5 mM lactate, C) areas. (D) The effect of inhibition of the glucose transport step (starting at t = 50 min,
resulting in 50% reduction in glycolytic ﬂux in the parasite) on blood glucose and lactate concentrations in a malaria patient
(5% parasitaemia) was simulated.
that are detailed enough to be useful in medical applications
(e.g. http://www.entelos.com). Specifically for the simulation
of pharmacological drug effects on the disease state there
is a big challenge in terms of modelling at the correct
level of detail. To simulate the drug effect at the reaction
step, a high level of detail is needed at the drug target
level, which cannot be sustained up to the whole-body
level.
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In the present paper, we illustrated how a hierarchical
model, with a high level of detail at the drug target site and
more coarse-grained for the whole-body level, can be used
to simulate the effect of a pharmaceutical drug on blood
glucose concentration. Clearly, the model is still in a very
rudimentary stage; we only simulate the direct metabolic
effect of parasite activity and have ignored any effects on
blood perfusion or reduced red blood cell contents due to
cell lysis or any of the large number of secondary effects
caused by the malaria parasites. In addition, we simulated
the drug effect by simply assuming a constant inhibitor
concentration in the blood, a much more realistic simulation
would have to include a full PK/PD (pharmacokinetics/
pharmacodynamics) model to evaluate the drug efficacy
[5,54].
The aim tomechanistically simulate drug effects (inhibiting
a specific target reaction) at the whole-body level (physiolo-
gical disease state) is very ambitious. However, we feel the
time is right for this. Some large-scale projects have existed
for quite some time and produced detailed kinetic models at
the organ level that can be extended to the whole-body level
(e.g. the physiome project, http://physiomeproject.org [55];
the virtual liver, http://www.virtual-liver.de [56]). In addition,
a much stronger adherence to modelling standards, such as
description in standard formats [systems biology markup
language (SBML) and CellML)] and storage in curated model
databases (JWS Online, Biomodels and CellML), makes
model reuse much easier. For our initial model construction,
we merged three existing models and this enabled us to make
some preliminary simulations at different hierarchical levels.
Of course, one cannot simple merge all existing models; they
must be compatible and constructed for similar physiological
conditions [57]. After merging of existing models, one can
start a number of iterative cycles to improve the integral
model and adapt it to specific disease states.
With the present concept paper, we hope to have illustrated
the approach we follow towards whole-body modelling of
blood glucose and lactate metabolism in malaria patients.
Clearly,muchwork is still needed and especially at thewhole-
body level the model needs to be validated more thoroughly.
For this, we will first work in a rat model system for which
it is much easier to obtain longitudinal data. Although the
specific model for malaria patients is still very preliminary,
the suggested approach of a hierarchical model structure
with a high level of detail at the drug target level and more
coarse-grainedmodels at the whole-body physiological level,
is generic and could be applied to other complex metabolic
diseases such as type II diabetes.
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